Gene_Function_Set,Total_Number_Gene_Set,Number_Genes_Overlap,Number_Expected_Overlap,over_or_under,Fold_enrichment,Raw_P_value,FDR,Method,Number_of_Groups,Direction_of_Expression_Change,Region_of_Change,TABI_test_type
"phagocytosis, recognition (GO:0006910)",106,33,6.33,+,5.21,1.19E-12,1.05E-09,Linear_Group,3,Decrease,Early,NA
"complement activation, classical pathway (GO:0006958)",161,50,9.62,+,5.20,2.04E-18,3.60E-15,Linear_Group,3,Decrease,Early,NA
regulation of natural killer cell mediated cytotoxicity (GO:0042269),39,12,2.33,+,5.15,2.00E-05,3.39E-03,Linear_Group,3,Decrease,Early,NA
humoral immune response mediated by circulating immunoglobulin (GO:0002455),167,51,9.98,+,5.11,1.67E-18,3.33E-15,Linear_Group,3,Decrease,Early,NA
complement activation (GO:0006956),176,52,10.52,+,4.94,2.53E-18,4.02E-15,Linear_Group,3,Decrease,Early,NA
immunoglobulin production (GO:0002377),155,44,9.26,+,4.75,3.45E-15,3.66E-12,Linear_Group,3,Decrease,Early,NA
regulation of natural killer cell mediated immunity (GO:0002715),43,12,2.57,+,4.67,4.49E-05,7.16E-03,Linear_Group,3,Decrease,Early,NA
B cell receptor signaling pathway (GO:0050853),128,35,7.65,+,4.58,5.60E-12,3.71E-09,Linear_Group,3,Decrease,Early,NA
antibacterial humoral response (GO:0019731),45,12,2.69,+,4.46,6.52E-05,9.71E-03,Linear_Group,3,Decrease,Early,NA
B cell mediated immunity (GO:0019724),208,55,12.43,+,4.42,1.71E-17,2.27E-14,Linear_Group,3,Decrease,Early,NA
"phagocytosis, engulfment (GO:0006911)",129,34,7.71,+,4.41,2.62E-11,1.49E-08,Linear_Group,3,Decrease,Early,NA
immunoglobulin mediated immune response (GO:0016064),205,54,12.25,+,4.41,3.87E-17,4.75E-14,Linear_Group,3,Decrease,Early,NA
regulation of leukocyte mediated cytotoxicity (GO:0001910),76,20,4.54,+,4.40,3.23E-07,9.35E-05,Linear_Group,3,Decrease,Early,NA
production of molecular mediator of immune response (GO:0002440),179,47,10.70,+,4.39,4.78E-15,4.76E-12,Linear_Group,3,Decrease,Early,NA
positive regulation of leukocyte mediated cytotoxicity (GO:0001912),54,14,3.23,+,4.34,2.14E-05,3.59E-03,Linear_Group,3,Decrease,Early,NA
plasma membrane invagination (GO:0099024),138,35,8.25,+,4.24,3.32E-11,1.83E-08,Linear_Group,3,Decrease,Early,NA
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),270,68,16.13,+,4.21,2.34E-20,7.45E-17,Linear_Group,3,Decrease,Early,NA
lymphocyte mediated immunity (GO:0002449),263,66,15.72,+,4.20,1.00E-19,2.66E-16,Linear_Group,3,Decrease,Early,NA
regulation of complement activation (GO:0030449),117,29,6.99,+,4.15,2.49E-09,1.04E-06,Linear_Group,3,Decrease,Early,NA
defense response to fungus (GO:0050832),45,11,2.69,+,4.09,2.50E-04,3.09E-02,Linear_Group,3,Decrease,Early,NA
membrane invagination (GO:0010324),145,35,8.66,+,4.04,1.06E-10,5.63E-08,Linear_Group,3,Decrease,Early,NA
regulation of cell killing (GO:0031341),96,23,5.74,+,4.01,1.84E-07,5.63E-05,Linear_Group,3,Decrease,Early,NA
positive regulation of cell killing (GO:0031343),66,15,3.94,+,3.80,4.13E-05,6.64E-03,Linear_Group,3,Decrease,Early,NA
humoral immune response (GO:0006959),372,83,22.23,+,3.73,1.09E-21,8.65E-18,Linear_Group,3,Decrease,Early,NA
regulation of humoral immune response (GO:0002920),136,30,8.13,+,3.69,1.34E-08,4.45E-06,Linear_Group,3,Decrease,Early,NA
positive regulation of B cell activation (GO:0050871),169,37,10.10,+,3.66,3.37E-10,1.63E-07,Linear_Group,3,Decrease,Early,NA
immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002433),135,27,8.07,+,3.35,3.88E-07,1.09E-04,Linear_Group,3,Decrease,Early,NA
Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),135,27,8.07,+,3.35,3.88E-07,1.07E-04,Linear_Group,3,Decrease,Early,NA
Fc receptor mediated stimulatory signaling pathway (GO:0002431),137,27,8.19,+,3.30,5.00E-07,1.35E-04,Linear_Group,3,Decrease,Early,NA
Fc-gamma receptor signaling pathway (GO:0038094),139,27,8.31,+,3.25,6.40E-07,1.59E-04,Linear_Group,3,Decrease,Early,NA
defense response to bacterium (GO:0042742),336,64,20.08,+,3.19,3.60E-14,3.38E-11,Linear_Group,3,Decrease,Early,NA
regulation of B cell activation (GO:0050864),213,39,12.73,+,3.06,9.45E-09,3.34E-06,Linear_Group,3,Decrease,Early,NA
antimicrobial humoral response (GO:0019730),142,26,8.49,+,3.06,2.68E-06,5.48E-04,Linear_Group,3,Decrease,Early,NA
adaptive immune response (GO:0002250),613,109,36.63,+,2.98,2.46E-21,1.31E-17,Linear_Group,3,Decrease,Early,NA
cell recognition (GO:0008037),232,41,13.86,+,2.96,9.66E-09,3.34E-06,Linear_Group,3,Decrease,Early,NA
phagocytosis (GO:0006909),325,57,19.42,+,2.93,1.67E-11,9.88E-09,Linear_Group,3,Decrease,Early,NA
leukocyte mediated immunity (GO:0002443),760,124,45.42,+,2.73,3.28E-21,1.31E-17,Linear_Group,3,Decrease,Early,NA
antigen receptor-mediated signaling pathway (GO:0050851),296,48,17.69,+,2.71,8.14E-09,2.95E-06,Linear_Group,3,Decrease,Early,NA
immune response-activating cell surface receptor signaling pathway (GO:0002429),448,72,26.77,+,2.69,1.53E-12,1.28E-09,Linear_Group,3,Decrease,Early,NA
immune response-regulating cell surface receptor signaling pathway (GO:0002768),483,74,28.86,+,2.56,9.25E-12,5.67E-09,Linear_Group,3,Decrease,Early,NA
leukocyte migration (GO:0050900),372,56,22.23,+,2.52,4.18E-09,1.63E-06,Linear_Group,3,Decrease,Early,NA
regulation of lymphocyte mediated immunity (GO:0002706),153,23,9.14,+,2.52,1.84E-04,2.46E-02,Linear_Group,3,Decrease,Early,NA
immune response-activating signal transduction (GO:0002757),549,82,32.81,+,2.50,2.01E-12,1.52E-09,Linear_Group,3,Decrease,Early,NA
receptor-mediated endocytosis (GO:0006898),239,35,14.28,+,2.45,7.37E-06,1.28E-03,Linear_Group,3,Decrease,Early,NA
immune response-regulating signaling pathway (GO:0002764),586,85,35.02,+,2.43,2.81E-12,2.03E-09,Linear_Group,3,Decrease,Early,NA
Fc-epsilon receptor signaling pathway (GO:0038095),173,25,10.34,+,2.42,1.46E-04,2.03E-02,Linear_Group,3,Decrease,Early,NA
regulation of immune effector process (GO:0002697),468,66,27.97,+,2.36,1.85E-09,8.17E-07,Linear_Group,3,Decrease,Early,NA
activation of immune response (GO:0002253),619,87,36.99,+,2.35,5.93E-12,3.78E-09,Linear_Group,3,Decrease,Early,NA
immune effector process (GO:0002252),1080,149,64.54,+,2.31,2.71E-19,6.16E-16,Linear_Group,3,Decrease,Early,NA
regulation of leukocyte mediated immunity (GO:0002703),205,28,12.25,+,2.29,1.52E-04,2.08E-02,Linear_Group,3,Decrease,Early,NA
carbohydrate derivative catabolic process (GO:1901136),191,26,11.41,+,2.28,2.83E-04,3.44E-02,Linear_Group,3,Decrease,Early,NA
positive regulation of lymphocyte activation (GO:0051251),367,49,21.93,+,2.23,1.41E-06,3.31E-04,Linear_Group,3,Decrease,Early,NA
endocytosis (GO:0006897),547,72,32.69,+,2.20,5.05E-09,1.91E-06,Linear_Group,3,Decrease,Early,NA
positive regulation of immune response (GO:0050778),847,108,50.61,+,2.13,4.03E-12,2.79E-09,Linear_Group,3,Decrease,Early,NA
immune response (GO:0006955),1869,236,111.69,+,2.11,1.04E-25,1.65E-21,Linear_Group,3,Decrease,Early,NA
import into cell (GO:0098657),668,84,39.92,+,2.10,2.33E-09,1.00E-06,Linear_Group,3,Decrease,Early,NA
innate immune response (GO:0045087),774,97,46.25,+,2.10,1.53E-10,7.62E-08,Linear_Group,3,Decrease,Early,NA
positive regulation of cell activation (GO:0050867),423,53,25.28,+,2.10,2.59E-06,5.57E-04,Linear_Group,3,Decrease,Early,NA
Fc receptor signaling pathway (GO:0038093),240,30,14.34,+,2.09,4.36E-04,4.90E-02,Linear_Group,3,Decrease,Early,NA
positive regulation of leukocyte activation (GO:0002696),409,51,24.44,+,2.09,4.82E-06,8.82E-04,Linear_Group,3,Decrease,Early,NA
granulocyte activation (GO:0036230),499,62,29.82,+,2.08,3.87E-07,1.10E-04,Linear_Group,3,Decrease,Early,NA
defense response to other organism (GO:0098542),962,119,57.49,+,2.07,1.57E-12,1.25E-09,Linear_Group,3,Decrease,Early,NA
neutrophil activation (GO:0042119),495,61,29.58,+,2.06,8.65E-07,2.09E-04,Linear_Group,3,Decrease,Early,NA
defense response (GO:0006952),1352,165,80.79,+,2.04,1.41E-16,1.61E-13,Linear_Group,3,Decrease,Early,NA
neutrophil activation involved in immune response (GO:0002283),486,59,29.04,+,2.03,1.80E-06,4.10E-04,Linear_Group,3,Decrease,Early,NA
neutrophil degranulation (GO:0043312),482,58,28.80,+,2.01,2.65E-06,5.49E-04,Linear_Group,3,Decrease,Early,NA
neutrophil mediated immunity (GO:0002446),493,58,29.46,+,1.97,5.32E-06,9.62E-04,Linear_Group,3,Decrease,Early,NA
leukocyte degranulation (GO:0043299),503,59,30.06,+,1.96,4.31E-06,8.08E-04,Linear_Group,3,Decrease,Early,NA
myeloid leukocyte mediated immunity (GO:0002444),513,60,30.66,+,1.96,3.58E-06,6.79E-04,Linear_Group,3,Decrease,Early,NA
myeloid cell activation involved in immune response (GO:0002275),517,60,30.89,+,1.94,5.60E-06,9.91E-04,Linear_Group,3,Decrease,Early,NA
cell activation involved in immune response (GO:0002263),622,71,37.17,+,1.91,1.38E-06,3.28E-04,Linear_Group,3,Decrease,Early,NA
leukocyte activation involved in immune response (GO:0002366),618,70,36.93,+,1.90,1.95E-06,4.31E-04,Linear_Group,3,Decrease,Early,NA
regulation of lymphocyte activation (GO:0051249),523,59,31.25,+,1.89,1.48E-05,2.53E-03,Linear_Group,3,Decrease,Early,NA
response to bacterium (GO:0009617),704,79,42.07,+,1.88,5.08E-07,1.35E-04,Linear_Group,3,Decrease,Early,NA
myeloid leukocyte activation (GO:0002274),580,65,34.66,+,1.88,5.41E-06,9.69E-04,Linear_Group,3,Decrease,Early,NA
regulation of immune response (GO:0050776),1144,128,68.36,+,1.87,1.10E-10,5.64E-08,Linear_Group,3,Decrease,Early,NA
inflammatory response (GO:0006954),502,56,30.00,+,1.87,3.51E-05,5.76E-03,Linear_Group,3,Decrease,Early,NA
positive regulation of immune system process (GO:0002684),1160,126,69.32,+,1.82,1.03E-09,4.84E-07,Linear_Group,3,Decrease,Early,NA
carbohydrate metabolic process (GO:0005975),479,51,28.62,+,1.78,1.84E-04,2.48E-02,Linear_Group,3,Decrease,Early,NA
response to other organism (GO:0051707),1330,137,79.48,+,1.72,3.60E-09,1.47E-06,Linear_Group,3,Decrease,Early,NA
response to external biotic stimulus (GO:0043207),1332,137,79.60,+,1.72,3.76E-09,1.50E-06,Linear_Group,3,Decrease,Early,NA
leukocyte activation (GO:0045321),915,94,54.68,+,1.72,1.68E-06,3.87E-04,Linear_Group,3,Decrease,Early,NA
regulation of leukocyte activation (GO:0002694),606,62,36.21,+,1.71,1.14E-04,1.61E-02,Linear_Group,3,Decrease,Early,NA
regulation of cell activation (GO:0050865),646,66,38.60,+,1.71,6.73E-05,9.92E-03,Linear_Group,3,Decrease,Early,NA
immune system process (GO:0002376),2807,284,167.74,+,1.69,7.20E-18,1.04E-14,Linear_Group,3,Decrease,Early,NA
response to biotic stimulus (GO:0009607),1356,137,81.03,+,1.69,1.35E-08,4.40E-06,Linear_Group,3,Decrease,Early,NA
regulated exocytosis (GO:0045055),695,69,41.53,+,1.66,1.15E-04,1.60E-02,Linear_Group,3,Decrease,Early,NA
exocytosis (GO:0006887),784,77,46.85,+,1.64,5.92E-05,9.06E-03,Linear_Group,3,Decrease,Early,NA
cell activation (GO:0001775),1062,104,63.46,+,1.64,3.16E-06,6.22E-04,Linear_Group,3,Decrease,Early,NA
regulation of immune system process (GO:0002682),1681,162,100.45,+,1.61,9.92E-09,3.36E-06,Linear_Group,3,Decrease,Early,NA
membrane organization (GO:0061024),858,82,51.27,+,1.60,8.69E-05,1.24E-02,Linear_Group,3,Decrease,Early,NA
vesicle-mediated transport (GO:0016192),1938,185,115.81,+,1.60,1.26E-09,5.74E-07,Linear_Group,3,Decrease,Early,NA
regulation of defense response (GO:0031347),769,73,45.95,+,1.59,2.42E-04,3.01E-02,Linear_Group,3,Decrease,Early,NA
export from cell (GO:0140352),1042,98,62.27,+,1.57,2.98E-05,4.94E-03,Linear_Group,3,Decrease,Early,NA
secretion (GO:0046903),1114,103,66.57,+,1.55,3.92E-05,6.37E-03,Linear_Group,3,Decrease,Early,NA
cell migration (GO:0016477),950,87,56.77,+,1.53,1.88E-04,2.49E-02,Linear_Group,3,Decrease,Early,NA
secretion by cell (GO:0032940),998,91,59.64,+,1.53,1.54E-04,2.09E-02,Linear_Group,3,Decrease,Early,NA
localization of cell (GO:0051674),1066,94,63.70,+,1.48,3.93E-04,4.51E-02,Linear_Group,3,Decrease,Early,NA
cell motility (GO:0048870),1066,94,63.70,+,1.48,3.93E-04,4.47E-02,Linear_Group,3,Decrease,Early,NA
positive regulation of response to stimulus (GO:0048584),2477,217,148.02,+,1.47,3.69E-08,1.18E-05,Linear_Group,3,Decrease,Early,NA
cell surface receptor signaling pathway (GO:0007166),2483,198,148.38,+,1.33,5.61E-05,8.68E-03,Linear_Group,3,Decrease,Early,NA
response to external stimulus (GO:0009605),2449,195,146.35,+,1.33,7.41E-05,1.07E-02,Linear_Group,3,Decrease,Early,NA
response to stress (GO:0006950),3612,282,215.84,+,1.31,3.49E-06,6.71E-04,Linear_Group,3,Decrease,Early,NA
transport (GO:0006810),4535,353,271.00,+,1.30,1.28E-07,3.99E-05,Linear_Group,3,Decrease,Early,NA
multi-organism process (GO:0051704),2842,218,169.83,+,1.28,1.98E-04,2.59E-02,Linear_Group,3,Decrease,Early,NA
establishment of localization (GO:0051234),4665,357,278.77,+,1.28,5.21E-07,1.36E-04,Linear_Group,3,Decrease,Early,NA
regulation of response to stimulus (GO:0048583),4334,331,258.99,+,1.28,2.30E-06,5.01E-04,Linear_Group,3,Decrease,Early,NA
localization (GO:0051179),5768,427,344.68,+,1.24,7.70E-07,1.89E-04,Linear_Group,3,Decrease,Early,NA
response to stimulus (GO:0050896),8534,581,509.97,+,1.14,8.06E-05,1.16E-02,Linear_Group,3,Decrease,Early,NA
regulation of primary metabolic process (GO:0080090),6055,304,361.83,-,.84,3.92E-04,4.53E-02,Linear_Group,3,Decrease,Early,NA
regulation of nitrogen compound metabolic process (GO:0051171),5870,293,350.78,-,.84,3.45E-04,4.10E-02,Linear_Group,3,Decrease,Early,NA
regulation of macromolecule metabolic process (GO:0060255),6183,303,369.48,-,.82,4.70E-05,7.42E-03,Linear_Group,3,Decrease,Early,NA
regulation of cellular biosynthetic process (GO:0031326),4212,195,251.70,-,.77,6.82E-05,9.97E-03,Linear_Group,3,Decrease,Early,NA
regulation of biosynthetic process (GO:0009889),4291,198,256.42,-,.77,4.80E-05,7.50E-03,Linear_Group,3,Decrease,Early,NA
regulation of gene expression (GO:0010468),4483,200,267.89,-,.75,2.84E-06,5.73E-04,Linear_Group,3,Decrease,Early,NA
regulation of cellular macromolecule biosynthetic process (GO:2000112),3931,173,234.91,-,.74,6.61E-06,1.16E-03,Linear_Group,3,Decrease,Early,NA
regulation of macromolecule biosynthetic process (GO:0010556),4068,178,243.09,-,.73,2.99E-06,5.96E-04,Linear_Group,3,Decrease,Early,NA
regulation of nucleobase-containing compound metabolic process (GO:0019219),4062,173,242.73,-,.71,5.36E-07,1.38E-04,Linear_Group,3,Decrease,Early,NA
regulation of nucleic acid-templated transcription (GO:1903506),3544,150,211.78,-,.71,2.61E-06,5.55E-04,Linear_Group,3,Decrease,Early,NA
nucleic acid metabolic process (GO:0090304),2292,97,136.96,-,.71,2.91E-04,3.51E-02,Linear_Group,3,Decrease,Early,NA
"regulation of transcription, DNA-templated (GO:0006355)",3478,147,207.84,-,.71,3.21E-06,6.25E-04,Linear_Group,3,Decrease,Early,NA
regulation of RNA biosynthetic process (GO:2001141),3549,150,212.08,-,.71,2.63E-06,5.50E-04,Linear_Group,3,Decrease,Early,NA
regulation of RNA metabolic process (GO:0051252),3808,158,227.56,-,.69,2.70E-07,8.12E-05,Linear_Group,3,Decrease,Early,NA
gene expression (GO:0010467),2026,83,121.07,-,.69,2.33E-04,2.93E-02,Linear_Group,3,Decrease,Early,NA
regulation of cell cycle (GO:0051726),1243,38,74.28,-,.51,4.72E-06,8.75E-04,Linear_Group,3,Decrease,Early,NA
cell cycle (GO:0007049),1331,39,79.54,-,.49,6.18E-07,1.56E-04,Linear_Group,3,Decrease,Early,NA
regulation of cell cycle process (GO:0010564),763,22,45.59,-,.48,1.95E-04,2.57E-02,Linear_Group,3,Decrease,Early,NA
mRNA metabolic process (GO:0016071),696,20,41.59,-,.48,3.68E-04,4.31E-02,Linear_Group,3,Decrease,Early,NA
mitotic cell cycle process (GO:1903047),614,16,36.69,-,.44,2.17E-04,2.81E-02,Linear_Group,3,Decrease,Early,NA
cell cycle process (GO:0022402),995,24,59.46,-,.40,3.14E-07,9.25E-05,Linear_Group,3,Decrease,Early,NA
chromosome organization (GO:0051276),1053,22,62.92,-,.35,5.71E-09,2.12E-06,Linear_Group,3,Decrease,Early,NA
chromatin organization (GO:0006325),694,14,41.47,-,.34,1.84E-06,4.14E-04,Linear_Group,3,Decrease,Early,NA
covalent chromatin modification (GO:0016569),369,7,22.05,-,.32,4.22E-04,4.77E-02,Linear_Group,3,Decrease,Early,NA
positive regulation of cell cycle (GO:0045787),391,6,23.37,-,.26,6.04E-05,9.16E-03,Linear_Group,3,Decrease,Early,NA
positive regulation of cell cycle process (GO:0090068),294,4,17.57,-,.23,3.21E-04,3.85E-02,Linear_Group,3,Decrease,Early,NA
"mRNA splicing, via spliceosome (GO:0000398)",299,4,17.87,-,.22,2.25E-04,2.90E-02,Linear_Group,3,Decrease,Early,NA
"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",299,4,17.87,-,.22,2.25E-04,2.87E-02,Linear_Group,3,Decrease,Early,NA
"RNA splicing, via transesterification reactions (GO:0000375)",302,4,18.05,-,.22,2.33E-04,2.94E-02,Linear_Group,3,Decrease,Early,NA
protein-containing complex localization (GO:0031503),259,3,15.48,-,.19,3.67E-04,4.32E-02,Linear_Group,3,Decrease,Early,NA
DNA conformation change (GO:0071103),291,3,17.39,-,.17,6.34E-05,9.52E-03,Linear_Group,3,Decrease,Early,NA
regulation of cell size (GO:0008361),187,1,11.17,-,.09,3.70E-04,4.31E-02,Linear_Group,3,Decrease,Early,NA
regulation of microtubule cytoskeleton organization (GO:0070507),197,1,11.77,-,.08,2.62E-04,3.21E-02,Linear_Group,3,Decrease,Early,NA
negative regulation of mitotic metaphase/anaphase transition (GO:0045841),27,13,1.31,+,9.96,1.49E-08,3.44E-06,Linear_Group,3,Increase,Early,NA
mitotic spindle assembly checkpoint (GO:0007094),25,12,1.21,+,9.93,5.51E-08,1.14E-05,Linear_Group,3,Increase,Early,NA
mitotic spindle checkpoint (GO:0071174),25,12,1.21,+,9.93,5.51E-08,1.12E-05,Linear_Group,3,Increase,Early,NA
spindle assembly checkpoint (GO:0071173),25,12,1.21,+,9.93,5.51E-08,1.11E-05,Linear_Group,3,Increase,Early,NA
spindle checkpoint (GO:0031577),25,12,1.21,+,9.93,5.51E-08,1.10E-05,Linear_Group,3,Increase,Early,NA
negative regulation of mitotic sister chromatid separation (GO:2000816),30,14,1.45,+,9.65,5.66E-09,1.64E-06,Linear_Group,3,Increase,Early,NA
negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100),28,13,1.35,+,9.60,2.09E-08,4.75E-06,Linear_Group,3,Increase,Early,NA
negative regulation of chromosome separation (GO:1905819),31,14,1.50,+,9.34,7.86E-09,2.09E-06,Linear_Group,3,Increase,Early,NA
negative regulation of sister chromatid segregation (GO:0033046),35,15,1.69,+,8.87,4.04E-09,1.29E-06,Linear_Group,3,Increase,Early,NA
negative regulation of mitotic sister chromatid segregation (GO:0033048),33,14,1.60,+,8.78,1.48E-08,3.46E-06,Linear_Group,3,Increase,Early,NA
negative regulation of chromosome segregation (GO:0051985),36,15,1.74,+,8.62,5.48E-09,1.62E-06,Linear_Group,3,Increase,Early,NA
mitotic chromosome condensation (GO:0007076),17,7,.82,+,8.52,7.53E-05,7.59E-03,Linear_Group,3,Increase,Early,NA
prophase (GO:0051324),15,6,.73,+,8.27,2.83E-04,2.36E-02,Linear_Group,3,Increase,Early,NA
mitotic prophase (GO:0000088),15,6,.73,+,8.27,2.83E-04,2.35E-02,Linear_Group,3,Increase,Early,NA
kinetochore organization (GO:0051383),18,7,.87,+,8.04,1.00E-04,9.82E-03,Linear_Group,3,Increase,Early,NA
microtubule depolymerization (GO:0007019),17,6,.82,+,7.30,4.86E-04,3.78E-02,Linear_Group,3,Increase,Early,NA
negative regulation of mitotic nuclear division (GO:0045839),43,15,2.08,+,7.22,3.77E-08,8.12E-06,Linear_Group,3,Increase,Early,NA
"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",23,8,1.11,+,7.19,6.08E-05,6.37E-03,Linear_Group,3,Increase,Early,NA
meiotic chromosome separation (GO:0051307),21,7,1.02,+,6.90,2.19E-04,1.89E-02,Linear_Group,3,Increase,Early,NA
attachment of spindle microtubules to kinetochore (GO:0008608),21,7,1.02,+,6.90,2.19E-04,1.88E-02,Linear_Group,3,Increase,Early,NA
negative regulation of nuclear division (GO:0051784),52,17,2.51,+,6.76,1.04E-08,2.56E-06,Linear_Group,3,Increase,Early,NA
regulation of mitotic sister chromatid separation (GO:0010965),63,20,3.05,+,6.57,8.10E-10,3.39E-07,Linear_Group,3,Increase,Early,NA
negative regulation of mRNA processing (GO:0050686),32,10,1.55,+,6.46,1.59E-05,1.93E-03,Linear_Group,3,Increase,Early,NA
mitotic spindle organization (GO:0007052),77,24,3.72,+,6.45,2.29E-11,1.26E-08,Linear_Group,3,Increase,Early,NA
regulation of mitotic metaphase/anaphase transition (GO:0030071),58,18,2.80,+,6.42,7.60E-09,2.05E-06,Linear_Group,3,Increase,Early,NA
regulation of chromosome separation (GO:1905818),68,21,3.29,+,6.39,4.66E-10,2.12E-07,Linear_Group,3,Increase,Early,NA
sister chromatid segregation (GO:0000819),139,42,6.72,+,6.25,1.90E-18,3.37E-15,Linear_Group,3,Increase,Early,NA
mitotic sister chromatid segregation (GO:0000070),106,32,5.12,+,6.24,2.27E-14,1.91E-11,Linear_Group,3,Increase,Early,NA
regulation of metaphase/anaphase transition of cell cycle (GO:1902099),60,18,2.90,+,6.21,1.18E-08,2.81E-06,Linear_Group,3,Increase,Early,NA
mitotic spindle assembly (GO:0090307),37,11,1.79,+,6.15,8.92E-06,1.19E-03,Linear_Group,3,Increase,Early,NA
negative regulation of RNA splicing (GO:0033119),27,8,1.31,+,6.13,1.54E-04,1.43E-02,Linear_Group,3,Increase,Early,NA
microtubule cytoskeleton organization involved in mitosis (GO:1902850),108,31,5.22,+,5.94,1.79E-13,1.43E-10,Linear_Group,3,Increase,Early,NA
sister chromatid cohesion (GO:0007062),49,14,2.37,+,5.91,8.11E-07,1.27E-04,Linear_Group,3,Increase,Early,NA
regulation of mitotic sister chromatid segregation (GO:0033047),74,21,3.58,+,5.87,1.68E-09,6.53E-07,Linear_Group,3,Increase,Early,NA
chromosome separation (GO:0051304),30,8,1.45,+,5.52,2.83E-04,2.37E-02,Linear_Group,3,Increase,Early,NA
mitotic nuclear division (GO:0140014),143,38,6.91,+,5.50,2.73E-15,3.63E-12,Linear_Group,3,Increase,Early,NA
female meiotic nuclear division (GO:0007143),31,8,1.50,+,5.34,3.42E-04,2.81E-02,Linear_Group,3,Increase,Early,NA
regulation of sister chromatid segregation (GO:0033045),86,22,4.16,+,5.29,3.55E-09,1.20E-06,Linear_Group,3,Increase,Early,NA
nuclear chromosome segregation (GO:0098813),217,55,10.49,+,5.24,9.78E-21,2.23E-17,Linear_Group,3,Increase,Early,NA
mitotic metaphase plate congression (GO:0007080),44,11,2.13,+,5.17,3.52E-05,3.81E-03,Linear_Group,3,Increase,Early,NA
regulation of chromosome segregation (GO:0051983),108,27,5.22,+,5.17,9.40E-11,4.83E-08,Linear_Group,3,Increase,Early,NA
meiotic chromosome segregation (GO:0045132),90,22,4.35,+,5.06,7.24E-09,2.02E-06,Linear_Group,3,Increase,Early,NA
centromere complex assembly (GO:0034508),37,9,1.79,+,5.03,2.15E-04,1.88E-02,Linear_Group,3,Increase,Early,NA
M phase (GO:0000279),170,41,8.22,+,4.99,3.71E-15,4.54E-12,Linear_Group,3,Increase,Early,NA
mitotic prometaphase (GO:0000236),170,41,8.22,+,4.99,3.71E-15,4.22E-12,Linear_Group,3,Increase,Early,NA
mitotic M phase (GO:0000087),170,41,8.22,+,4.99,3.71E-15,3.94E-12,Linear_Group,3,Increase,Early,NA
chromosome segregation (GO:0007059),275,65,13.29,+,4.89,6.85E-23,1.82E-19,Linear_Group,3,Increase,Early,NA
microtubule polymerization or depolymerization (GO:0031109),51,12,2.47,+,4.87,2.62E-05,2.94E-03,Linear_Group,3,Increase,Early,NA
chromosome condensation (GO:0030261),43,10,2.08,+,4.81,1.33E-04,1.28E-02,Linear_Group,3,Increase,Early,NA
anaphase (GO:0051322),156,36,7.54,+,4.77,5.48E-13,4.16E-10,Linear_Group,3,Increase,Early,NA
mitotic anaphase (GO:0000090),156,36,7.54,+,4.77,5.48E-13,3.97E-10,Linear_Group,3,Increase,Early,NA
metaphase plate congression (GO:0051310),53,12,2.56,+,4.68,3.64E-05,3.91E-03,Linear_Group,3,Increase,Early,NA
establishment of chromosome localization (GO:0051303),72,16,3.48,+,4.60,2.36E-06,3.55E-04,Linear_Group,3,Increase,Early,NA
chromosome localization (GO:0050000),73,16,3.53,+,4.53,2.76E-06,4.10E-04,Linear_Group,3,Increase,Early,NA
nuclear division (GO:0000280),284,59,13.73,+,4.30,1.47E-18,2.93E-15,Linear_Group,3,Increase,Early,NA
positive regulation of mitotic nuclear division (GO:0045840),58,12,2.80,+,4.28,7.77E-05,7.79E-03,Linear_Group,3,Increase,Early,NA
regulation of mitotic nuclear division (GO:0007088),171,35,8.27,+,4.23,2.16E-11,1.23E-08,Linear_Group,3,Increase,Early,NA
negative regulation of chromosome organization (GO:2001251),138,28,6.67,+,4.20,2.56E-09,9.49E-07,Linear_Group,3,Increase,Early,NA
mitotic cytokinesis (GO:0000281),70,14,3.38,+,4.14,2.80E-05,3.12E-03,Linear_Group,3,Increase,Early,NA
negative regulation of mRNA metabolic process (GO:1903312),85,17,4.11,+,4.14,4.00E-06,5.74E-04,Linear_Group,3,Increase,Early,NA
meiotic nuclear division (GO:0140013),156,31,7.54,+,4.11,5.65E-10,2.43E-07,Linear_Group,3,Increase,Early,NA
spindle organization (GO:0007051),142,28,6.86,+,4.08,4.44E-09,1.33E-06,Linear_Group,3,Increase,Early,NA
organelle fission (GO:0048285),313,61,15.13,+,4.03,5.59E-18,8.90E-15,Linear_Group,3,Increase,Early,NA
regulation of cytokinesis (GO:0032465),88,17,4.25,+,4.00,6.00E-06,8.46E-04,Linear_Group,3,Increase,Early,NA
centrosome cycle (GO:0007098),83,16,4.01,+,3.99,1.15E-05,1.44E-03,Linear_Group,3,Increase,Early,NA
reciprocal meiotic recombination (GO:0007131),52,10,2.51,+,3.98,5.04E-04,3.88E-02,Linear_Group,3,Increase,Early,NA
spindle localization (GO:0051653),52,10,2.51,+,3.98,5.04E-04,3.86E-02,Linear_Group,3,Increase,Early,NA
biological phase (GO:0044848),269,51,13.00,+,3.92,8.08E-15,8.04E-12,Linear_Group,3,Increase,Early,NA
mitotic cell cycle phase (GO:0098763),269,51,13.00,+,3.92,8.08E-15,7.57E-12,Linear_Group,3,Increase,Early,NA
cell cycle phase (GO:0022403),269,51,13.00,+,3.92,8.08E-15,7.15E-12,Linear_Group,3,Increase,Early,NA
meiotic cell cycle process (GO:1903046),169,32,8.17,+,3.92,8.59E-10,3.51E-07,Linear_Group,3,Increase,Early,NA
homologous recombination (GO:0035825),53,10,2.56,+,3.90,5.75E-04,4.34E-02,Linear_Group,3,Increase,Early,NA
cell division (GO:0051301),495,93,23.93,+,3.89,6.97E-26,5.55E-22,Linear_Group,3,Increase,Early,NA
regulation of microtubule polymerization (GO:0031113),54,10,2.61,+,3.83,6.53E-04,4.80E-02,Linear_Group,3,Increase,Early,NA
regulation of nuclear division (GO:0051783),195,36,9.43,+,3.82,1.42E-10,6.84E-08,Linear_Group,3,Increase,Early,NA
microtubule organizing center organization (GO:0031023),93,17,4.50,+,3.78,1.14E-05,1.45E-03,Linear_Group,3,Increase,Early,NA
G2/M transition of mitotic cell cycle (GO:0000086),139,25,6.72,+,3.72,1.41E-07,2.55E-05,Linear_Group,3,Increase,Early,NA
cell cycle G2/M phase transition (GO:0044839),141,25,6.82,+,3.67,1.79E-07,3.17E-05,Linear_Group,3,Increase,Early,NA
chromosome organization involved in meiotic cell cycle (GO:0070192),68,12,3.29,+,3.65,2.88E-04,2.38E-02,Linear_Group,3,Increase,Early,NA
meiotic cell cycle (GO:0051321),223,39,10.78,+,3.62,9.99E-11,4.97E-08,Linear_Group,3,Increase,Early,NA
regulation of microtubule cytoskeleton organization (GO:0070507),197,34,9.52,+,3.57,2.13E-09,8.07E-07,Linear_Group,3,Increase,Early,NA
cell cycle G1/S phase transition (GO:0044843),124,21,5.99,+,3.50,3.22E-06,4.66E-04,Linear_Group,3,Increase,Early,NA
positive regulation of nuclear division (GO:0051785),71,12,3.43,+,3.50,4.09E-04,3.27E-02,Linear_Group,3,Increase,Early,NA
mitotic cell cycle phase transition (GO:0044772),280,47,13.54,+,3.47,4.28E-12,2.84E-09,Linear_Group,3,Increase,Early,NA
cell cycle phase transition (GO:0044770),288,48,13.92,+,3.45,3.17E-12,2.19E-09,Linear_Group,3,Increase,Early,NA
meiosis I (GO:0007127),114,19,5.51,+,3.45,1.14E-05,1.45E-03,Linear_Group,3,Increase,Early,NA
G1/S transition of mitotic cell cycle (GO:0000082),122,20,5.90,+,3.39,8.43E-06,1.16E-03,Linear_Group,3,Increase,Early,NA
meiosis I cell cycle process (GO:0061982),116,19,5.61,+,3.39,1.42E-05,1.74E-03,Linear_Group,3,Increase,Early,NA
cytokinesis (GO:0000910),110,18,5.32,+,3.38,2.40E-05,2.75E-03,Linear_Group,3,Increase,Early,NA
cytoskeleton-dependent cytokinesis (GO:0061640),98,16,4.74,+,3.38,6.85E-05,7.04E-03,Linear_Group,3,Increase,Early,NA
mitotic cell cycle process (GO:1903047),614,100,29.68,+,3.37,1.31E-23,5.22E-20,Linear_Group,3,Increase,Early,NA
regulation of microtubule polymerization or depolymerization (GO:0031110),87,14,4.21,+,3.33,2.19E-04,1.89E-02,Linear_Group,3,Increase,Early,NA
regulation of microtubule-based process (GO:0032886),232,37,11.22,+,3.30,2.84E-09,1.00E-06,Linear_Group,3,Increase,Early,NA
DNA-dependent DNA replication (GO:0006261),120,19,5.80,+,3.28,2.17E-05,2.56E-03,Linear_Group,3,Increase,Early,NA
cell cycle checkpoint (GO:0000075),201,31,9.72,+,3.19,1.06E-07,1.98E-05,Linear_Group,3,Increase,Early,NA
DNA replication (GO:0006260),208,32,10.06,+,3.18,6.95E-08,1.35E-05,Linear_Group,3,Increase,Early,NA
mitotic cell cycle (GO:0000278),696,106,33.65,+,3.15,5.66E-23,1.80E-19,Linear_Group,3,Increase,Early,NA
mitotic cell cycle checkpoint (GO:0007093),160,24,7.73,+,3.10,4.34E-06,6.17E-04,Linear_Group,3,Increase,Early,NA
DNA packaging (GO:0006323),177,25,8.56,+,2.92,7.11E-06,9.93E-04,Linear_Group,3,Increase,Early,NA
cell cycle process (GO:0022402),995,134,48.10,+,2.79,1.98E-24,1.05E-20,Linear_Group,3,Increase,Early,NA
positive regulation of mitotic cell cycle (GO:0045931),158,21,7.64,+,2.75,8.25E-05,8.16E-03,Linear_Group,3,Increase,Early,NA
regulation of cell division (GO:0051302),167,22,8.07,+,2.73,6.35E-05,6.61E-03,Linear_Group,3,Increase,Early,NA
DNA conformation change (GO:0071103),291,38,14.07,+,2.70,2.00E-07,3.46E-05,Linear_Group,3,Increase,Early,NA
cell cycle (GO:0007049),1331,172,64.34,+,2.67,1.46E-29,2.32E-25,Linear_Group,3,Increase,Early,NA
microtubule cytoskeleton organization (GO:0000226),478,60,23.11,+,2.60,2.51E-10,1.18E-07,Linear_Group,3,Increase,Early,NA
establishment of organelle localization (GO:0051656),373,44,18.03,+,2.44,3.51E-07,5.76E-05,Linear_Group,3,Increase,Early,NA
DNA recombination (GO:0006310),222,26,10.73,+,2.42,9.36E-05,9.21E-03,Linear_Group,3,Increase,Early,NA
microtubule-based process (GO:0007017),667,78,32.24,+,2.42,1.36E-11,8.33E-09,Linear_Group,3,Increase,Early,NA
cytoskeleton-dependent intracellular transport (GO:0030705),181,21,8.75,+,2.40,5.13E-04,3.91E-02,Linear_Group,3,Increase,Early,NA
protein-DNA complex assembly (GO:0065004),207,24,10.01,+,2.40,1.99E-04,1.79E-02,Linear_Group,3,Increase,Early,NA
regulation of chromosome organization (GO:0033044),371,43,17.94,+,2.40,6.86E-07,1.08E-04,Linear_Group,3,Increase,Early,NA
DNA repair (GO:0006281),513,59,24.80,+,2.38,7.28E-09,2.00E-06,Linear_Group,3,Increase,Early,NA
chromosome organization (GO:0051276),1053,118,50.91,+,2.32,6.93E-16,1.00E-12,Linear_Group,3,Increase,Early,NA
negative regulation of organelle organization (GO:0010639),395,44,19.10,+,2.30,1.44E-06,2.20E-04,Linear_Group,3,Increase,Early,NA
microtubule-based movement (GO:0007018),271,30,13.10,+,2.29,7.50E-05,7.66E-03,Linear_Group,3,Increase,Early,NA
regulation of mitotic cell cycle (GO:0007346),686,75,33.16,+,2.26,5.59E-10,2.47E-07,Linear_Group,3,Increase,Early,NA
regulation of mitotic cell cycle phase transition (GO:1901990),420,45,20.30,+,2.22,2.94E-06,4.33E-04,Linear_Group,3,Increase,Early,NA
organelle localization (GO:0051640),588,63,28.43,+,2.22,3.33E-08,7.26E-06,Linear_Group,3,Increase,Early,NA
regulation of small GTPase mediated signal transduction (GO:0051056),320,34,15.47,+,2.20,5.48E-05,5.78E-03,Linear_Group,3,Increase,Early,NA
establishment of localization in cell (GO:0051649),399,42,19.29,+,2.18,9.15E-06,1.21E-03,Linear_Group,3,Increase,Early,NA
Ras protein signal transduction (GO:0007265),248,26,11.99,+,2.17,6.52E-04,4.81E-02,Linear_Group,3,Increase,Early,NA
regulation of cell cycle process (GO:0010564),763,78,36.89,+,2.11,4.06E-09,1.27E-06,Linear_Group,3,Increase,Early,NA
positive regulation of cell cycle process (GO:0090068),294,30,14.21,+,2.11,4.05E-04,3.26E-02,Linear_Group,3,Increase,Early,NA
negative regulation of cell cycle process (GO:0010948),326,33,15.76,+,2.09,1.80E-04,1.65E-02,Linear_Group,3,Increase,Early,NA
cellular response to DNA damage stimulus (GO:0006974),781,79,37.76,+,2.09,5.76E-09,1.64E-06,Linear_Group,3,Increase,Early,NA
negative regulation of mitotic cell cycle (GO:0045930),313,31,15.13,+,2.05,3.83E-04,3.12E-02,Linear_Group,3,Increase,Early,NA
regulation of cell cycle phase transition (GO:1901987),456,45,22.04,+,2.04,2.03E-05,2.42E-03,Linear_Group,3,Increase,Early,NA
cellular response to growth factor stimulus (GO:0071363),502,49,24.27,+,2.02,1.17E-05,1.46E-03,Linear_Group,3,Increase,Early,NA
regulation of mRNA metabolic process (GO:1903311),331,32,16.00,+,2.00,5.32E-04,4.03E-02,Linear_Group,3,Increase,Early,NA
regulation of cell cycle (GO:0051726),1243,120,60.09,+,2.00,5.35E-12,3.41E-09,Linear_Group,3,Increase,Early,NA
DNA metabolic process (GO:0006259),749,72,36.21,+,1.99,1.60E-07,2.87E-05,Linear_Group,3,Increase,Early,NA
response to growth factor (GO:0070848),532,50,25.72,+,1.94,3.12E-05,3.43E-03,Linear_Group,3,Increase,Early,NA
regulation of cytoskeleton organization (GO:0051493),560,52,27.07,+,1.92,2.18E-05,2.55E-03,Linear_Group,3,Increase,Early,NA
negative regulation of cellular component organization (GO:0051129),723,67,34.95,+,1.92,1.53E-06,2.32E-04,Linear_Group,3,Increase,Early,NA
RNA splicing (GO:0008380),400,37,19.34,+,1.91,4.56E-04,3.60E-02,Linear_Group,3,Increase,Early,NA
positive regulation of cell cycle (GO:0045787),391,36,18.90,+,1.90,6.12E-04,4.55E-02,Linear_Group,3,Increase,Early,NA
regulation of organelle organization (GO:0033043),1328,116,64.20,+,1.81,3.66E-09,1.22E-06,Linear_Group,3,Increase,Early,NA
organelle assembly (GO:0070925),723,63,34.95,+,1.80,1.90E-05,2.29E-03,Linear_Group,3,Increase,Early,NA
negative regulation of cell cycle (GO:0045786),575,50,27.80,+,1.80,1.46E-04,1.36E-02,Linear_Group,3,Increase,Early,NA
modification-dependent macromolecule catabolic process (GO:0043632),546,46,26.40,+,1.74,6.49E-04,4.81E-02,Linear_Group,3,Increase,Early,NA
cytoskeleton organization (GO:0007010),1106,86,53.47,+,1.61,3.48E-05,3.80E-03,Linear_Group,3,Increase,Early,NA
regulation of cellular component organization (GO:0051128),2529,189,122.26,+,1.55,3.82E-09,1.24E-06,Linear_Group,3,Increase,Early,NA
protein phosphorylation (GO:0006468),965,72,46.65,+,1.54,5.98E-04,4.50E-02,Linear_Group,3,Increase,Early,NA
organelle organization (GO:0006996),3428,252,165.72,+,1.52,1.83E-11,1.08E-08,Linear_Group,3,Increase,Early,NA
reproductive process (GO:0022414),1433,103,69.28,+,1.49,1.13E-04,1.09E-02,Linear_Group,3,Increase,Early,NA
reproduction (GO:0000003),1436,103,69.42,+,1.48,1.46E-04,1.36E-02,Linear_Group,3,Increase,Early,NA
negative regulation of nucleobase-containing compound metabolic process (GO:0045934),1484,105,71.74,+,1.46,1.84E-04,1.66E-02,Linear_Group,3,Increase,Early,NA
negative regulation of RNA metabolic process (GO:0051253),1381,97,66.76,+,1.45,3.98E-04,3.22E-02,Linear_Group,3,Increase,Early,NA
cellular response to stress (GO:0033554),1751,121,84.65,+,1.43,1.36E-04,1.30E-02,Linear_Group,3,Increase,Early,NA
nucleic acid metabolic process (GO:0090304),2292,158,110.80,+,1.43,1.04E-05,1.35E-03,Linear_Group,3,Increase,Early,NA
cellular localization (GO:0051641),2411,165,116.55,+,1.42,1.01E-05,1.33E-03,Linear_Group,3,Increase,Early,NA
regulation of protein modification process (GO:0031399),1873,126,90.55,+,1.39,2.70E-04,2.28E-02,Linear_Group,3,Increase,Early,NA
regulation of cellular macromolecule biosynthetic process (GO:2000112),3931,264,190.04,+,1.39,2.89E-08,6.49E-06,Linear_Group,3,Increase,Early,NA
regulation of nucleobase-containing compound metabolic process (GO:0019219),4062,270,196.37,+,1.37,4.29E-08,9.10E-06,Linear_Group,3,Increase,Early,NA
regulation of macromolecule biosynthetic process (GO:0010556),4068,270,196.66,+,1.37,5.45E-08,1.14E-05,Linear_Group,3,Increase,Early,NA
regulation of RNA metabolic process (GO:0051252),3808,252,184.09,+,1.37,2.50E-07,4.18E-05,Linear_Group,3,Increase,Early,NA
nervous system development (GO:0007399),2373,154,114.72,+,1.34,2.74E-04,2.31E-02,Linear_Group,3,Increase,Early,NA
regulation of cellular biosynthetic process (GO:0031326),4212,273,203.62,+,1.34,3.00E-07,4.98E-05,Linear_Group,3,Increase,Early,NA
regulation of nucleic acid-templated transcription (GO:1903506),3544,228,171.33,+,1.33,8.62E-06,1.17E-03,Linear_Group,3,Increase,Early,NA
regulation of RNA biosynthetic process (GO:2001141),3549,228,171.57,+,1.33,8.78E-06,1.19E-03,Linear_Group,3,Increase,Early,NA
negative regulation of cellular process (GO:0048523),4795,308,231.80,+,1.33,7.14E-08,1.37E-05,Linear_Group,3,Increase,Early,NA
"regulation of transcription, DNA-templated (GO:0006355)",3478,223,168.14,+,1.33,1.35E-05,1.66E-03,Linear_Group,3,Increase,Early,NA
regulation of biosynthetic process (GO:0009889),4291,275,207.44,+,1.33,6.75E-07,1.08E-04,Linear_Group,3,Increase,Early,NA
cellular component organization (GO:0016043),5620,357,271.69,+,1.31,9.88E-09,2.46E-06,Linear_Group,3,Increase,Early,NA
regulation of cellular protein metabolic process (GO:0032268),2661,169,128.64,+,1.31,3.68E-04,3.01E-02,Linear_Group,3,Increase,Early,NA
negative regulation of cellular metabolic process (GO:0031324),2603,165,125.84,+,1.31,4.69E-04,3.68E-02,Linear_Group,3,Increase,Early,NA
regulation of nitrogen compound metabolic process (GO:0051171),5870,372,283.77,+,1.31,4.35E-09,1.33E-06,Linear_Group,3,Increase,Early,NA
regulation of protein metabolic process (GO:0051246),2832,179,136.91,+,1.31,2.59E-04,2.20E-02,Linear_Group,3,Increase,Early,NA
cellular macromolecule metabolic process (GO:0044260),5073,320,245.24,+,1.30,2.28E-07,3.90E-05,Linear_Group,3,Increase,Early,NA
regulation of primary metabolic process (GO:0080090),6055,380,292.72,+,1.30,9.03E-09,2.32E-06,Linear_Group,3,Increase,Early,NA
nucleobase-containing compound metabolic process (GO:0006139),2805,176,135.60,+,1.30,4.94E-04,3.82E-02,Linear_Group,3,Increase,Early,NA
regulation of gene expression (GO:0010468),4483,281,216.72,+,1.30,3.20E-06,4.68E-04,Linear_Group,3,Increase,Early,NA
regulation of cellular metabolic process (GO:0031323),6263,391,302.77,+,1.29,8.26E-09,2.16E-06,Linear_Group,3,Increase,Early,NA
regulation of macromolecule metabolic process (GO:0060255),6183,386,298.90,+,1.29,1.11E-08,2.68E-06,Linear_Group,3,Increase,Early,NA
cellular component organization or biogenesis (GO:0071840),5810,362,280.87,+,1.29,5.91E-08,1.16E-05,Linear_Group,3,Increase,Early,NA
positive regulation of macromolecule metabolic process (GO:0010604),3394,210,164.08,+,1.28,2.16E-04,1.88E-02,Linear_Group,3,Increase,Early,NA
negative regulation of biological process (GO:0048519),5377,332,259.94,+,1.28,8.27E-07,1.28E-04,Linear_Group,3,Increase,Early,NA
macromolecule metabolic process (GO:0043170),6181,378,298.81,+,1.27,1.82E-07,3.18E-05,Linear_Group,3,Increase,Early,NA
regulation of metabolic process (GO:0019222),6733,408,325.49,+,1.25,1.12E-07,2.07E-05,Linear_Group,3,Increase,Early,NA
multicellular organism development (GO:0007275),5064,295,244.81,+,1.21,4.21E-04,3.35E-02,Linear_Group,3,Increase,Early,NA
regulation of cellular process (GO:0050794),11071,642,535.21,+,1.20,3.67E-11,1.95E-08,Linear_Group,3,Increase,Early,NA
developmental process (GO:0032502),5901,341,285.27,+,1.20,2.01E-04,1.80E-02,Linear_Group,3,Increase,Early,NA
positive regulation of cellular process (GO:0048522),5516,317,266.66,+,1.19,6.03E-04,4.51E-02,Linear_Group,3,Increase,Early,NA
anatomical structure development (GO:0048856),5451,313,263.52,+,1.19,6.61E-04,4.83E-02,Linear_Group,3,Increase,Early,NA
nitrogen compound metabolic process (GO:0006807),7000,399,338.40,+,1.18,1.01E-04,9.79E-03,Linear_Group,3,Increase,Early,NA
cellular metabolic process (GO:0044237),7652,430,369.92,+,1.16,1.58E-04,1.45E-02,Linear_Group,3,Increase,Early,NA
regulation of biological process (GO:0050789),11770,661,569.00,+,1.16,9.24E-09,2.34E-06,Linear_Group,3,Increase,Early,NA
primary metabolic process (GO:0044238),7465,416,360.88,+,1.15,4.74E-04,3.70E-02,Linear_Group,3,Increase,Early,NA
biological regulation (GO:0065007),12470,686,602.84,+,1.14,1.29E-07,2.37E-05,Linear_Group,3,Increase,Early,NA
biological_process (GO:0008150),17780,901,859.54,+,1.05,2.06E-04,1.82E-02,Linear_Group,3,Increase,Early,NA
Unclassified (UNCLASSIFIED),3071,107,148.46,-,.72,2.06E-04,1.81E-02,Linear_Group,3,Increase,Early,NA
immune system process (GO:0002376),2807,89,135.70,-,.66,1.14E-05,1.46E-03,Linear_Group,3,Increase,Early,NA
system process (GO:0003008),1979,59,95.67,-,.62,4.89E-05,5.23E-03,Linear_Group,3,Increase,Early,NA
regulation of immune system process (GO:0002682),1681,48,81.26,-,.59,7.52E-05,7.63E-03,Linear_Group,3,Increase,Early,NA
nervous system process (GO:0050877),1398,37,67.58,-,.55,6.56E-05,6.79E-03,Linear_Group,3,Increase,Early,NA
response to biotic stimulus (GO:0009607),1356,35,65.55,-,.53,5.09E-05,5.41E-03,Linear_Group,3,Increase,Early,NA
G protein-coupled receptor signaling pathway (GO:0007186),1320,33,63.81,-,.52,3.02E-05,3.34E-03,Linear_Group,3,Increase,Early,NA
response to other organism (GO:0051707),1330,33,64.30,-,.51,2.38E-05,2.75E-03,Linear_Group,3,Increase,Early,NA
response to external biotic stimulus (GO:0043207),1332,33,64.39,-,.51,2.41E-05,2.72E-03,Linear_Group,3,Increase,Early,NA
oxidation-reduction process (GO:0055114),963,23,46.55,-,.49,1.82E-04,1.66E-02,Linear_Group,3,Increase,Early,NA
sensory perception (GO:0007600),977,23,47.23,-,.49,1.43E-04,1.35E-02,Linear_Group,3,Increase,Early,NA
defense response (GO:0006952),1352,29,65.36,-,.44,5.58E-07,9.08E-05,Linear_Group,3,Increase,Early,NA
immune response (GO:0006955),1869,39,90.35,-,.43,1.02E-09,4.04E-07,Linear_Group,3,Increase,Early,NA
defense response to other organism (GO:0098542),962,20,46.51,-,.43,2.25E-05,2.62E-03,Linear_Group,3,Increase,Early,NA
regulation of cell activation (GO:0050865),646,12,31.23,-,.38,2.02E-04,1.79E-02,Linear_Group,3,Increase,Early,NA
innate immune response (GO:0045087),774,14,37.42,-,.37,1.98E-05,2.37E-03,Linear_Group,3,Increase,Early,NA
regulation of leukocyte activation (GO:0002694),606,10,29.30,-,.34,8.21E-05,8.18E-03,Linear_Group,3,Increase,Early,NA
detection of stimulus (GO:0051606),698,11,33.74,-,.33,1.03E-05,1.35E-03,Linear_Group,3,Increase,Early,NA
regulation of lymphocyte activation (GO:0051249),523,8,25.28,-,.32,1.38E-04,1.31E-02,Linear_Group,3,Increase,Early,NA
adaptive immune response (GO:0002250),613,9,29.63,-,.30,2.40E-05,2.73E-03,Linear_Group,3,Increase,Early,NA
sensory perception of chemical stimulus (GO:0007606),541,4,26.15,-,.15,2.35E-07,3.98E-05,Linear_Group,3,Increase,Early,NA
sensory perception of smell (GO:0007608),468,3,22.62,-,.13,6.58E-07,1.06E-04,Linear_Group,3,Increase,Early,NA
detection of chemical stimulus (GO:0009593),525,3,25.38,-,.12,7.58E-08,1.44E-05,Linear_Group,3,Increase,Early,NA
humoral immune response (GO:0006959),372,2,17.98,-,.11,8.16E-06,1.13E-03,Linear_Group,3,Increase,Early,NA
detection of stimulus involved in sensory perception (GO:0050906),549,2,26.54,-,.08,3.10E-09,1.07E-06,Linear_Group,3,Increase,Early,NA
detection of chemical stimulus involved in sensory perception of smell (GO:0050911),439,1,21.22,-,.05,2.90E-08,6.42E-06,Linear_Group,3,Increase,Early,NA
detection of chemical stimulus involved in sensory perception (GO:0050907),488,1,23.59,-,.04,2.83E-09,1.03E-06,Linear_Group,3,Increase,Early,NA
complement activation (GO:0006956),176,0,8.51,-, < 0.01,4.25E-04,3.37E-02,Linear_Group,3,Increase,Early,NA
negative regulation of chronic inflammatory response (GO:0002677),4,4,.17,+,24.19,1.52E-04,2.60E-02,Linear_Group,3,Both,Early,NA
regulation of chronic inflammatory response (GO:0002676),9,5,.37,+,13.44,1.45E-04,2.53E-02,Linear_Group,3,Both,Early,NA
lymph node development (GO:0048535),18,7,.74,+,9.41,3.89E-05,9.40E-03,Linear_Group,3,Both,Early,NA
NADH regeneration (GO:0006735),27,9,1.12,+,8.06,8.42E-06,3.44E-03,Linear_Group,3,Both,Early,NA
glucose catabolic process to pyruvate (GO:0061718),27,9,1.12,+,8.06,8.42E-06,3.35E-03,Linear_Group,3,Both,Early,NA
canonical glycolysis (GO:0061621),27,9,1.12,+,8.06,8.42E-06,3.27E-03,Linear_Group,3,Both,Early,NA
glycolytic process through glucose-6-phosphate (GO:0061620),28,9,1.16,+,7.78,1.07E-05,3.88E-03,Linear_Group,3,Both,Early,NA
glycolytic process through fructose-6-phosphate (GO:0061615),28,9,1.16,+,7.78,1.07E-05,3.80E-03,Linear_Group,3,Both,Early,NA
glucose catabolic process (GO:0006007),31,9,1.28,+,7.02,2.12E-05,6.03E-03,Linear_Group,3,Both,Early,NA
glycolytic process (GO:0006096),42,12,1.74,+,6.91,1.05E-06,8.77E-04,Linear_Group,3,Both,Early,NA
ATP generation from ADP (GO:0006757),43,12,1.78,+,6.75,1.29E-06,8.57E-04,Linear_Group,3,Both,Early,NA
NADH metabolic process (GO:0006734),38,10,1.57,+,6.37,1.53E-05,4.69E-03,Linear_Group,3,Both,Early,NA
NAD metabolic process (GO:0019674),45,11,1.86,+,5.91,1.05E-05,3.89E-03,Linear_Group,3,Both,Early,NA
negative regulation of B cell activation (GO:0050869),33,8,1.36,+,5.86,1.78E-04,2.92E-02,Linear_Group,3,Both,Early,NA
ADP metabolic process (GO:0046031),51,12,2.11,+,5.69,5.86E-06,2.52E-03,Linear_Group,3,Both,Early,NA
purine ribonucleoside diphosphate metabolic process (GO:0009179),63,14,2.60,+,5.38,1.78E-06,1.09E-03,Linear_Group,3,Both,Early,NA
purine nucleoside diphosphate metabolic process (GO:0009135),63,14,2.60,+,5.38,1.78E-06,1.05E-03,Linear_Group,3,Both,Early,NA
gluconeogenesis (GO:0006094),45,10,1.86,+,5.38,5.33E-05,1.13E-02,Linear_Group,3,Both,Early,NA
ribonucleoside diphosphate metabolic process (GO:0009185),65,14,2.69,+,5.21,2.45E-06,1.30E-03,Linear_Group,3,Both,Early,NA
hexose biosynthetic process (GO:0019319),48,10,1.98,+,5.04,8.54E-05,1.64E-02,Linear_Group,3,Both,Early,NA
cellular response to epidermal growth factor stimulus (GO:0071364),45,9,1.86,+,4.84,2.51E-04,3.73E-02,Linear_Group,3,Both,Early,NA
pyruvate metabolic process (GO:0006090),71,14,2.94,+,4.77,6.01E-06,2.52E-03,Linear_Group,3,Both,Early,NA
nucleoside diphosphate phosphorylation (GO:0006165),61,12,2.52,+,4.76,2.81E-05,7.71E-03,Linear_Group,3,Both,Early,NA
lymphocyte homeostasis (GO:0002260),52,10,2.15,+,4.65,1.52E-04,2.56E-02,Linear_Group,3,Both,Early,NA
nucleotide phosphorylation (GO:0046939),63,12,2.60,+,4.61,3.71E-05,9.23E-03,Linear_Group,3,Both,Early,NA
monosaccharide biosynthetic process (GO:0046364),54,10,2.23,+,4.48,2.00E-04,3.22E-02,Linear_Group,3,Both,Early,NA
regulation of immunoglobulin mediated immune response (GO:0002889),55,10,2.27,+,4.40,2.28E-04,3.60E-02,Linear_Group,3,Both,Early,NA
regulation of B cell mediated immunity (GO:0002712),55,10,2.27,+,4.40,2.28E-04,3.56E-02,Linear_Group,3,Both,Early,NA
regulation of interleukin-12 production (GO:0032655),57,10,2.36,+,4.24,2.94E-04,4.18E-02,Linear_Group,3,Both,Early,NA
positive regulation of T cell proliferation (GO:0042102),97,17,4.01,+,4.24,2.59E-06,1.25E-03,Linear_Group,3,Both,Early,NA
nucleoside diphosphate metabolic process (GO:0009132),83,14,3.43,+,4.08,2.85E-05,7.69E-03,Linear_Group,3,Both,Early,NA
positive regulation of lymphocyte mediated immunity (GO:0002708),107,16,4.42,+,3.62,2.95E-05,7.84E-03,Linear_Group,3,Both,Early,NA
regulation of T cell proliferation (GO:0042129),163,24,6.74,+,3.56,4.25E-07,5.21E-04,Linear_Group,3,Both,Early,NA
positive regulation of T cell activation (GO:0050870),206,28,8.52,+,3.29,2.10E-07,4.79E-04,Linear_Group,3,Both,Early,NA
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),104,14,4.30,+,3.26,2.46E-04,3.70E-02,Linear_Group,3,Both,Early,NA
positive regulation of lymphocyte proliferation (GO:0050671),134,18,5.54,+,3.25,3.49E-05,8.82E-03,Linear_Group,3,Both,Early,NA
positive regulation of mononuclear cell proliferation (GO:0032946),135,18,5.58,+,3.23,3.81E-05,9.33E-03,Linear_Group,3,Both,Early,NA
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002822),151,20,6.24,+,3.20,1.57E-05,4.72E-03,Linear_Group,3,Both,Early,NA
regulation of leukocyte proliferation (GO:0070663),229,30,9.47,+,3.17,1.61E-07,4.26E-04,Linear_Group,3,Both,Early,NA
regulation of lymphocyte proliferation (GO:0050670),216,28,8.93,+,3.14,5.00E-07,5.69E-04,Linear_Group,3,Both,Early,NA
regulation of cytokine biosynthetic process (GO:0042035),108,14,4.46,+,3.14,3.49E-04,4.83E-02,Linear_Group,3,Both,Early,NA
positive regulation of leukocyte cell-cell adhesion (GO:1903039),224,29,9.26,+,3.13,3.22E-07,5.69E-04,Linear_Group,3,Both,Early,NA
regulation of mononuclear cell proliferation (GO:0032944),218,28,9.01,+,3.11,5.91E-07,6.28E-04,Linear_Group,3,Both,Early,NA
positive regulation of leukocyte proliferation (GO:0070665),141,18,5.83,+,3.09,6.35E-05,1.28E-02,Linear_Group,3,Both,Early,NA
regulation of adaptive immune response (GO:0002819),166,21,6.86,+,3.06,1.82E-05,5.36E-03,Linear_Group,3,Both,Early,NA
positive regulation of leukocyte differentiation (GO:1902107),151,19,6.24,+,3.04,4.79E-05,1.06E-02,Linear_Group,3,Both,Early,NA
positive regulation of leukocyte mediated immunity (GO:0002705),136,17,5.62,+,3.02,1.27E-04,2.24E-02,Linear_Group,3,Both,Early,NA
regulation of lymphocyte mediated immunity (GO:0002706),153,19,6.33,+,3.00,5.63E-05,1.18E-02,Linear_Group,3,Both,Early,NA
regulation of lymphocyte differentiation (GO:0045619),171,20,7.07,+,2.83,7.73E-05,1.52E-02,Linear_Group,3,Both,Early,NA
positive regulation of cell-cell adhesion (GO:0022409),268,31,11.08,+,2.80,1.16E-06,8.39E-04,Linear_Group,3,Both,Early,NA
regulation of leukocyte cell-cell adhesion (GO:1903037),307,35,12.69,+,2.76,3.28E-07,5.22E-04,Linear_Group,3,Both,Early,NA
adaptive immune response (GO:0002250),613,69,25.34,+,2.72,1.63E-12,8.67E-09,Linear_Group,3,Both,Early,NA
regulation of T cell activation (GO:0050863),323,36,13.35,+,2.70,3.67E-07,4.87E-04,Linear_Group,3,Both,Early,NA
cellular response to tumor necrosis factor (GO:0071356),245,27,10.13,+,2.67,1.25E-05,4.05E-03,Linear_Group,3,Both,Early,NA
positive regulation of hemopoiesis (GO:1903708),192,21,7.94,+,2.65,1.23E-04,2.20E-02,Linear_Group,3,Both,Early,NA
regulation of leukocyte mediated immunity (GO:0002703),205,22,8.47,+,2.60,1.10E-04,2.04E-02,Linear_Group,3,Both,Early,NA
regulation of B cell activation (GO:0050864),213,22,8.81,+,2.50,2.51E-04,3.68E-02,Linear_Group,3,Both,Early,NA
response to tumor necrosis factor (GO:0034612),272,28,11.24,+,2.49,3.18E-05,8.31E-03,Linear_Group,3,Both,Early,NA
positive regulation of lymphocyte activation (GO:0051251),367,37,15.17,+,2.44,3.48E-06,1.63E-03,Linear_Group,3,Both,Early,NA
regulation of leukocyte differentiation (GO:1902105),280,28,11.58,+,2.42,4.67E-05,1.05E-02,Linear_Group,3,Both,Early,NA
positive regulation of cell activation (GO:0050867),423,42,17.49,+,2.40,7.99E-07,7.49E-04,Linear_Group,3,Both,Early,NA
regulation of cell-cell adhesion (GO:0022407),414,41,17.12,+,2.40,1.16E-06,8.76E-04,Linear_Group,3,Both,Early,NA
positive regulation of leukocyte activation (GO:0002696),409,40,16.91,+,2.37,1.99E-06,1.09E-03,Linear_Group,3,Both,Early,NA
regulation of lymphocyte activation (GO:0051249),523,51,21.62,+,2.36,9.31E-08,2.97E-04,Linear_Group,3,Both,Early,NA
response to molecule of bacterial origin (GO:0002237),340,32,14.06,+,2.28,4.19E-05,9.67E-03,Linear_Group,3,Both,Early,NA
response to lipopolysaccharide (GO:0032496),324,30,13.39,+,2.24,9.38E-05,1.76E-02,Linear_Group,3,Both,Early,NA
lymphocyte activation (GO:0046649),379,34,15.67,+,2.17,6.08E-05,1.24E-02,Linear_Group,3,Both,Early,NA
positive regulation of cytokine production (GO:0001819),458,41,18.93,+,2.17,1.21E-05,4.03E-03,Linear_Group,3,Both,Early,NA
regulation of leukocyte activation (GO:0002694),606,54,25.05,+,2.16,7.21E-07,7.18E-04,Linear_Group,3,Both,Early,NA
leukocyte migration (GO:0050900),372,33,15.38,+,2.15,9.33E-05,1.77E-02,Linear_Group,3,Both,Early,NA
regulation of cell activation (GO:0050865),646,57,26.71,+,2.13,3.47E-07,5.03E-04,Linear_Group,3,Both,Early,NA
immune system development (GO:0002520),658,56,27.20,+,2.06,1.26E-06,8.75E-04,Linear_Group,3,Both,Early,NA
regulation of immune effector process (GO:0002697),468,39,19.35,+,2.02,1.13E-04,2.05E-02,Linear_Group,3,Both,Early,NA
hematopoietic or lymphoid organ development (GO:0048534),621,51,25.67,+,1.99,1.18E-05,4.08E-03,Linear_Group,3,Both,Early,NA
inflammatory response (GO:0006954),502,41,20.75,+,1.98,8.21E-05,1.59E-02,Linear_Group,3,Both,Early,NA
immune response (GO:0006955),1869,151,77.27,+,1.95,1.31E-14,2.08E-10,Linear_Group,3,Both,Early,NA
negative regulation of immune system process (GO:0002683),458,37,18.93,+,1.95,2.51E-04,3.70E-02,Linear_Group,3,Both,Early,NA
regulation of cytokine production (GO:0001817),724,56,29.93,+,1.87,2.11E-05,6.11E-03,Linear_Group,3,Both,Early,NA
cytokine-mediated signaling pathway (GO:0019221),694,53,28.69,+,1.85,5.08E-05,1.09E-02,Linear_Group,3,Both,Early,NA
hemopoiesis (GO:0030097),571,43,23.61,+,1.82,3.21E-04,4.49E-02,Linear_Group,3,Both,Early,NA
cellular response to cytokine stimulus (GO:0071345),1031,76,42.62,+,1.78,3.67E-06,1.67E-03,Linear_Group,3,Both,Early,NA
positive regulation of immune system process (GO:0002684),1160,85,47.96,+,1.77,9.52E-07,8.42E-04,Linear_Group,3,Both,Early,NA
regulation of cell adhesion (GO:0030155),701,51,28.98,+,1.76,1.91E-04,3.10E-02,Linear_Group,3,Both,Early,NA
positive regulation of cell population proliferation (GO:0008284),926,66,38.28,+,1.72,3.98E-05,9.33E-03,Linear_Group,3,Both,Early,NA
regulation of response to external stimulus (GO:0032101),1097,78,45.35,+,1.72,1.00E-05,3.80E-03,Linear_Group,3,Both,Early,NA
immune system process (GO:0002376),2807,198,116.04,+,1.71,1.72E-13,1.37E-09,Linear_Group,3,Both,Early,NA
response to cytokine (GO:0034097),1122,77,46.38,+,1.66,3.47E-05,8.92E-03,Linear_Group,3,Both,Early,NA
regulation of locomotion (GO:0040012),1010,68,41.75,+,1.63,1.56E-04,2.60E-02,Linear_Group,3,Both,Early,NA
regulation of immune response (GO:0050776),1144,77,47.29,+,1.63,5.75E-05,1.19E-02,Linear_Group,3,Both,Early,NA
regulation of cellular component movement (GO:0051270),1022,68,42.25,+,1.61,2.30E-04,3.56E-02,Linear_Group,3,Both,Early,NA
regulation of immune system process (GO:0002682),1681,111,69.49,+,1.60,2.56E-06,1.27E-03,Linear_Group,3,Both,Early,NA
cell surface receptor signaling pathway (GO:0007166),2483,156,102.65,+,1.52,2.85E-07,5.67E-04,Linear_Group,3,Both,Early,NA
intracellular signal transduction (GO:0035556),1698,103,70.20,+,1.47,1.50E-04,2.60E-02,Linear_Group,3,Both,Early,NA
positive regulation of multicellular organismal process (GO:0051240),1771,107,73.21,+,1.46,1.52E-04,2.58E-02,Linear_Group,3,Both,Early,NA
cellular response to organic substance (GO:0071310),2400,143,99.22,+,1.44,1.44E-05,4.57E-03,Linear_Group,3,Both,Early,NA
cellular response to chemical stimulus (GO:0070887),2937,169,121.42,+,1.39,1.47E-05,4.60E-03,Linear_Group,3,Both,Early,NA
signal transduction (GO:0007165),5135,275,212.29,+,1.30,2.45E-06,1.26E-03,Linear_Group,3,Both,Early,NA
cell communication (GO:0007154),5576,297,230.52,+,1.29,1.15E-06,9.19E-04,Linear_Group,3,Both,Early,NA
signaling (GO:0023052),5473,291,226.26,+,1.29,1.82E-06,1.03E-03,Linear_Group,3,Both,Early,NA
response to chemical (GO:0042221),4496,238,185.87,+,1.28,4.29E-05,9.77E-03,Linear_Group,3,Both,Early,NA
response to stimulus (GO:0050896),8534,441,352.80,+,1.25,3.38E-09,1.35E-05,Linear_Group,3,Both,Early,NA
cellular response to stimulus (GO:0051716),6782,349,280.37,+,1.24,1.72E-06,1.10E-03,Linear_Group,3,Both,Early,NA
macromolecule localization (GO:0033036),2537,70,104.88,-,.67,2.17E-04,3.45E-02,Linear_Group,3,Both,Early,NA
cellular localization (GO:0051641),2411,66,99.67,-,.66,2.43E-04,3.68E-02,Linear_Group,3,Both,Early,NA
gene expression (GO:0010467),2026,53,83.76,-,.63,3.01E-04,4.25E-02,Linear_Group,3,Both,Early,NA
protein localization (GO:0008104),2201,56,90.99,-,.62,6.36E-05,1.27E-02,Linear_Group,3,Both,Early,NA
nucleic acid metabolic process (GO:0090304),2292,56,94.75,-,.59,1.18E-05,4.00E-03,Linear_Group,3,Both,Early,NA
RNA metabolic process (GO:0016070),1690,40,69.87,-,.57,1.10E-04,2.02E-02,Linear_Group,3,Both,Early,NA
protein transport (GO:0015031),1525,36,63.04,-,.57,2.63E-04,3.81E-02,Linear_Group,3,Both,Early,NA
cellular protein localization (GO:0034613),1635,37,67.59,-,.55,4.94E-05,1.08E-02,Linear_Group,3,Both,Early,NA
cellular macromolecule localization (GO:0070727),1643,37,67.92,-,.54,3.93E-05,9.34E-03,Linear_Group,3,Both,Early,NA
intracellular transport (GO:0046907),1527,30,63.13,-,.48,4.02E-06,1.78E-03,Linear_Group,3,Both,Early,NA
cellular macromolecule catabolic process (GO:0044265),912,17,37.70,-,.45,2.79E-04,4.01E-02,Linear_Group,3,Both,Early,NA
intracellular protein transport (GO:0006886),1003,17,41.46,-,.41,2.47E-05,6.91E-03,Linear_Group,3,Both,Early,NA
ribonucleoprotein complex biogenesis (GO:0022613),423,4,17.49,-,.23,2.42E-04,3.71E-02,Linear_Group,3,Both,Early,NA
negative regulation of chronic inflammatory response (GO:0002677),4,4,.17,+,24.19,1.52E-04,2.60E-02,Linear_Group,4,Decrease,Early,NA
regulation of chronic inflammatory response (GO:0002676),9,5,.37,+,13.44,1.45E-04,2.53E-02,Linear_Group,4,Decrease,Early,NA
lymph node development (GO:0048535),18,7,.74,+,9.41,3.89E-05,9.40E-03,Linear_Group,4,Decrease,Early,NA
NADH regeneration (GO:0006735),27,9,1.12,+,8.06,8.42E-06,3.44E-03,Linear_Group,4,Decrease,Early,NA
glucose catabolic process to pyruvate (GO:0061718),27,9,1.12,+,8.06,8.42E-06,3.35E-03,Linear_Group,4,Decrease,Early,NA
canonical glycolysis (GO:0061621),27,9,1.12,+,8.06,8.42E-06,3.27E-03,Linear_Group,4,Decrease,Early,NA
glycolytic process through glucose-6-phosphate (GO:0061620),28,9,1.16,+,7.78,1.07E-05,3.88E-03,Linear_Group,4,Decrease,Early,NA
glycolytic process through fructose-6-phosphate (GO:0061615),28,9,1.16,+,7.78,1.07E-05,3.80E-03,Linear_Group,4,Decrease,Early,NA
glucose catabolic process (GO:0006007),31,9,1.28,+,7.02,2.12E-05,6.03E-03,Linear_Group,4,Decrease,Early,NA
glycolytic process (GO:0006096),42,12,1.74,+,6.91,1.05E-06,8.77E-04,Linear_Group,4,Decrease,Early,NA
ATP generation from ADP (GO:0006757),43,12,1.78,+,6.75,1.29E-06,8.57E-04,Linear_Group,4,Decrease,Early,NA
NADH metabolic process (GO:0006734),38,10,1.57,+,6.37,1.53E-05,4.69E-03,Linear_Group,4,Decrease,Early,NA
NAD metabolic process (GO:0019674),45,11,1.86,+,5.91,1.05E-05,3.89E-03,Linear_Group,4,Decrease,Early,NA
negative regulation of B cell activation (GO:0050869),33,8,1.36,+,5.86,1.78E-04,2.92E-02,Linear_Group,4,Decrease,Early,NA
ADP metabolic process (GO:0046031),51,12,2.11,+,5.69,5.86E-06,2.52E-03,Linear_Group,4,Decrease,Early,NA
purine ribonucleoside diphosphate metabolic process (GO:0009179),63,14,2.60,+,5.38,1.78E-06,1.09E-03,Linear_Group,4,Decrease,Early,NA
purine nucleoside diphosphate metabolic process (GO:0009135),63,14,2.60,+,5.38,1.78E-06,1.05E-03,Linear_Group,4,Decrease,Early,NA
gluconeogenesis (GO:0006094),45,10,1.86,+,5.38,5.33E-05,1.13E-02,Linear_Group,4,Decrease,Early,NA
ribonucleoside diphosphate metabolic process (GO:0009185),65,14,2.69,+,5.21,2.45E-06,1.30E-03,Linear_Group,4,Decrease,Early,NA
hexose biosynthetic process (GO:0019319),48,10,1.98,+,5.04,8.54E-05,1.64E-02,Linear_Group,4,Decrease,Early,NA
cellular response to epidermal growth factor stimulus (GO:0071364),45,9,1.86,+,4.84,2.51E-04,3.73E-02,Linear_Group,4,Decrease,Early,NA
pyruvate metabolic process (GO:0006090),71,14,2.94,+,4.77,6.01E-06,2.52E-03,Linear_Group,4,Decrease,Early,NA
nucleoside diphosphate phosphorylation (GO:0006165),61,12,2.52,+,4.76,2.81E-05,7.71E-03,Linear_Group,4,Decrease,Early,NA
lymphocyte homeostasis (GO:0002260),52,10,2.15,+,4.65,1.52E-04,2.56E-02,Linear_Group,4,Decrease,Early,NA
nucleotide phosphorylation (GO:0046939),63,12,2.60,+,4.61,3.71E-05,9.23E-03,Linear_Group,4,Decrease,Early,NA
monosaccharide biosynthetic process (GO:0046364),54,10,2.23,+,4.48,2.00E-04,3.22E-02,Linear_Group,4,Decrease,Early,NA
regulation of immunoglobulin mediated immune response (GO:0002889),55,10,2.27,+,4.40,2.28E-04,3.60E-02,Linear_Group,4,Decrease,Early,NA
regulation of B cell mediated immunity (GO:0002712),55,10,2.27,+,4.40,2.28E-04,3.56E-02,Linear_Group,4,Decrease,Early,NA
regulation of interleukin-12 production (GO:0032655),57,10,2.36,+,4.24,2.94E-04,4.18E-02,Linear_Group,4,Decrease,Early,NA
positive regulation of T cell proliferation (GO:0042102),97,17,4.01,+,4.24,2.59E-06,1.25E-03,Linear_Group,4,Decrease,Early,NA
nucleoside diphosphate metabolic process (GO:0009132),83,14,3.43,+,4.08,2.85E-05,7.69E-03,Linear_Group,4,Decrease,Early,NA
positive regulation of lymphocyte mediated immunity (GO:0002708),107,16,4.42,+,3.62,2.95E-05,7.84E-03,Linear_Group,4,Decrease,Early,NA
regulation of T cell proliferation (GO:0042129),163,24,6.74,+,3.56,4.25E-07,5.21E-04,Linear_Group,4,Decrease,Early,NA
positive regulation of T cell activation (GO:0050870),206,28,8.52,+,3.29,2.10E-07,4.79E-04,Linear_Group,4,Decrease,Early,NA
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),104,14,4.30,+,3.26,2.46E-04,3.70E-02,Linear_Group,4,Decrease,Early,NA
positive regulation of lymphocyte proliferation (GO:0050671),134,18,5.54,+,3.25,3.49E-05,8.82E-03,Linear_Group,4,Decrease,Early,NA
positive regulation of mononuclear cell proliferation (GO:0032946),135,18,5.58,+,3.23,3.81E-05,9.33E-03,Linear_Group,4,Decrease,Early,NA
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002822),151,20,6.24,+,3.20,1.57E-05,4.72E-03,Linear_Group,4,Decrease,Early,NA
regulation of leukocyte proliferation (GO:0070663),229,30,9.47,+,3.17,1.61E-07,4.26E-04,Linear_Group,4,Decrease,Early,NA
regulation of lymphocyte proliferation (GO:0050670),216,28,8.93,+,3.14,5.00E-07,5.69E-04,Linear_Group,4,Decrease,Early,NA
regulation of cytokine biosynthetic process (GO:0042035),108,14,4.46,+,3.14,3.49E-04,4.83E-02,Linear_Group,4,Decrease,Early,NA
positive regulation of leukocyte cell-cell adhesion (GO:1903039),224,29,9.26,+,3.13,3.22E-07,5.69E-04,Linear_Group,4,Decrease,Early,NA
regulation of mononuclear cell proliferation (GO:0032944),218,28,9.01,+,3.11,5.91E-07,6.28E-04,Linear_Group,4,Decrease,Early,NA
positive regulation of leukocyte proliferation (GO:0070665),141,18,5.83,+,3.09,6.35E-05,1.28E-02,Linear_Group,4,Decrease,Early,NA
regulation of adaptive immune response (GO:0002819),166,21,6.86,+,3.06,1.82E-05,5.36E-03,Linear_Group,4,Decrease,Early,NA
positive regulation of leukocyte differentiation (GO:1902107),151,19,6.24,+,3.04,4.79E-05,1.06E-02,Linear_Group,4,Decrease,Early,NA
positive regulation of leukocyte mediated immunity (GO:0002705),136,17,5.62,+,3.02,1.27E-04,2.24E-02,Linear_Group,4,Decrease,Early,NA
regulation of lymphocyte mediated immunity (GO:0002706),153,19,6.33,+,3.00,5.63E-05,1.18E-02,Linear_Group,4,Decrease,Early,NA
regulation of lymphocyte differentiation (GO:0045619),171,20,7.07,+,2.83,7.73E-05,1.52E-02,Linear_Group,4,Decrease,Early,NA
positive regulation of cell-cell adhesion (GO:0022409),268,31,11.08,+,2.80,1.16E-06,8.39E-04,Linear_Group,4,Decrease,Early,NA
regulation of leukocyte cell-cell adhesion (GO:1903037),307,35,12.69,+,2.76,3.28E-07,5.22E-04,Linear_Group,4,Decrease,Early,NA
adaptive immune response (GO:0002250),613,69,25.34,+,2.72,1.63E-12,8.67E-09,Linear_Group,4,Decrease,Early,NA
regulation of T cell activation (GO:0050863),323,36,13.35,+,2.70,3.67E-07,4.87E-04,Linear_Group,4,Decrease,Early,NA
cellular response to tumor necrosis factor (GO:0071356),245,27,10.13,+,2.67,1.25E-05,4.05E-03,Linear_Group,4,Decrease,Early,NA
positive regulation of hemopoiesis (GO:1903708),192,21,7.94,+,2.65,1.23E-04,2.20E-02,Linear_Group,4,Decrease,Early,NA
regulation of leukocyte mediated immunity (GO:0002703),205,22,8.47,+,2.60,1.10E-04,2.04E-02,Linear_Group,4,Decrease,Early,NA
regulation of B cell activation (GO:0050864),213,22,8.81,+,2.50,2.51E-04,3.68E-02,Linear_Group,4,Decrease,Early,NA
response to tumor necrosis factor (GO:0034612),272,28,11.24,+,2.49,3.18E-05,8.31E-03,Linear_Group,4,Decrease,Early,NA
positive regulation of lymphocyte activation (GO:0051251),367,37,15.17,+,2.44,3.48E-06,1.63E-03,Linear_Group,4,Decrease,Early,NA
regulation of leukocyte differentiation (GO:1902105),280,28,11.58,+,2.42,4.67E-05,1.05E-02,Linear_Group,4,Decrease,Early,NA
positive regulation of cell activation (GO:0050867),423,42,17.49,+,2.40,7.99E-07,7.49E-04,Linear_Group,4,Decrease,Early,NA
regulation of cell-cell adhesion (GO:0022407),414,41,17.12,+,2.40,1.16E-06,8.76E-04,Linear_Group,4,Decrease,Early,NA
positive regulation of leukocyte activation (GO:0002696),409,40,16.91,+,2.37,1.99E-06,1.09E-03,Linear_Group,4,Decrease,Early,NA
regulation of lymphocyte activation (GO:0051249),523,51,21.62,+,2.36,9.31E-08,2.97E-04,Linear_Group,4,Decrease,Early,NA
response to molecule of bacterial origin (GO:0002237),340,32,14.06,+,2.28,4.19E-05,9.67E-03,Linear_Group,4,Decrease,Early,NA
response to lipopolysaccharide (GO:0032496),324,30,13.39,+,2.24,9.38E-05,1.76E-02,Linear_Group,4,Decrease,Early,NA
lymphocyte activation (GO:0046649),379,34,15.67,+,2.17,6.08E-05,1.24E-02,Linear_Group,4,Decrease,Early,NA
positive regulation of cytokine production (GO:0001819),458,41,18.93,+,2.17,1.21E-05,4.03E-03,Linear_Group,4,Decrease,Early,NA
regulation of leukocyte activation (GO:0002694),606,54,25.05,+,2.16,7.21E-07,7.18E-04,Linear_Group,4,Decrease,Early,NA
leukocyte migration (GO:0050900),372,33,15.38,+,2.15,9.33E-05,1.77E-02,Linear_Group,4,Decrease,Early,NA
regulation of cell activation (GO:0050865),646,57,26.71,+,2.13,3.47E-07,5.03E-04,Linear_Group,4,Decrease,Early,NA
immune system development (GO:0002520),658,56,27.20,+,2.06,1.26E-06,8.75E-04,Linear_Group,4,Decrease,Early,NA
regulation of immune effector process (GO:0002697),468,39,19.35,+,2.02,1.13E-04,2.05E-02,Linear_Group,4,Decrease,Early,NA
hematopoietic or lymphoid organ development (GO:0048534),621,51,25.67,+,1.99,1.18E-05,4.08E-03,Linear_Group,4,Decrease,Early,NA
inflammatory response (GO:0006954),502,41,20.75,+,1.98,8.21E-05,1.59E-02,Linear_Group,4,Decrease,Early,NA
immune response (GO:0006955),1869,151,77.27,+,1.95,1.31E-14,2.08E-10,Linear_Group,4,Decrease,Early,NA
negative regulation of immune system process (GO:0002683),458,37,18.93,+,1.95,2.51E-04,3.70E-02,Linear_Group,4,Decrease,Early,NA
regulation of cytokine production (GO:0001817),724,56,29.93,+,1.87,2.11E-05,6.11E-03,Linear_Group,4,Decrease,Early,NA
cytokine-mediated signaling pathway (GO:0019221),694,53,28.69,+,1.85,5.08E-05,1.09E-02,Linear_Group,4,Decrease,Early,NA
hemopoiesis (GO:0030097),571,43,23.61,+,1.82,3.21E-04,4.49E-02,Linear_Group,4,Decrease,Early,NA
cellular response to cytokine stimulus (GO:0071345),1031,76,42.62,+,1.78,3.67E-06,1.67E-03,Linear_Group,4,Decrease,Early,NA
positive regulation of immune system process (GO:0002684),1160,85,47.96,+,1.77,9.52E-07,8.42E-04,Linear_Group,4,Decrease,Early,NA
regulation of cell adhesion (GO:0030155),701,51,28.98,+,1.76,1.91E-04,3.10E-02,Linear_Group,4,Decrease,Early,NA
positive regulation of cell population proliferation (GO:0008284),926,66,38.28,+,1.72,3.98E-05,9.33E-03,Linear_Group,4,Decrease,Early,NA
regulation of response to external stimulus (GO:0032101),1097,78,45.35,+,1.72,1.00E-05,3.80E-03,Linear_Group,4,Decrease,Early,NA
immune system process (GO:0002376),2807,198,116.04,+,1.71,1.72E-13,1.37E-09,Linear_Group,4,Decrease,Early,NA
response to cytokine (GO:0034097),1122,77,46.38,+,1.66,3.47E-05,8.92E-03,Linear_Group,4,Decrease,Early,NA
regulation of locomotion (GO:0040012),1010,68,41.75,+,1.63,1.56E-04,2.60E-02,Linear_Group,4,Decrease,Early,NA
regulation of immune response (GO:0050776),1144,77,47.29,+,1.63,5.75E-05,1.19E-02,Linear_Group,4,Decrease,Early,NA
regulation of cellular component movement (GO:0051270),1022,68,42.25,+,1.61,2.30E-04,3.56E-02,Linear_Group,4,Decrease,Early,NA
regulation of immune system process (GO:0002682),1681,111,69.49,+,1.60,2.56E-06,1.27E-03,Linear_Group,4,Decrease,Early,NA
cell surface receptor signaling pathway (GO:0007166),2483,156,102.65,+,1.52,2.85E-07,5.67E-04,Linear_Group,4,Decrease,Early,NA
intracellular signal transduction (GO:0035556),1698,103,70.20,+,1.47,1.50E-04,2.60E-02,Linear_Group,4,Decrease,Early,NA
positive regulation of multicellular organismal process (GO:0051240),1771,107,73.21,+,1.46,1.52E-04,2.58E-02,Linear_Group,4,Decrease,Early,NA
cellular response to organic substance (GO:0071310),2400,143,99.22,+,1.44,1.44E-05,4.57E-03,Linear_Group,4,Decrease,Early,NA
cellular response to chemical stimulus (GO:0070887),2937,169,121.42,+,1.39,1.47E-05,4.60E-03,Linear_Group,4,Decrease,Early,NA
signal transduction (GO:0007165),5135,275,212.29,+,1.30,2.45E-06,1.26E-03,Linear_Group,4,Decrease,Early,NA
cell communication (GO:0007154),5576,297,230.52,+,1.29,1.15E-06,9.19E-04,Linear_Group,4,Decrease,Early,NA
signaling (GO:0023052),5473,291,226.26,+,1.29,1.82E-06,1.03E-03,Linear_Group,4,Decrease,Early,NA
response to chemical (GO:0042221),4496,238,185.87,+,1.28,4.29E-05,9.77E-03,Linear_Group,4,Decrease,Early,NA
response to stimulus (GO:0050896),8534,441,352.80,+,1.25,3.38E-09,1.35E-05,Linear_Group,4,Decrease,Early,NA
cellular response to stimulus (GO:0051716),6782,349,280.37,+,1.24,1.72E-06,1.10E-03,Linear_Group,4,Decrease,Early,NA
macromolecule localization (GO:0033036),2537,70,104.88,-,.67,2.17E-04,3.45E-02,Linear_Group,4,Decrease,Early,NA
cellular localization (GO:0051641),2411,66,99.67,-,.66,2.43E-04,3.68E-02,Linear_Group,4,Decrease,Early,NA
gene expression (GO:0010467),2026,53,83.76,-,.63,3.01E-04,4.25E-02,Linear_Group,4,Decrease,Early,NA
protein localization (GO:0008104),2201,56,90.99,-,.62,6.36E-05,1.27E-02,Linear_Group,4,Decrease,Early,NA
nucleic acid metabolic process (GO:0090304),2292,56,94.75,-,.59,1.18E-05,4.00E-03,Linear_Group,4,Decrease,Early,NA
RNA metabolic process (GO:0016070),1690,40,69.87,-,.57,1.10E-04,2.02E-02,Linear_Group,4,Decrease,Early,NA
protein transport (GO:0015031),1525,36,63.04,-,.57,2.63E-04,3.81E-02,Linear_Group,4,Decrease,Early,NA
cellular protein localization (GO:0034613),1635,37,67.59,-,.55,4.94E-05,1.08E-02,Linear_Group,4,Decrease,Early,NA
cellular macromolecule localization (GO:0070727),1643,37,67.92,-,.54,3.93E-05,9.34E-03,Linear_Group,4,Decrease,Early,NA
intracellular transport (GO:0046907),1527,30,63.13,-,.48,4.02E-06,1.78E-03,Linear_Group,4,Decrease,Early,NA
cellular macromolecule catabolic process (GO:0044265),912,17,37.70,-,.45,2.79E-04,4.01E-02,Linear_Group,4,Decrease,Early,NA
intracellular protein transport (GO:0006886),1003,17,41.46,-,.41,2.47E-05,6.91E-03,Linear_Group,4,Decrease,Early,NA
ribonucleoprotein complex biogenesis (GO:0022613),423,4,17.49,-,.23,2.42E-04,3.71E-02,Linear_Group,4,Decrease,Early,NA
regulation of RNA metabolic process (GO:0051252),3808,96,58.81,+,1.63,6.64E-07,1.06E-02,Linear_Group,4,Increase,Early,NA
regulation of nucleobase-containing compound metabolic process (GO:0019219),4062,98,62.73,+,1.56,3.64E-06,1.94E-02,Linear_Group,4,Increase,Early,NA
regulation of cellular macromolecule biosynthetic process (GO:2000112),3931,94,60.71,+,1.55,8.09E-06,3.22E-02,Linear_Group,4,Increase,Early,NA
regulation of gene expression (GO:0010468),4483,106,69.23,+,1.53,3.01E-06,2.40E-02,Linear_Group,4,Increase,Early,NA
threonine catabolic process (GO:0006567),5,3,.03,+,90.66,1.52E-05,6.05E-02,Linear_Group,4,Both,Early,NA
L-serine catabolic process (GO:0006565),5,3,.03,+,90.66,1.52E-05,4.84E-02,Linear_Group,4,Both,Early,NA
L-threonine catabolic process to glycine (GO:0019518),5,3,.03,+,90.66,1.52E-05,4.04E-02,Linear_Group,4,Both,Early,NA
serine family amino acid metabolic process (GO:0009069),39,5,.26,+,19.37,1.01E-05,8.04E-02,Linear_Group,4,Both,Early,NA
drug catabolic process (GO:0042737),141,8,.93,+,8.57,6.51E-06,1.04E-01,Linear_Group,4,Both,Early,NA
alpha-amino acid metabolic process (GO:1901605),200,9,1.32,+,6.80,1.02E-05,5.44E-02,Linear_Group,4,Both,Early,NA
regulation of locomotion (GO:0040012),1010,22,6.83,+,3.22,1.50E-06,2.39E-02,Linear_Group,3,Decrease,Late,NA
regulation of cell migration (GO:0030334),873,19,5.90,+,3.22,8.48E-06,4.51E-02,Linear_Group,3,Decrease,Late,NA
regulation of cell motility (GO:2000145),938,20,6.34,+,3.15,6.46E-06,5.15E-02,Linear_Group,3,Decrease,Late,NA
skeletal muscle adaptation (GO:0043501),13,5,.45,+,11.12,2.45E-04,3.37E-02,Linear_Group,3,Increase,Late,NA
NADH regeneration (GO:0006735),27,9,.93,+,9.64,2.07E-06,9.18E-04,Linear_Group,3,Increase,Late,NA
glucose catabolic process to pyruvate (GO:0061718),27,9,.93,+,9.64,2.07E-06,8.93E-04,Linear_Group,3,Increase,Late,NA
canonical glycolysis (GO:0061621),27,9,.93,+,9.64,2.07E-06,8.69E-04,Linear_Group,3,Increase,Late,NA
glycolytic process through glucose-6-phosphate (GO:0061620),28,9,.97,+,9.30,2.66E-06,1.01E-03,Linear_Group,3,Increase,Late,NA
glycolytic process through fructose-6-phosphate (GO:0061615),28,9,.97,+,9.30,2.66E-06,9.85E-04,Linear_Group,3,Increase,Late,NA
glucose catabolic process (GO:0006007),31,9,1.07,+,8.40,5.34E-06,1.55E-03,Linear_Group,3,Increase,Late,NA
glycolytic process (GO:0006096),42,12,1.45,+,8.26,1.68E-07,1.16E-04,Linear_Group,3,Increase,Late,NA
ATP generation from ADP (GO:0006757),43,12,1.49,+,8.07,2.08E-07,1.38E-04,Linear_Group,3,Increase,Late,NA
positive regulation of nitric-oxide synthase activity (GO:0051000),22,6,.76,+,7.89,2.74E-04,3.64E-02,Linear_Group,3,Increase,Late,NA
NADH metabolic process (GO:0006734),38,10,1.31,+,7.61,3.39E-06,1.20E-03,Linear_Group,3,Increase,Late,NA
B cell homeostasis (GO:0001782),23,6,.80,+,7.54,3.36E-04,4.15E-02,Linear_Group,3,Increase,Late,NA
NAD metabolic process (GO:0019674),45,11,1.56,+,7.07,2.04E-06,9.27E-04,Linear_Group,3,Increase,Late,NA
negative regulation of B cell activation (GO:0050869),33,8,1.14,+,7.01,5.38E-05,1.13E-02,Linear_Group,3,Increase,Late,NA
ADP metabolic process (GO:0046031),51,12,1.76,+,6.80,9.91E-07,4.93E-04,Linear_Group,3,Increase,Late,NA
purine ribonucleoside diphosphate metabolic process (GO:0009179),63,14,2.18,+,6.43,2.29E-07,1.46E-04,Linear_Group,3,Increase,Late,NA
purine nucleoside diphosphate metabolic process (GO:0009135),63,14,2.18,+,6.43,2.29E-07,1.40E-04,Linear_Group,3,Increase,Late,NA
ribonucleoside diphosphate metabolic process (GO:0009185),65,14,2.25,+,6.23,3.19E-07,1.81E-04,Linear_Group,3,Increase,Late,NA
actin-myosin filament sliding (GO:0033275),38,8,1.31,+,6.09,1.27E-04,2.15E-02,Linear_Group,3,Increase,Late,NA
muscle filament sliding (GO:0030049),38,8,1.31,+,6.09,1.27E-04,2.13E-02,Linear_Group,3,Increase,Late,NA
regulation of T-helper cell differentiation (GO:0045622),34,7,1.18,+,5.95,3.78E-04,4.59E-02,Linear_Group,3,Increase,Late,NA
gluconeogenesis (GO:0006094),45,9,1.56,+,5.78,6.84E-05,1.30E-02,Linear_Group,3,Increase,Late,NA
regulation of defense response to virus by host (GO:0050691),40,8,1.38,+,5.78,1.73E-04,2.70E-02,Linear_Group,3,Increase,Late,NA
nucleoside diphosphate phosphorylation (GO:0006165),61,12,2.11,+,5.69,5.03E-06,1.48E-03,Linear_Group,3,Increase,Late,NA
lymphocyte homeostasis (GO:0002260),52,10,1.80,+,5.56,3.65E-05,8.31E-03,Linear_Group,3,Increase,Late,NA
monocyte chemotaxis (GO:0002548),42,8,1.45,+,5.51,2.32E-04,3.30E-02,Linear_Group,3,Increase,Late,NA
nucleotide phosphorylation (GO:0046939),63,12,2.18,+,5.51,6.73E-06,1.88E-03,Linear_Group,3,Increase,Late,NA
hexose biosynthetic process (GO:0019319),48,9,1.66,+,5.42,1.06E-04,1.83E-02,Linear_Group,3,Increase,Late,NA
pyruvate metabolic process (GO:0006090),71,13,2.46,+,5.30,4.10E-06,1.36E-03,Linear_Group,3,Increase,Late,NA
regulation of interleukin-12 production (GO:0032655),57,10,1.97,+,5.07,7.25E-05,1.36E-02,Linear_Group,3,Increase,Late,NA
positive regulation of T cell proliferation (GO:0042102),97,17,3.35,+,5.07,2.42E-07,1.43E-04,Linear_Group,3,Increase,Late,NA
hexose catabolic process (GO:0019320),53,9,1.83,+,4.91,2.06E-04,3.12E-02,Linear_Group,3,Increase,Late,NA
leukocyte cell-cell adhesion (GO:0007159),53,9,1.83,+,4.91,2.06E-04,3.09E-02,Linear_Group,3,Increase,Late,NA
nucleoside diphosphate metabolic process (GO:0009132),83,14,2.87,+,4.88,4.12E-06,1.34E-03,Linear_Group,3,Increase,Late,NA
positive regulation of leukocyte mediated cytotoxicity (GO:0001912),54,9,1.87,+,4.82,2.33E-04,3.29E-02,Linear_Group,3,Increase,Late,NA
monosaccharide biosynthetic process (GO:0046364),54,9,1.87,+,4.82,2.33E-04,3.26E-02,Linear_Group,3,Increase,Late,NA
regulation of immunoglobulin mediated immune response (GO:0002889),55,9,1.90,+,4.73,2.63E-04,3.59E-02,Linear_Group,3,Increase,Late,NA
regulation of B cell mediated immunity (GO:0002712),55,9,1.90,+,4.73,2.63E-04,3.56E-02,Linear_Group,3,Increase,Late,NA
positive regulation of cell killing (GO:0031343),66,10,2.28,+,4.38,2.13E-04,3.11E-02,Linear_Group,3,Increase,Late,NA
regulation of T cell proliferation (GO:0042129),163,24,5.64,+,4.26,1.76E-08,2.00E-05,Linear_Group,3,Increase,Late,NA
leukocyte homeostasis (GO:0001776),70,10,2.42,+,4.13,3.26E-04,4.12E-02,Linear_Group,3,Increase,Late,NA
positive regulation of T cell activation (GO:0050870),206,28,7.12,+,3.93,5.63E-09,1.28E-05,Linear_Group,3,Increase,Late,NA
positive regulation of lymphocyte proliferation (GO:0050671),134,18,4.63,+,3.88,3.43E-06,1.19E-03,Linear_Group,3,Increase,Late,NA
positive regulation of mononuclear cell proliferation (GO:0032946),135,18,4.67,+,3.86,3.77E-06,1.28E-03,Linear_Group,3,Increase,Late,NA
regulation of calcium-mediated signaling (GO:0050848),98,13,3.39,+,3.84,8.62E-05,1.56E-02,Linear_Group,3,Increase,Late,NA
positive regulation of lymphocyte mediated immunity (GO:0002708),107,14,3.70,+,3.78,5.33E-05,1.13E-02,Linear_Group,3,Increase,Late,NA
regulation of lymphocyte proliferation (GO:0050670),216,28,7.47,+,3.75,1.43E-08,2.27E-05,Linear_Group,3,Increase,Late,NA
positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),85,11,2.94,+,3.74,3.60E-04,4.41E-02,Linear_Group,3,Increase,Late,NA
regulation of mononuclear cell proliferation (GO:0032944),218,28,7.54,+,3.71,1.70E-08,2.09E-05,Linear_Group,3,Increase,Late,NA
positive regulation of leukocyte proliferation (GO:0070665),141,18,4.88,+,3.69,6.51E-06,1.85E-03,Linear_Group,3,Increase,Late,NA
regulation of leukocyte proliferation (GO:0070663),229,29,7.92,+,3.66,1.26E-08,2.23E-05,Linear_Group,3,Increase,Late,NA
positive regulation of lymphocyte differentiation (GO:0045621),96,12,3.32,+,3.61,2.63E-04,3.53E-02,Linear_Group,3,Increase,Late,NA
positive regulation of leukocyte cell-cell adhesion (GO:1903039),224,28,7.75,+,3.61,2.88E-08,2.87E-05,Linear_Group,3,Increase,Late,NA
regulation of cytokine biosynthetic process (GO:0042035),108,13,3.73,+,3.48,2.08E-04,3.06E-02,Linear_Group,3,Increase,Late,NA
positive regulation of leukocyte differentiation (GO:1902107),151,18,5.22,+,3.45,1.52E-05,3.79E-03,Linear_Group,3,Increase,Late,NA
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002822),151,18,5.22,+,3.45,1.52E-05,3.73E-03,Linear_Group,3,Increase,Late,NA
regulation of lymphocyte differentiation (GO:0045619),171,20,5.91,+,3.38,6.73E-06,1.85E-03,Linear_Group,3,Increase,Late,NA
leukocyte chemotaxis (GO:0030595),139,16,4.81,+,3.33,6.53E-05,1.27E-02,Linear_Group,3,Increase,Late,NA
regulation of adaptive immune response (GO:0002819),166,19,5.74,+,3.31,1.50E-05,3.79E-03,Linear_Group,3,Increase,Late,NA
glucose metabolic process (GO:0006006),116,13,4.01,+,3.24,3.91E-04,4.71E-02,Linear_Group,3,Increase,Late,NA
positive regulation of cell-cell adhesion (GO:0022409),268,30,9.27,+,3.24,8.69E-08,6.59E-05,Linear_Group,3,Increase,Late,NA
regulation of T cell differentiation (GO:0045580),143,16,4.94,+,3.24,8.86E-05,1.59E-02,Linear_Group,3,Increase,Late,NA
regulation of T cell activation (GO:0050863),323,36,11.17,+,3.22,4.95E-09,1.32E-05,Linear_Group,3,Increase,Late,NA
regulation of lymphocyte mediated immunity (GO:0002706),153,17,5.29,+,3.21,5.84E-05,1.21E-02,Linear_Group,3,Increase,Late,NA
adaptive immune response (GO:0002250),613,68,21.20,+,3.21,6.84E-16,3.63E-12,Linear_Group,3,Increase,Late,NA
regulation of leukocyte cell-cell adhesion (GO:1903037),307,34,10.62,+,3.20,1.53E-08,2.03E-05,Linear_Group,3,Increase,Late,NA
positive regulation of leukocyte mediated immunity (GO:0002705),136,15,4.70,+,3.19,1.68E-04,2.68E-02,Linear_Group,3,Increase,Late,NA
cellular response to tumor necrosis factor (GO:0071356),245,26,8.47,+,3.07,1.56E-06,7.32E-04,Linear_Group,3,Increase,Late,NA
immunoglobulin production (GO:0002377),155,16,5.36,+,2.99,2.08E-04,3.09E-02,Linear_Group,3,Increase,Late,NA
response to tumor necrosis factor (GO:0034612),272,27,9.41,+,2.87,3.15E-06,1.14E-03,Linear_Group,3,Increase,Late,NA
positive regulation of hemopoiesis (GO:1903708),192,19,6.64,+,2.86,9.18E-05,1.62E-02,Linear_Group,3,Increase,Late,NA
regulation of B cell activation (GO:0050864),213,21,7.37,+,2.85,4.20E-05,9.29E-03,Linear_Group,3,Increase,Late,NA
positive regulation of lymphocyte activation (GO:0051251),367,36,12.69,+,2.84,9.73E-08,7.04E-05,Linear_Group,3,Increase,Late,NA
regulation of leukocyte mediated immunity (GO:0002703),205,20,7.09,+,2.82,7.26E-05,1.34E-02,Linear_Group,3,Increase,Late,NA
regulation of lymphocyte activation (GO:0051249),523,50,18.08,+,2.76,6.80E-10,2.71E-06,Linear_Group,3,Increase,Late,NA
positive regulation of leukocyte activation (GO:0002696),409,39,14.14,+,2.76,5.68E-08,4.52E-05,Linear_Group,3,Increase,Late,NA
production of molecular mediator of immune response (GO:0002440),179,17,6.19,+,2.75,3.29E-04,4.13E-02,Linear_Group,3,Increase,Late,NA
negative regulation of leukocyte activation (GO:0002695),179,17,6.19,+,2.75,3.29E-04,4.10E-02,Linear_Group,3,Increase,Late,NA
positive regulation of cell activation (GO:0050867),423,40,14.63,+,2.73,4.71E-08,4.17E-05,Linear_Group,3,Increase,Late,NA
regulation of leukocyte differentiation (GO:1902105),280,26,9.68,+,2.69,1.42E-05,3.70E-03,Linear_Group,3,Increase,Late,NA
lymphocyte differentiation (GO:0030098),237,22,8.20,+,2.68,6.38E-05,1.25E-02,Linear_Group,3,Increase,Late,NA
lymphocyte activation (GO:0046649),379,34,13.11,+,2.59,2.14E-06,8.74E-04,Linear_Group,3,Increase,Late,NA
regulation of cell-cell adhesion (GO:0022407),414,37,14.32,+,2.58,7.28E-07,3.74E-04,Linear_Group,3,Increase,Late,NA
regulation of leukocyte activation (GO:0002694),606,53,20.95,+,2.53,3.81E-09,1.21E-05,Linear_Group,3,Increase,Late,NA
leukocyte differentiation (GO:0002521),343,29,11.86,+,2.45,2.65E-05,6.30E-03,Linear_Group,3,Increase,Late,NA
regulation of cell activation (GO:0050865),646,54,22.34,+,2.42,1.18E-08,2.35E-05,Linear_Group,3,Increase,Late,NA
regulation of immune effector process (GO:0002697),468,37,16.18,+,2.29,8.18E-06,2.21E-03,Linear_Group,3,Increase,Late,NA
leukocyte migration (GO:0050900),372,29,12.86,+,2.25,1.07E-04,1.83E-02,Linear_Group,3,Increase,Late,NA
immune response (GO:0006955),1869,145,64.63,+,2.24,3.58E-19,5.71E-15,Linear_Group,3,Increase,Late,NA
immune system development (GO:0002520),658,51,22.75,+,2.24,3.25E-07,1.78E-04,Linear_Group,3,Increase,Late,NA
response to molecule of bacterial origin (GO:0002237),340,26,11.76,+,2.21,3.22E-04,4.11E-02,Linear_Group,3,Increase,Late,NA
positive regulation of cytokine production (GO:0001819),458,35,15.84,+,2.21,3.33E-05,7.70E-03,Linear_Group,3,Increase,Late,NA
positive regulation of cell adhesion (GO:0045785),419,32,14.49,+,2.21,8.44E-05,1.55E-02,Linear_Group,3,Increase,Late,NA
inflammatory response (GO:0006954),502,38,17.36,+,2.19,1.61E-05,3.89E-03,Linear_Group,3,Increase,Late,NA
negative regulation of immune system process (GO:0002683),458,34,15.84,+,2.15,6.54E-05,1.25E-02,Linear_Group,3,Increase,Late,NA
hematopoietic or lymphoid organ development (GO:0048534),621,46,21.47,+,2.14,4.68E-06,1.43E-03,Linear_Group,3,Increase,Late,NA
cytokine-mediated signaling pathway (GO:0019221),694,51,24.00,+,2.13,1.28E-06,6.18E-04,Linear_Group,3,Increase,Late,NA
regulation of hemopoiesis (GO:1903706),460,33,15.91,+,2.07,1.80E-04,2.76E-02,Linear_Group,3,Increase,Late,NA
hemopoiesis (GO:0030097),571,40,19.74,+,2.03,5.24E-05,1.13E-02,Linear_Group,3,Increase,Late,NA
positive regulation of immune system process (GO:0002684),1160,80,40.11,+,1.99,1.90E-08,2.02E-05,Linear_Group,3,Increase,Late,NA
cellular response to cytokine stimulus (GO:0071345),1031,69,35.65,+,1.94,4.48E-07,2.38E-04,Linear_Group,3,Increase,Late,NA
regulation of cytokine production (GO:0001817),724,48,25.03,+,1.92,3.72E-05,8.35E-03,Linear_Group,3,Increase,Late,NA
immune system process (GO:0002376),2807,185,97.06,+,1.91,1.62E-17,1.29E-13,Linear_Group,3,Increase,Late,NA
regulation of immune response (GO:0050776),1144,72,39.56,+,1.82,2.29E-06,9.12E-04,Linear_Group,3,Increase,Late,NA
response to cytokine (GO:0034097),1122,70,38.80,+,1.80,4.23E-06,1.32E-03,Linear_Group,3,Increase,Late,NA
positive regulation of immune response (GO:0050778),847,52,29.29,+,1.78,1.29E-04,2.15E-02,Linear_Group,3,Increase,Late,NA
regulation of immune system process (GO:0002682),1681,103,58.13,+,1.77,4.08E-08,3.82E-05,Linear_Group,3,Increase,Late,NA
leukocyte activation (GO:0045321),915,55,31.64,+,1.74,1.54E-04,2.51E-02,Linear_Group,3,Increase,Late,NA
positive regulation of cell population proliferation (GO:0008284),926,55,32.02,+,1.72,1.75E-04,2.70E-02,Linear_Group,3,Increase,Late,NA
regulation of response to external stimulus (GO:0032101),1097,64,37.93,+,1.69,9.87E-05,1.73E-02,Linear_Group,3,Increase,Late,NA
cell activation (GO:0001775),1062,60,36.72,+,1.63,3.17E-04,4.07E-02,Linear_Group,3,Increase,Late,NA
cell surface receptor signaling pathway (GO:0007166),2483,140,85.86,+,1.63,1.47E-08,2.13E-05,Linear_Group,3,Increase,Late,NA
defense response (GO:0006952),1352,74,46.75,+,1.58,1.71E-04,2.70E-02,Linear_Group,3,Increase,Late,NA
positive regulation of multicellular organismal process (GO:0051240),1771,94,61.24,+,1.53,6.38E-05,1.27E-02,Linear_Group,3,Increase,Late,NA
movement of cell or subcellular component (GO:0006928),1544,81,53.39,+,1.52,3.10E-04,4.02E-02,Linear_Group,3,Increase,Late,NA
cellular response to organic substance (GO:0071310),2400,116,82.99,+,1.40,3.06E-04,4.00E-02,Linear_Group,3,Increase,Late,NA
signal transduction (GO:0007165),5135,235,177.56,+,1.32,2.58E-06,1.00E-03,Linear_Group,3,Increase,Late,NA
signaling (GO:0023052),5473,246,189.25,+,1.30,4.22E-06,1.34E-03,Linear_Group,3,Increase,Late,NA
cell communication (GO:0007154),5576,250,192.81,+,1.30,4.72E-06,1.42E-03,Linear_Group,3,Increase,Late,NA
response to stimulus (GO:0050896),8534,369,295.09,+,1.25,5.31E-08,4.46E-05,Linear_Group,3,Increase,Late,NA
cellular response to stimulus (GO:0051716),6782,289,234.51,+,1.23,3.12E-05,7.32E-03,Linear_Group,3,Increase,Late,NA
cellular metabolic process (GO:0044237),7652,215,264.60,-,.81,1.55E-04,2.49E-02,Linear_Group,3,Increase,Late,NA
macromolecule localization (GO:0033036),2537,56,87.73,-,.64,2.31E-04,3.32E-02,Linear_Group,3,Increase,Late,NA
protein localization (GO:0008104),2201,46,76.11,-,.60,1.50E-04,2.46E-02,Linear_Group,3,Increase,Late,NA
cellular catabolic process (GO:0044248),1795,36,62.07,-,.58,3.06E-04,4.02E-02,Linear_Group,3,Increase,Late,NA
amide transport (GO:0042886),1589,30,54.95,-,.55,2.36E-04,3.26E-02,Linear_Group,3,Increase,Late,NA
protein transport (GO:0015031),1525,28,52.73,-,.53,2.30E-04,3.33E-02,Linear_Group,3,Increase,Late,NA
cellular protein localization (GO:0034613),1635,29,56.54,-,.51,6.36E-05,1.28E-02,Linear_Group,3,Increase,Late,NA
cellular macromolecule localization (GO:0070727),1643,29,56.81,-,.51,4.94E-05,1.08E-02,Linear_Group,3,Increase,Late,NA
intracellular transport (GO:0046907),1527,24,52.80,-,.45,9.62E-06,2.55E-03,Linear_Group,3,Increase,Late,NA
organonitrogen compound catabolic process (GO:1901565),1072,15,37.07,-,.40,5.94E-05,1.21E-02,Linear_Group,3,Increase,Late,NA
intracellular protein transport (GO:0006886),1003,12,34.68,-,.35,1.44E-05,3.71E-03,Linear_Group,3,Increase,Late,NA
negative regulation of chronic inflammatory response (GO:0002677),4,4,.17,+,24.19,1.52E-04,2.60E-02,Linear_Group,3,Both,Late,NA
regulation of chronic inflammatory response (GO:0002676),9,5,.37,+,13.44,1.45E-04,2.53E-02,Linear_Group,3,Both,Late,NA
lymph node development (GO:0048535),18,7,.74,+,9.41,3.89E-05,9.40E-03,Linear_Group,3,Both,Late,NA
NADH regeneration (GO:0006735),27,9,1.12,+,8.06,8.42E-06,3.44E-03,Linear_Group,3,Both,Late,NA
glucose catabolic process to pyruvate (GO:0061718),27,9,1.12,+,8.06,8.42E-06,3.35E-03,Linear_Group,3,Both,Late,NA
canonical glycolysis (GO:0061621),27,9,1.12,+,8.06,8.42E-06,3.27E-03,Linear_Group,3,Both,Late,NA
glycolytic process through glucose-6-phosphate (GO:0061620),28,9,1.16,+,7.78,1.07E-05,3.88E-03,Linear_Group,3,Both,Late,NA
glycolytic process through fructose-6-phosphate (GO:0061615),28,9,1.16,+,7.78,1.07E-05,3.80E-03,Linear_Group,3,Both,Late,NA
glucose catabolic process (GO:0006007),31,9,1.28,+,7.02,2.12E-05,6.03E-03,Linear_Group,3,Both,Late,NA
glycolytic process (GO:0006096),42,12,1.74,+,6.91,1.05E-06,8.77E-04,Linear_Group,3,Both,Late,NA
ATP generation from ADP (GO:0006757),43,12,1.78,+,6.75,1.29E-06,8.57E-04,Linear_Group,3,Both,Late,NA
NADH metabolic process (GO:0006734),38,10,1.57,+,6.37,1.53E-05,4.69E-03,Linear_Group,3,Both,Late,NA
NAD metabolic process (GO:0019674),45,11,1.86,+,5.91,1.05E-05,3.89E-03,Linear_Group,3,Both,Late,NA
negative regulation of B cell activation (GO:0050869),33,8,1.36,+,5.86,1.78E-04,2.92E-02,Linear_Group,3,Both,Late,NA
ADP metabolic process (GO:0046031),51,12,2.11,+,5.69,5.86E-06,2.52E-03,Linear_Group,3,Both,Late,NA
purine ribonucleoside diphosphate metabolic process (GO:0009179),63,14,2.60,+,5.38,1.78E-06,1.09E-03,Linear_Group,3,Both,Late,NA
purine nucleoside diphosphate metabolic process (GO:0009135),63,14,2.60,+,5.38,1.78E-06,1.05E-03,Linear_Group,3,Both,Late,NA
gluconeogenesis (GO:0006094),45,10,1.86,+,5.38,5.33E-05,1.13E-02,Linear_Group,3,Both,Late,NA
ribonucleoside diphosphate metabolic process (GO:0009185),65,14,2.69,+,5.21,2.45E-06,1.30E-03,Linear_Group,3,Both,Late,NA
hexose biosynthetic process (GO:0019319),48,10,1.98,+,5.04,8.54E-05,1.64E-02,Linear_Group,3,Both,Late,NA
cellular response to epidermal growth factor stimulus (GO:0071364),45,9,1.86,+,4.84,2.51E-04,3.73E-02,Linear_Group,3,Both,Late,NA
pyruvate metabolic process (GO:0006090),71,14,2.94,+,4.77,6.01E-06,2.52E-03,Linear_Group,3,Both,Late,NA
nucleoside diphosphate phosphorylation (GO:0006165),61,12,2.52,+,4.76,2.81E-05,7.71E-03,Linear_Group,3,Both,Late,NA
lymphocyte homeostasis (GO:0002260),52,10,2.15,+,4.65,1.52E-04,2.56E-02,Linear_Group,3,Both,Late,NA
nucleotide phosphorylation (GO:0046939),63,12,2.60,+,4.61,3.71E-05,9.23E-03,Linear_Group,3,Both,Late,NA
monosaccharide biosynthetic process (GO:0046364),54,10,2.23,+,4.48,2.00E-04,3.22E-02,Linear_Group,3,Both,Late,NA
regulation of immunoglobulin mediated immune response (GO:0002889),55,10,2.27,+,4.40,2.28E-04,3.60E-02,Linear_Group,3,Both,Late,NA
regulation of B cell mediated immunity (GO:0002712),55,10,2.27,+,4.40,2.28E-04,3.56E-02,Linear_Group,3,Both,Late,NA
regulation of interleukin-12 production (GO:0032655),57,10,2.36,+,4.24,2.94E-04,4.18E-02,Linear_Group,3,Both,Late,NA
positive regulation of T cell proliferation (GO:0042102),97,17,4.01,+,4.24,2.59E-06,1.25E-03,Linear_Group,3,Both,Late,NA
nucleoside diphosphate metabolic process (GO:0009132),83,14,3.43,+,4.08,2.85E-05,7.69E-03,Linear_Group,3,Both,Late,NA
positive regulation of lymphocyte mediated immunity (GO:0002708),107,16,4.42,+,3.62,2.95E-05,7.84E-03,Linear_Group,3,Both,Late,NA
regulation of T cell proliferation (GO:0042129),163,24,6.74,+,3.56,4.25E-07,5.21E-04,Linear_Group,3,Both,Late,NA
positive regulation of T cell activation (GO:0050870),206,28,8.52,+,3.29,2.10E-07,4.79E-04,Linear_Group,3,Both,Late,NA
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),104,14,4.30,+,3.26,2.46E-04,3.70E-02,Linear_Group,3,Both,Late,NA
positive regulation of lymphocyte proliferation (GO:0050671),134,18,5.54,+,3.25,3.49E-05,8.82E-03,Linear_Group,3,Both,Late,NA
positive regulation of mononuclear cell proliferation (GO:0032946),135,18,5.58,+,3.23,3.81E-05,9.33E-03,Linear_Group,3,Both,Late,NA
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002822),151,20,6.24,+,3.20,1.57E-05,4.72E-03,Linear_Group,3,Both,Late,NA
regulation of leukocyte proliferation (GO:0070663),229,30,9.47,+,3.17,1.61E-07,4.26E-04,Linear_Group,3,Both,Late,NA
regulation of lymphocyte proliferation (GO:0050670),216,28,8.93,+,3.14,5.00E-07,5.69E-04,Linear_Group,3,Both,Late,NA
regulation of cytokine biosynthetic process (GO:0042035),108,14,4.46,+,3.14,3.49E-04,4.83E-02,Linear_Group,3,Both,Late,NA
positive regulation of leukocyte cell-cell adhesion (GO:1903039),224,29,9.26,+,3.13,3.22E-07,5.69E-04,Linear_Group,3,Both,Late,NA
regulation of mononuclear cell proliferation (GO:0032944),218,28,9.01,+,3.11,5.91E-07,6.28E-04,Linear_Group,3,Both,Late,NA
positive regulation of leukocyte proliferation (GO:0070665),141,18,5.83,+,3.09,6.35E-05,1.28E-02,Linear_Group,3,Both,Late,NA
regulation of adaptive immune response (GO:0002819),166,21,6.86,+,3.06,1.82E-05,5.36E-03,Linear_Group,3,Both,Late,NA
positive regulation of leukocyte differentiation (GO:1902107),151,19,6.24,+,3.04,4.79E-05,1.06E-02,Linear_Group,3,Both,Late,NA
positive regulation of leukocyte mediated immunity (GO:0002705),136,17,5.62,+,3.02,1.27E-04,2.24E-02,Linear_Group,3,Both,Late,NA
regulation of lymphocyte mediated immunity (GO:0002706),153,19,6.33,+,3.00,5.63E-05,1.18E-02,Linear_Group,3,Both,Late,NA
regulation of lymphocyte differentiation (GO:0045619),171,20,7.07,+,2.83,7.73E-05,1.52E-02,Linear_Group,3,Both,Late,NA
positive regulation of cell-cell adhesion (GO:0022409),268,31,11.08,+,2.80,1.16E-06,8.39E-04,Linear_Group,3,Both,Late,NA
regulation of leukocyte cell-cell adhesion (GO:1903037),307,35,12.69,+,2.76,3.28E-07,5.22E-04,Linear_Group,3,Both,Late,NA
adaptive immune response (GO:0002250),613,69,25.34,+,2.72,1.63E-12,8.67E-09,Linear_Group,3,Both,Late,NA
regulation of T cell activation (GO:0050863),323,36,13.35,+,2.70,3.67E-07,4.87E-04,Linear_Group,3,Both,Late,NA
cellular response to tumor necrosis factor (GO:0071356),245,27,10.13,+,2.67,1.25E-05,4.05E-03,Linear_Group,3,Both,Late,NA
positive regulation of hemopoiesis (GO:1903708),192,21,7.94,+,2.65,1.23E-04,2.20E-02,Linear_Group,3,Both,Late,NA
regulation of leukocyte mediated immunity (GO:0002703),205,22,8.47,+,2.60,1.10E-04,2.04E-02,Linear_Group,3,Both,Late,NA
regulation of B cell activation (GO:0050864),213,22,8.81,+,2.50,2.51E-04,3.68E-02,Linear_Group,3,Both,Late,NA
response to tumor necrosis factor (GO:0034612),272,28,11.24,+,2.49,3.18E-05,8.31E-03,Linear_Group,3,Both,Late,NA
positive regulation of lymphocyte activation (GO:0051251),367,37,15.17,+,2.44,3.48E-06,1.63E-03,Linear_Group,3,Both,Late,NA
regulation of leukocyte differentiation (GO:1902105),280,28,11.58,+,2.42,4.67E-05,1.05E-02,Linear_Group,3,Both,Late,NA
positive regulation of cell activation (GO:0050867),423,42,17.49,+,2.40,7.99E-07,7.49E-04,Linear_Group,3,Both,Late,NA
regulation of cell-cell adhesion (GO:0022407),414,41,17.12,+,2.40,1.16E-06,8.76E-04,Linear_Group,3,Both,Late,NA
positive regulation of leukocyte activation (GO:0002696),409,40,16.91,+,2.37,1.99E-06,1.09E-03,Linear_Group,3,Both,Late,NA
regulation of lymphocyte activation (GO:0051249),523,51,21.62,+,2.36,9.31E-08,2.97E-04,Linear_Group,3,Both,Late,NA
response to molecule of bacterial origin (GO:0002237),340,32,14.06,+,2.28,4.19E-05,9.67E-03,Linear_Group,3,Both,Late,NA
response to lipopolysaccharide (GO:0032496),324,30,13.39,+,2.24,9.38E-05,1.76E-02,Linear_Group,3,Both,Late,NA
lymphocyte activation (GO:0046649),379,34,15.67,+,2.17,6.08E-05,1.24E-02,Linear_Group,3,Both,Late,NA
positive regulation of cytokine production (GO:0001819),458,41,18.93,+,2.17,1.21E-05,4.03E-03,Linear_Group,3,Both,Late,NA
regulation of leukocyte activation (GO:0002694),606,54,25.05,+,2.16,7.21E-07,7.18E-04,Linear_Group,3,Both,Late,NA
leukocyte migration (GO:0050900),372,33,15.38,+,2.15,9.33E-05,1.77E-02,Linear_Group,3,Both,Late,NA
regulation of cell activation (GO:0050865),646,57,26.71,+,2.13,3.47E-07,5.03E-04,Linear_Group,3,Both,Late,NA
immune system development (GO:0002520),658,56,27.20,+,2.06,1.26E-06,8.75E-04,Linear_Group,3,Both,Late,NA
regulation of immune effector process (GO:0002697),468,39,19.35,+,2.02,1.13E-04,2.05E-02,Linear_Group,3,Both,Late,NA
hematopoietic or lymphoid organ development (GO:0048534),621,51,25.67,+,1.99,1.18E-05,4.08E-03,Linear_Group,3,Both,Late,NA
inflammatory response (GO:0006954),502,41,20.75,+,1.98,8.21E-05,1.59E-02,Linear_Group,3,Both,Late,NA
immune response (GO:0006955),1869,151,77.27,+,1.95,1.31E-14,2.08E-10,Linear_Group,3,Both,Late,NA
negative regulation of immune system process (GO:0002683),458,37,18.93,+,1.95,2.51E-04,3.70E-02,Linear_Group,3,Both,Late,NA
regulation of cytokine production (GO:0001817),724,56,29.93,+,1.87,2.11E-05,6.11E-03,Linear_Group,3,Both,Late,NA
cytokine-mediated signaling pathway (GO:0019221),694,53,28.69,+,1.85,5.08E-05,1.09E-02,Linear_Group,3,Both,Late,NA
hemopoiesis (GO:0030097),571,43,23.61,+,1.82,3.21E-04,4.49E-02,Linear_Group,3,Both,Late,NA
cellular response to cytokine stimulus (GO:0071345),1031,76,42.62,+,1.78,3.67E-06,1.67E-03,Linear_Group,3,Both,Late,NA
positive regulation of immune system process (GO:0002684),1160,85,47.96,+,1.77,9.52E-07,8.42E-04,Linear_Group,3,Both,Late,NA
regulation of cell adhesion (GO:0030155),701,51,28.98,+,1.76,1.91E-04,3.10E-02,Linear_Group,3,Both,Late,NA
positive regulation of cell population proliferation (GO:0008284),926,66,38.28,+,1.72,3.98E-05,9.33E-03,Linear_Group,3,Both,Late,NA
regulation of response to external stimulus (GO:0032101),1097,78,45.35,+,1.72,1.00E-05,3.80E-03,Linear_Group,3,Both,Late,NA
immune system process (GO:0002376),2807,198,116.04,+,1.71,1.72E-13,1.37E-09,Linear_Group,3,Both,Late,NA
response to cytokine (GO:0034097),1122,77,46.38,+,1.66,3.47E-05,8.92E-03,Linear_Group,3,Both,Late,NA
regulation of locomotion (GO:0040012),1010,68,41.75,+,1.63,1.56E-04,2.60E-02,Linear_Group,3,Both,Late,NA
regulation of immune response (GO:0050776),1144,77,47.29,+,1.63,5.75E-05,1.19E-02,Linear_Group,3,Both,Late,NA
regulation of cellular component movement (GO:0051270),1022,68,42.25,+,1.61,2.30E-04,3.56E-02,Linear_Group,3,Both,Late,NA
regulation of immune system process (GO:0002682),1681,111,69.49,+,1.60,2.56E-06,1.27E-03,Linear_Group,3,Both,Late,NA
cell surface receptor signaling pathway (GO:0007166),2483,156,102.65,+,1.52,2.85E-07,5.67E-04,Linear_Group,3,Both,Late,NA
intracellular signal transduction (GO:0035556),1698,103,70.20,+,1.47,1.50E-04,2.60E-02,Linear_Group,3,Both,Late,NA
positive regulation of multicellular organismal process (GO:0051240),1771,107,73.21,+,1.46,1.52E-04,2.58E-02,Linear_Group,3,Both,Late,NA
cellular response to organic substance (GO:0071310),2400,143,99.22,+,1.44,1.44E-05,4.57E-03,Linear_Group,3,Both,Late,NA
cellular response to chemical stimulus (GO:0070887),2937,169,121.42,+,1.39,1.47E-05,4.60E-03,Linear_Group,3,Both,Late,NA
signal transduction (GO:0007165),5135,275,212.29,+,1.30,2.45E-06,1.26E-03,Linear_Group,3,Both,Late,NA
cell communication (GO:0007154),5576,297,230.52,+,1.29,1.15E-06,9.19E-04,Linear_Group,3,Both,Late,NA
signaling (GO:0023052),5473,291,226.26,+,1.29,1.82E-06,1.03E-03,Linear_Group,3,Both,Late,NA
response to chemical (GO:0042221),4496,238,185.87,+,1.28,4.29E-05,9.77E-03,Linear_Group,3,Both,Late,NA
response to stimulus (GO:0050896),8534,441,352.80,+,1.25,3.38E-09,1.35E-05,Linear_Group,3,Both,Late,NA
cellular response to stimulus (GO:0051716),6782,349,280.37,+,1.24,1.72E-06,1.10E-03,Linear_Group,3,Both,Late,NA
macromolecule localization (GO:0033036),2537,70,104.88,-,.67,2.17E-04,3.45E-02,Linear_Group,3,Both,Late,NA
cellular localization (GO:0051641),2411,66,99.67,-,.66,2.43E-04,3.68E-02,Linear_Group,3,Both,Late,NA
gene expression (GO:0010467),2026,53,83.76,-,.63,3.01E-04,4.25E-02,Linear_Group,3,Both,Late,NA
protein localization (GO:0008104),2201,56,90.99,-,.62,6.36E-05,1.27E-02,Linear_Group,3,Both,Late,NA
nucleic acid metabolic process (GO:0090304),2292,56,94.75,-,.59,1.18E-05,4.00E-03,Linear_Group,3,Both,Late,NA
RNA metabolic process (GO:0016070),1690,40,69.87,-,.57,1.10E-04,2.02E-02,Linear_Group,3,Both,Late,NA
protein transport (GO:0015031),1525,36,63.04,-,.57,2.63E-04,3.81E-02,Linear_Group,3,Both,Late,NA
cellular protein localization (GO:0034613),1635,37,67.59,-,.55,4.94E-05,1.08E-02,Linear_Group,3,Both,Late,NA
cellular macromolecule localization (GO:0070727),1643,37,67.92,-,.54,3.93E-05,9.34E-03,Linear_Group,3,Both,Late,NA
intracellular transport (GO:0046907),1527,30,63.13,-,.48,4.02E-06,1.78E-03,Linear_Group,3,Both,Late,NA
cellular macromolecule catabolic process (GO:0044265),912,17,37.70,-,.45,2.79E-04,4.01E-02,Linear_Group,3,Both,Late,NA
intracellular protein transport (GO:0006886),1003,17,41.46,-,.41,2.47E-05,6.91E-03,Linear_Group,3,Both,Late,NA
ribonucleoprotein complex biogenesis (GO:0022613),423,4,17.49,-,.23,2.42E-04,3.71E-02,Linear_Group,3,Both,Late,NA
regulation of chronic inflammatory response (GO:0002676),9,5,.27,+,18.81,3.09E-05,1.97E-02,Linear_Group,4,Both,Late,NA
NADH regeneration (GO:0006735),27,8,.80,+,10.03,5.21E-06,1.04E-02,Linear_Group,4,Both,Late,NA
glucose catabolic process to pyruvate (GO:0061718),27,8,.80,+,10.03,5.21E-06,9.23E-03,Linear_Group,4,Both,Late,NA
canonical glycolysis (GO:0061621),27,8,.80,+,10.03,5.21E-06,8.30E-03,Linear_Group,4,Both,Late,NA
glycolytic process through glucose-6-phosphate (GO:0061620),28,8,.83,+,9.67,6.53E-06,8.01E-03,Linear_Group,4,Both,Late,NA
glycolytic process through fructose-6-phosphate (GO:0061615),28,8,.83,+,9.67,6.53E-06,7.43E-03,Linear_Group,4,Both,Late,NA
glucose catabolic process (GO:0006007),31,8,.92,+,8.74,1.23E-05,9.81E-03,Linear_Group,4,Both,Late,NA
glycolytic process (GO:0006096),42,10,1.24,+,8.06,1.88E-06,7.48E-03,Linear_Group,4,Both,Late,NA
NADH metabolic process (GO:0006734),38,9,1.12,+,8.02,6.40E-06,8.50E-03,Linear_Group,4,Both,Late,NA
ATP generation from ADP (GO:0006757),43,10,1.27,+,7.87,2.26E-06,7.19E-03,Linear_Group,4,Both,Late,NA
gluconeogenesis (GO:0006094),45,10,1.33,+,7.52,3.21E-06,8.53E-03,Linear_Group,4,Both,Late,NA
NAD metabolic process (GO:0019674),45,10,1.33,+,7.52,3.21E-06,7.31E-03,Linear_Group,4,Both,Late,NA
hexose biosynthetic process (GO:0019319),48,10,1.42,+,7.05,5.31E-06,7.69E-03,Linear_Group,4,Both,Late,NA
ADP metabolic process (GO:0046031),51,10,1.51,+,6.64,8.49E-06,7.96E-03,Linear_Group,4,Both,Late,NA
monosaccharide biosynthetic process (GO:0046364),54,10,1.60,+,6.27,1.32E-05,9.56E-03,Linear_Group,4,Both,Late,NA
pyruvate metabolic process (GO:0006090),71,13,2.10,+,6.20,7.62E-07,1.21E-02,Linear_Group,4,Both,Late,NA
purine ribonucleoside diphosphate metabolic process (GO:0009179),63,11,1.86,+,5.91,8.06E-06,8.56E-03,Linear_Group,4,Both,Late,NA
purine nucleoside diphosphate metabolic process (GO:0009135),63,11,1.86,+,5.91,8.06E-06,8.02E-03,Linear_Group,4,Both,Late,NA
ribonucleoside diphosphate metabolic process (GO:0009185),65,11,1.92,+,5.73,1.05E-05,9.28E-03,Linear_Group,4,Both,Late,NA
nucleoside diphosphate phosphorylation (GO:0006165),61,10,1.80,+,5.55,3.36E-05,2.06E-02,Linear_Group,4,Both,Late,NA
nucleotide phosphorylation (GO:0046939),63,10,1.86,+,5.37,4.30E-05,2.36E-02,Linear_Group,4,Both,Late,NA
nucleoside diphosphate metabolic process (GO:0009132),83,11,2.45,+,4.49,7.94E-05,3.83E-02,Linear_Group,4,Both,Late,NA
glucose metabolic process (GO:0006006),116,14,3.43,+,4.09,2.27E-05,1.51E-02,Linear_Group,4,Both,Late,NA
adaptive immune response (GO:0002250),613,42,18.11,+,2.32,1.23E-06,9.77E-03,Linear_Group,4,Both,Late,NA
immune response (GO:0006955),1869,89,55.22,+,1.61,1.30E-05,9.90E-03,Linear_Group,4,Both,Late,NA
nucleic acid metabolic process (GO:0090304),2292,36,67.71,-,.53,1.74E-05,1.21E-02,Linear_Group,4,Both,Late,NA
establishment of protein localization (GO:0045184),1617,23,47.77,-,.48,7.81E-05,3.89E-02,Linear_Group,4,Both,Late,NA
RNA metabolic process (GO:0016070),1690,24,49.93,-,.48,4.29E-05,2.44E-02,Linear_Group,4,Both,Late,NA
amide transport (GO:0042886),1589,22,46.94,-,.47,5.01E-05,2.57E-02,Linear_Group,4,Both,Late,NA
peptide transport (GO:0015833),1555,21,45.94,-,.46,4.14E-05,2.44E-02,Linear_Group,4,Both,Late,NA
protein transport (GO:0015031),1525,19,45.05,-,.42,1.20E-05,1.00E-02,Linear_Group,4,Both,Late,NA
intracellular transport (GO:0046907),1527,17,45.11,-,.38,1.71E-06,9.09E-03,Linear_Group,4,Both,Late,NA
intracellular protein transport (GO:0006886),1003,10,29.63,-,.34,4.44E-05,2.36E-02,Linear_Group,4,Both,Late,NA
threonine catabolic process (GO:0006567),5,3,.03,+,90.66,1.52E-05,6.05E-02,Linear_Group,4,Decrease,Late,NA
L-serine catabolic process (GO:0006565),5,3,.03,+,90.66,1.52E-05,4.84E-02,Linear_Group,4,Decrease,Late,NA
L-threonine catabolic process to glycine (GO:0019518),5,3,.03,+,90.66,1.52E-05,4.04E-02,Linear_Group,4,Decrease,Late,NA
serine family amino acid metabolic process (GO:0009069),39,5,.26,+,19.37,1.01E-05,8.04E-02,Linear_Group,4,Decrease,Late,NA
drug catabolic process (GO:0042737),141,8,.93,+,8.57,6.51E-06,1.04E-01,Linear_Group,4,Decrease,Late,NA
alpha-amino acid metabolic process (GO:1901605),200,9,1.32,+,6.80,1.02E-05,5.44E-02,Linear_Group,4,Decrease,Late,NA
positive regulation of fever generation (GO:0031622),7,4,.16,+,24.93,7.25E-05,3.73E-02,Linear_Group,4,Increase,Late,NA
regulation of heat generation (GO:0031650),13,5,.30,+,16.78,3.73E-05,2.12E-02,Linear_Group,4,Increase,Late,NA
NADH regeneration (GO:0006735),27,8,.62,+,12.92,8.30E-07,1.65E-03,Linear_Group,4,Increase,Late,NA
glucose catabolic process to pyruvate (GO:0061718),27,8,.62,+,12.92,8.30E-07,1.47E-03,Linear_Group,4,Increase,Late,NA
canonical glycolysis (GO:0061621),27,8,.62,+,12.92,8.30E-07,1.32E-03,Linear_Group,4,Increase,Late,NA
glycolytic process through glucose-6-phosphate (GO:0061620),28,8,.64,+,12.46,1.05E-06,1.19E-03,Linear_Group,4,Increase,Late,NA
glycolytic process through fructose-6-phosphate (GO:0061615),28,8,.64,+,12.46,1.05E-06,1.11E-03,Linear_Group,4,Increase,Late,NA
glucose catabolic process (GO:0006007),31,8,.71,+,11.26,2.01E-06,2.00E-03,Linear_Group,4,Increase,Late,NA
glycolytic process (GO:0006096),42,10,.96,+,10.39,1.98E-07,1.58E-03,Linear_Group,4,Increase,Late,NA
NADH metabolic process (GO:0006734),38,9,.87,+,10.33,8.46E-07,1.23E-03,Linear_Group,4,Increase,Late,NA
ATP generation from ADP (GO:0006757),43,10,.99,+,10.14,2.39E-07,9.53E-04,Linear_Group,4,Increase,Late,NA
NAD metabolic process (GO:0019674),45,10,1.03,+,9.69,3.45E-07,1.10E-03,Linear_Group,4,Increase,Late,NA
gluconeogenesis (GO:0006094),45,9,1.03,+,8.72,2.87E-06,2.54E-03,Linear_Group,4,Increase,Late,NA
ADP metabolic process (GO:0046031),51,10,1.17,+,8.55,9.43E-07,1.25E-03,Linear_Group,4,Increase,Late,NA
hexose biosynthetic process (GO:0019319),48,9,1.10,+,8.18,4.58E-06,3.47E-03,Linear_Group,4,Increase,Late,NA
purine ribonucleoside diphosphate metabolic process (GO:0009179),63,11,1.44,+,7.62,7.48E-07,1.99E-03,Linear_Group,4,Increase,Late,NA
purine nucleoside diphosphate metabolic process (GO:0009135),63,11,1.44,+,7.62,7.48E-07,1.70E-03,Linear_Group,4,Increase,Late,NA
ribonucleoside diphosphate metabolic process (GO:0009185),65,11,1.49,+,7.38,9.84E-07,1.21E-03,Linear_Group,4,Increase,Late,NA
monosaccharide biosynthetic process (GO:0046364),54,9,1.24,+,7.27,1.07E-05,6.82E-03,Linear_Group,4,Increase,Late,NA
nucleoside diphosphate phosphorylation (GO:0006165),61,10,1.40,+,7.15,3.95E-06,3.15E-03,Linear_Group,4,Increase,Late,NA
nucleotide phosphorylation (GO:0046939),63,10,1.44,+,6.92,5.11E-06,3.70E-03,Linear_Group,4,Increase,Late,NA
pyruvate metabolic process (GO:0006090),71,11,1.63,+,6.76,2.13E-06,2.00E-03,Linear_Group,4,Increase,Late,NA
hexose catabolic process (GO:0019320),53,8,1.22,+,6.58,6.24E-05,3.43E-02,Linear_Group,4,Increase,Late,NA
monosaccharide catabolic process (GO:0046365),63,9,1.44,+,6.23,3.22E-05,1.90E-02,Linear_Group,4,Increase,Late,NA
nucleoside diphosphate metabolic process (GO:0009132),83,11,1.90,+,5.78,8.26E-06,5.48E-03,Linear_Group,4,Increase,Late,NA
glucose metabolic process (GO:0006006),116,13,2.66,+,4.89,6.78E-06,4.70E-03,Linear_Group,4,Increase,Late,NA
adaptive immune response (GO:0002250),613,41,14.05,+,2.92,3.43E-09,5.46E-05,Linear_Group,4,Increase,Late,NA
immune response (GO:0006955),1869,79,42.85,+,1.84,2.01E-07,1.07E-03,Linear_Group,4,Increase,Late,NA
immune system process (GO:0002376),2807,102,64.35,+,1.59,2.90E-06,2.43E-03,Linear_Group,4,Increase,Late,NA
protein transport (GO:0015031),1525,14,34.96,-,.40,7.22E-05,3.84E-02,Linear_Group,4,Increase,Late,NA
intracellular transport (GO:0046907),1527,13,35.01,-,.37,2.28E-05,1.40E-02,Linear_Group,4,Increase,Late,NA
nuclear cell cycle DNA replication initiation (GO:1902315),4,4,.26,+,15.32,8.05E-04,4.32E-02,TABI,NA,Both,Early,purity_score_500_iter
cell cycle DNA replication initiation (GO:1902292),4,4,.26,+,15.32,8.05E-04,4.30E-02,TABI,NA,Both,Early,purity_score_500_iter
leading strand elongation (GO:0006272),4,4,.26,+,15.32,8.05E-04,4.29E-02,TABI,NA,Both,Early,purity_score_500_iter
mitotic DNA replication initiation (GO:1902975),4,4,.26,+,15.32,8.05E-04,4.27E-02,TABI,NA,Both,Early,purity_score_500_iter
mitotic DNA replication (GO:1902969),11,8,.72,+,11.14,8.00E-06,7.16E-04,TABI,NA,Both,Early,purity_score_500_iter
pre-replicative complex assembly involved in cell cycle DNA replication (GO:1902299),7,5,.46,+,10.94,4.72E-04,2.77E-02,TABI,NA,Both,Early,purity_score_500_iter
pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),7,5,.46,+,10.94,4.72E-04,2.75E-02,TABI,NA,Both,Early,purity_score_500_iter
pre-replicative complex assembly (GO:0036388),7,5,.46,+,10.94,4.72E-04,2.74E-02,TABI,NA,Both,Early,purity_score_500_iter
protein localization to kinetochore (GO:0034501),13,9,.85,+,10.61,2.85E-06,2.98E-04,TABI,NA,Both,Early,purity_score_500_iter
DNA strand elongation involved in DNA replication (GO:0006271),18,12,1.17,+,10.21,8.21E-08,1.21E-05,TABI,NA,Both,Early,purity_score_500_iter
double-strand break repair via break-induced replication (GO:0000727),11,7,.72,+,9.75,5.58E-05,4.25E-03,TABI,NA,Both,Early,purity_score_500_iter
mitotic spindle elongation (GO:0000022),8,5,.52,+,9.58,7.29E-04,3.97E-02,TABI,NA,Both,Early,purity_score_500_iter
prophase (GO:0051324),15,9,.98,+,9.19,6.69E-06,6.23E-04,TABI,NA,Both,Early,purity_score_500_iter
mitotic prophase (GO:0000088),15,9,.98,+,9.19,6.69E-06,6.20E-04,TABI,NA,Both,Early,purity_score_500_iter
"protein localization to chromosome, centromeric region (GO:0071459)",17,10,1.11,+,9.01,2.33E-06,2.54E-04,TABI,NA,Both,Early,purity_score_500_iter
DNA strand elongation (GO:0022616),23,13,1.50,+,8.66,9.93E-08,1.41E-05,TABI,NA,Both,Early,purity_score_500_iter
mitotic spindle assembly checkpoint (GO:0007094),25,13,1.63,+,7.97,2.07E-07,2.66E-05,TABI,NA,Both,Early,purity_score_500_iter
mitotic spindle checkpoint (GO:0071174),25,13,1.63,+,7.97,2.07E-07,2.64E-05,TABI,NA,Both,Early,purity_score_500_iter
spindle assembly checkpoint (GO:0071173),25,13,1.63,+,7.97,2.07E-07,2.62E-05,TABI,NA,Both,Early,purity_score_500_iter
spindle checkpoint (GO:0031577),25,13,1.63,+,7.97,2.07E-07,2.60E-05,TABI,NA,Both,Early,purity_score_500_iter
negative regulation of mitotic metaphase/anaphase transition (GO:0045841),27,14,1.76,+,7.94,7.24E-08,1.08E-05,TABI,NA,Both,Early,purity_score_500_iter
kinetochore organization (GO:0051383),18,9,1.17,+,7.66,2.03E-05,1.67E-03,TABI,NA,Both,Early,purity_score_500_iter
positive regulation of ubiquitin protein ligase activity (GO:1904668),12,6,.78,+,7.66,5.12E-04,2.94E-02,TABI,NA,Both,Early,purity_score_500_iter
negative regulation of mitotic sister chromatid separation (GO:2000816),30,15,1.96,+,7.66,3.59E-08,5.77E-06,TABI,NA,Both,Early,purity_score_500_iter
negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100),28,14,1.83,+,7.66,1.03E-07,1.45E-05,TABI,NA,Both,Early,purity_score_500_iter
negative regulation of chromosome separation (GO:1905819),31,15,2.02,+,7.41,5.02E-08,7.77E-06,TABI,NA,Both,Early,purity_score_500_iter
mitotic chromosome condensation (GO:0007076),17,8,1.11,+,7.21,8.22E-05,5.93E-03,TABI,NA,Both,Early,purity_score_500_iter
regulation of attachment of spindle microtubules to kinetochore (GO:0051988),13,6,.85,+,7.07,7.10E-04,3.92E-02,TABI,NA,Both,Early,purity_score_500_iter
meiotic spindle organization (GO:0000212),13,6,.85,+,7.07,7.10E-04,3.90E-02,TABI,NA,Both,Early,purity_score_500_iter
negative regulation of sister chromatid segregation (GO:0033046),35,16,2.28,+,7.00,3.36E-08,5.46E-06,TABI,NA,Both,Early,purity_score_500_iter
negative regulation of mitotic sister chromatid segregation (GO:0033048),33,15,2.15,+,6.96,9.56E-08,1.38E-05,TABI,NA,Both,Early,purity_score_500_iter
DNA replication initiation (GO:0006270),33,15,2.15,+,6.96,9.56E-08,1.37E-05,TABI,NA,Both,Early,purity_score_500_iter
negative regulation of chromosome segregation (GO:0051985),36,16,2.35,+,6.81,4.58E-08,7.15E-06,TABI,NA,Both,Early,purity_score_500_iter
centromere complex assembly (GO:0034508),37,16,2.42,+,6.63,6.19E-08,9.38E-06,TABI,NA,Both,Early,purity_score_500_iter
attachment of spindle microtubules to kinetochore (GO:0008608),21,9,1.37,+,6.57,5.24E-05,4.03E-03,TABI,NA,Both,Early,purity_score_500_iter
nuclear DNA replication (GO:0033260),43,18,2.81,+,6.41,1.39E-08,2.41E-06,TABI,NA,Both,Early,purity_score_500_iter
DNA replication checkpoint (GO:0000076),17,7,1.11,+,6.31,4.39E-04,2.59E-02,TABI,NA,Both,Early,purity_score_500_iter
cell cycle DNA replication (GO:0044786),44,18,2.87,+,6.27,1.85E-08,3.10E-06,TABI,NA,Both,Early,purity_score_500_iter
CENP-A containing nucleosome assembly (GO:0034080),30,12,1.96,+,6.13,5.28E-06,5.16E-04,TABI,NA,Both,Early,purity_score_500_iter
CENP-A containing chromatin organization (GO:0061641),30,12,1.96,+,6.13,5.28E-06,5.13E-04,TABI,NA,Both,Early,purity_score_500_iter
mitotic sister chromatid segregation (GO:0000070),106,42,6.92,+,6.07,1.77E-17,1.48E-14,TABI,NA,Both,Early,purity_score_500_iter
chromatin remodeling at centromere (GO:0031055),33,13,2.15,+,6.04,2.46E-06,2.63E-04,TABI,NA,Both,Early,purity_score_500_iter
regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),28,11,1.83,+,6.02,1.49E-05,1.27E-03,TABI,NA,Both,Early,purity_score_500_iter
mitotic spindle organization (GO:0007052),77,30,5.03,+,5.97,9.81E-13,3.81E-10,TABI,NA,Both,Early,purity_score_500_iter
regulation of mitotic sister chromatid separation (GO:0010965),63,24,4.11,+,5.84,2.62E-10,6.32E-08,TABI,NA,Both,Early,purity_score_500_iter
regulation of mitotic metaphase/anaphase transition (GO:0030071),58,22,3.79,+,5.81,1.55E-09,3.12E-07,TABI,NA,Both,Early,purity_score_500_iter
mitotic spindle assembly (GO:0090307),37,14,2.42,+,5.80,1.49E-06,1.67E-04,TABI,NA,Both,Early,purity_score_500_iter
negative regulation of mitotic nuclear division (GO:0045839),43,16,2.81,+,5.70,3.22E-07,3.98E-05,TABI,NA,Both,Early,purity_score_500_iter
regulation of chromosome separation (GO:1905818),68,25,4.44,+,5.63,2.05E-10,5.35E-08,TABI,NA,Both,Early,purity_score_500_iter
sister chromatid segregation (GO:0000819),139,51,9.07,+,5.62,9.24E-20,1.34E-16,TABI,NA,Both,Early,purity_score_500_iter
regulation of metaphase/anaphase transition of cell cycle (GO:1902099),60,22,3.92,+,5.62,2.58E-09,5.01E-07,TABI,NA,Both,Early,purity_score_500_iter
regulation of nuclease activity (GO:0032069),22,8,1.44,+,5.57,3.38E-04,2.08E-02,TABI,NA,Both,Early,purity_score_500_iter
DNA replication-independent nucleosome assembly (GO:0006336),39,14,2.55,+,5.50,2.47E-06,2.62E-04,TABI,NA,Both,Early,purity_score_500_iter
DNA replication-independent nucleosome organization (GO:0034724),40,14,2.61,+,5.36,3.15E-06,3.26E-04,TABI,NA,Both,Early,purity_score_500_iter
mitotic nuclear division (GO:0140014),143,50,9.33,+,5.36,1.10E-18,1.35E-15,TABI,NA,Both,Early,purity_score_500_iter
"nucleotide-excision repair, DNA gap filling (GO:0006297)",23,8,1.50,+,5.33,4.32E-04,2.56E-02,TABI,NA,Both,Early,purity_score_500_iter
negative regulation of nuclear division (GO:0051784),52,18,3.39,+,5.30,1.45E-07,1.96E-05,TABI,NA,Both,Early,purity_score_500_iter
microtubule cytoskeleton organization involved in mitosis (GO:1902850),108,37,7.05,+,5.25,5.81E-14,2.57E-11,TABI,NA,Both,Early,purity_score_500_iter
regulation of mitotic sister chromatid segregation (GO:0033047),74,25,4.83,+,5.18,8.68E-10,1.87E-07,TABI,NA,Both,Early,purity_score_500_iter
regulation of chromosome segregation (GO:0051983),108,36,7.05,+,5.11,2.48E-13,1.07E-10,TABI,NA,Both,Early,purity_score_500_iter
centrosome duplication (GO:0051298),30,10,1.96,+,5.11,1.13E-04,7.80E-03,TABI,NA,Both,Early,purity_score_500_iter
regulation of sister chromatid segregation (GO:0033045),86,28,5.61,+,4.99,1.73E-10,4.75E-08,TABI,NA,Both,Early,purity_score_500_iter
telomere maintenance via semi-conservative replication (GO:0032201),25,8,1.63,+,4.90,6.81E-04,3.79E-02,TABI,NA,Both,Early,purity_score_500_iter
mitotic metaphase plate congression (GO:0007080),44,14,2.87,+,4.87,7.81E-06,7.03E-04,TABI,NA,Both,Early,purity_score_500_iter
DNA-dependent DNA replication (GO:0006261),120,37,7.83,+,4.72,8.17E-13,3.25E-10,TABI,NA,Both,Early,purity_score_500_iter
regulation of DNA-dependent DNA replication (GO:0090329),49,15,3.20,+,4.69,5.52E-06,5.26E-04,TABI,NA,Both,Early,purity_score_500_iter
positive regulation of chromosome segregation (GO:0051984),33,10,2.15,+,4.64,2.15E-04,1.41E-02,TABI,NA,Both,Early,purity_score_500_iter
centrosome cycle (GO:0007098),83,25,5.42,+,4.61,6.06E-09,1.08E-06,TABI,NA,Both,Early,purity_score_500_iter
mitotic cytokinesis (GO:0000281),70,21,4.57,+,4.60,1.04E-07,1.45E-05,TABI,NA,Both,Early,purity_score_500_iter
histone phosphorylation (GO:0016572),30,9,1.96,+,4.60,4.71E-04,2.77E-02,TABI,NA,Both,Early,purity_score_500_iter
nuclear chromosome segregation (GO:0098813),217,64,14.16,+,4.52,2.45E-20,3.91E-17,TABI,NA,Both,Early,purity_score_500_iter
histone exchange (GO:0043486),48,14,3.13,+,4.47,1.78E-05,1.51E-03,TABI,NA,Both,Early,purity_score_500_iter
M phase (GO:0000279),170,49,11.10,+,4.42,1.49E-15,8.78E-13,TABI,NA,Both,Early,purity_score_500_iter
mitotic prometaphase (GO:0000236),170,49,11.10,+,4.42,1.49E-15,8.46E-13,TABI,NA,Both,Early,purity_score_500_iter
mitotic M phase (GO:0000087),170,49,11.10,+,4.42,1.49E-15,8.17E-13,TABI,NA,Both,Early,purity_score_500_iter
sister chromatid cohesion (GO:0007062),49,14,3.20,+,4.38,2.16E-05,1.76E-03,TABI,NA,Both,Early,purity_score_500_iter
metaphase plate congression (GO:0051310),53,15,3.46,+,4.34,1.22E-05,1.07E-03,TABI,NA,Both,Early,purity_score_500_iter
spindle organization (GO:0007051),142,40,9.27,+,4.32,1.10E-12,4.16E-10,TABI,NA,Both,Early,purity_score_500_iter
chromosome segregation (GO:0007059),275,77,17.95,+,4.29,4.65E-23,1.06E-19,TABI,NA,Both,Early,purity_score_500_iter
microtubule organizing center organization (GO:0031023),93,26,6.07,+,4.28,1.11E-08,1.94E-06,TABI,NA,Both,Early,purity_score_500_iter
chromosome condensation (GO:0030261),43,12,2.81,+,4.28,1.00E-04,7.05E-03,TABI,NA,Both,Early,purity_score_500_iter
nuclear division (GO:0000280),284,78,18.54,+,4.21,6.58E-23,1.17E-19,TABI,NA,Both,Early,purity_score_500_iter
protein localization to chromosome (GO:0034502),64,17,4.18,+,4.07,6.66E-06,6.24E-04,TABI,NA,Both,Early,purity_score_500_iter
DNA replication (GO:0006260),208,55,13.58,+,4.05,6.34E-16,3.88E-13,TABI,NA,Both,Early,purity_score_500_iter
establishment of chromosome localization (GO:0051303),72,19,4.70,+,4.04,2.11E-06,2.34E-04,TABI,NA,Both,Early,purity_score_500_iter
anaphase (GO:0051322),156,41,10.18,+,4.03,3.76E-12,1.30E-09,TABI,NA,Both,Early,purity_score_500_iter
mitotic anaphase (GO:0000090),156,41,10.18,+,4.03,3.76E-12,1.27E-09,TABI,NA,Both,Early,purity_score_500_iter
mitotic cell cycle checkpoint (GO:0007093),160,42,10.44,+,4.02,2.12E-12,7.87E-10,TABI,NA,Both,Early,purity_score_500_iter
organelle fission (GO:0048285),313,82,20.43,+,4.01,6.53E-23,1.30E-19,TABI,NA,Both,Early,purity_score_500_iter
regulation of cytokinesis (GO:0032465),88,23,5.74,+,4.00,2.14E-07,2.66E-05,TABI,NA,Both,Early,purity_score_500_iter
chromosome localization (GO:0050000),73,19,4.76,+,3.99,2.51E-06,2.65E-04,TABI,NA,Both,Early,purity_score_500_iter
cell cycle G1/S phase transition (GO:0044843),124,32,8.09,+,3.95,1.26E-09,2.60E-07,TABI,NA,Both,Early,purity_score_500_iter
cytoskeleton-dependent cytokinesis (GO:0061640),98,25,6.40,+,3.91,9.56E-08,1.40E-05,TABI,NA,Both,Early,purity_score_500_iter
G1/S transition of mitotic cell cycle (GO:0000082),122,31,7.96,+,3.89,3.11E-09,5.82E-07,TABI,NA,Both,Early,purity_score_500_iter
cell cycle checkpoint (GO:0000075),201,51,13.12,+,3.89,2.89E-14,1.32E-11,TABI,NA,Both,Early,purity_score_500_iter
DNA packaging (GO:0006323),177,44,11.55,+,3.81,3.05E-12,1.08E-09,TABI,NA,Both,Early,purity_score_500_iter
biological phase (GO:0044848),269,66,17.56,+,3.76,1.92E-17,1.53E-14,TABI,NA,Both,Early,purity_score_500_iter
mitotic cell cycle phase (GO:0098763),269,66,17.56,+,3.76,1.92E-17,1.46E-14,TABI,NA,Both,Early,purity_score_500_iter
cell cycle phase (GO:0022403),269,66,17.56,+,3.76,1.92E-17,1.39E-14,TABI,NA,Both,Early,purity_score_500_iter
meiotic chromosome segregation (GO:0045132),90,22,5.87,+,3.74,1.02E-06,1.19E-04,TABI,NA,Both,Early,purity_score_500_iter
mitotic cell cycle process (GO:1903047),614,150,40.08,+,3.74,2.22E-38,1.18E-34,TABI,NA,Both,Early,purity_score_500_iter
meiotic nuclear division (GO:0140013),156,38,10.18,+,3.73,1.51E-10,4.30E-08,TABI,NA,Both,Early,purity_score_500_iter
somatic diversification of immune receptors (GO:0002200),46,11,3.00,+,3.66,5.96E-04,3.34E-02,TABI,NA,Both,Early,purity_score_500_iter
cytokinesis (GO:0000910),110,26,7.18,+,3.62,1.93E-07,2.52E-05,TABI,NA,Both,Early,purity_score_500_iter
mitotic cell cycle phase transition (GO:0044772),280,66,18.28,+,3.61,1.06E-16,7.34E-14,TABI,NA,Both,Early,purity_score_500_iter
postreplication repair (GO:0006301),51,12,3.33,+,3.60,3.86E-04,2.36E-02,TABI,NA,Both,Early,purity_score_500_iter
microtubule polymerization or depolymerization (GO:0031109),51,12,3.33,+,3.60,3.86E-04,2.35E-02,TABI,NA,Both,Early,purity_score_500_iter
regulation of double-strand break repair via homologous recombination (GO:0010569),47,11,3.07,+,3.59,6.95E-04,3.86E-02,TABI,NA,Both,Early,purity_score_500_iter
DNA integrity checkpoint (GO:0031570),150,35,9.79,+,3.57,2.10E-09,4.12E-07,TABI,NA,Both,Early,purity_score_500_iter
mitotic cell cycle (GO:0000278),696,162,45.43,+,3.57,3.02E-39,2.40E-35,TABI,NA,Both,Early,purity_score_500_iter
cell cycle phase transition (GO:0044770),288,67,18.80,+,3.56,1.09E-16,7.22E-14,TABI,NA,Both,Early,purity_score_500_iter
meiotic cell cycle process (GO:1903046),169,39,11.03,+,3.54,3.36E-10,8.00E-08,TABI,NA,Both,Early,purity_score_500_iter
regulation of mitotic nuclear division (GO:0007088),171,39,11.16,+,3.49,4.51E-10,1.04E-07,TABI,NA,Both,Early,purity_score_500_iter
nucleosome assembly (GO:0006334),115,26,7.51,+,3.46,4.04E-07,4.91E-05,TABI,NA,Both,Early,purity_score_500_iter
cell division (GO:0051301),495,111,32.31,+,3.44,8.28E-26,2.64E-22,TABI,NA,Both,Early,purity_score_500_iter
G2/M transition of mitotic cell cycle (GO:0000086),139,31,9.07,+,3.42,4.19E-08,6.68E-06,TABI,NA,Both,Early,purity_score_500_iter
double-strand break repair via homologous recombination (GO:0000724),99,22,6.46,+,3.40,3.93E-06,3.93E-04,TABI,NA,Both,Early,purity_score_500_iter
mitotic DNA integrity checkpoint (GO:0044774),108,24,7.05,+,3.40,1.45E-06,1.64E-04,TABI,NA,Both,Early,purity_score_500_iter
signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431),59,13,3.85,+,3.38,3.88E-04,2.35E-02,TABI,NA,Both,Early,purity_score_500_iter
signal transduction involved in mitotic cell cycle checkpoint (GO:0072413),59,13,3.85,+,3.38,3.88E-04,2.34E-02,TABI,NA,Both,Early,purity_score_500_iter
signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403),59,13,3.85,+,3.38,3.88E-04,2.33E-02,TABI,NA,Both,Early,purity_score_500_iter
signal transduction involved in mitotic DNA damage checkpoint (GO:1902402),59,13,3.85,+,3.38,3.88E-04,2.32E-02,TABI,NA,Both,Early,purity_score_500_iter
intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400),59,13,3.85,+,3.38,3.88E-04,2.31E-02,TABI,NA,Both,Early,purity_score_500_iter
double-strand break repair via nonhomologous end joining (GO:0006303),59,13,3.85,+,3.38,3.88E-04,2.30E-02,TABI,NA,Both,Early,purity_score_500_iter
recombinational repair (GO:0000725),100,22,6.53,+,3.37,4.52E-06,4.47E-04,TABI,NA,Both,Early,purity_score_500_iter
cell cycle G2/M phase transition (GO:0044839),141,31,9.20,+,3.37,5.55E-08,8.50E-06,TABI,NA,Both,Early,purity_score_500_iter
meiotic cell cycle (GO:0051321),223,49,14.56,+,3.37,8.54E-12,2.78E-09,TABI,NA,Both,Early,purity_score_500_iter
signal transduction involved in DNA damage checkpoint (GO:0072422),73,16,4.76,+,3.36,9.11E-05,6.53E-03,TABI,NA,Both,Early,purity_score_500_iter
signal transduction involved in DNA integrity checkpoint (GO:0072401),73,16,4.76,+,3.36,9.11E-05,6.50E-03,TABI,NA,Both,Early,purity_score_500_iter
chromatin assembly (GO:0031497),133,29,8.68,+,3.34,1.72E-07,2.26E-05,TABI,NA,Both,Early,purity_score_500_iter
negative regulation of chromosome organization (GO:2001251),138,30,9.01,+,3.33,1.12E-07,1.55E-05,TABI,NA,Both,Early,purity_score_500_iter
spindle assembly (GO:0051225),83,18,5.42,+,3.32,3.83E-05,2.97E-03,TABI,NA,Both,Early,purity_score_500_iter
DNA conformation change (GO:0071103),291,63,18.99,+,3.32,1.60E-14,7.72E-12,TABI,NA,Both,Early,purity_score_500_iter
signal transduction involved in cell cycle checkpoint (GO:0072395),74,16,4.83,+,3.31,1.05E-04,7.34E-03,TABI,NA,Both,Early,purity_score_500_iter
regulation of nuclear division (GO:0051783),195,41,12.73,+,3.22,1.32E-09,2.69E-07,TABI,NA,Both,Early,purity_score_500_iter
mitotic DNA damage checkpoint (GO:0044773),100,21,6.53,+,3.22,1.37E-05,1.18E-03,TABI,NA,Both,Early,purity_score_500_iter
DNA damage checkpoint (GO:0000077),139,29,9.07,+,3.20,3.82E-07,4.68E-05,TABI,NA,Both,Early,purity_score_500_iter
protein-DNA complex assembly (GO:0065004),207,43,13.51,+,3.18,7.24E-10,1.58E-07,TABI,NA,Both,Early,purity_score_500_iter
DNA recombination (GO:0006310),222,46,14.49,+,3.17,1.99E-10,5.30E-08,TABI,NA,Both,Early,purity_score_500_iter
double-strand break repair (GO:0006302),186,38,12.14,+,3.13,1.03E-08,1.82E-06,TABI,NA,Both,Early,purity_score_500_iter
regulation of double-strand break repair (GO:2000779),84,17,5.48,+,3.10,1.30E-04,8.89E-03,TABI,NA,Both,Early,purity_score_500_iter
DNA geometric change (GO:0032392),115,23,7.51,+,3.06,1.08E-05,9.64E-04,TABI,NA,Both,Early,purity_score_500_iter
non-recombinational repair (GO:0000726),65,13,4.24,+,3.06,8.57E-04,4.52E-02,TABI,NA,Both,Early,purity_score_500_iter
"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",80,16,5.22,+,3.06,2.28E-04,1.47E-02,TABI,NA,Both,Early,purity_score_500_iter
mitotic G1/S transition checkpoint (GO:0044819),66,13,4.31,+,3.02,9.70E-04,5.00E-02,TABI,NA,Both,Early,purity_score_500_iter
mitotic G1 DNA damage checkpoint (GO:0031571),66,13,4.31,+,3.02,9.70E-04,4.98E-02,TABI,NA,Both,Early,purity_score_500_iter
telomere maintenance (GO:0000723),97,19,6.33,+,3.00,7.84E-05,5.68E-03,TABI,NA,Both,Early,purity_score_500_iter
negative regulation of mitotic cell cycle phase transition (GO:1901991),220,43,14.36,+,2.99,3.60E-09,6.66E-07,TABI,NA,Both,Early,purity_score_500_iter
negative regulation of cell cycle phase transition (GO:1901988),236,46,15.40,+,2.99,1.11E-09,2.37E-07,TABI,NA,Both,Early,purity_score_500_iter
cell cycle process (GO:0022402),995,193,64.95,+,2.97,3.67E-37,1.46E-33,TABI,NA,Both,Early,purity_score_500_iter
positive regulation of cell cycle arrest (GO:0071158),83,16,5.42,+,2.95,3.28E-04,2.03E-02,TABI,NA,Both,Early,purity_score_500_iter
signal transduction in response to DNA damage (GO:0042770),104,20,6.79,+,2.95,6.43E-05,4.81E-03,TABI,NA,Both,Early,purity_score_500_iter
ATP-dependent chromatin remodeling (GO:0043044),78,15,5.09,+,2.95,5.09E-04,2.93E-02,TABI,NA,Both,Early,purity_score_500_iter
regulation of cyclin-dependent protein kinase activity (GO:1904029),104,20,6.79,+,2.95,6.43E-05,4.78E-03,TABI,NA,Both,Early,purity_score_500_iter
telomere organization (GO:0032200),100,19,6.53,+,2.91,1.11E-04,7.79E-03,TABI,NA,Both,Early,purity_score_500_iter
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),100,19,6.53,+,2.91,1.11E-04,7.75E-03,TABI,NA,Both,Early,purity_score_500_iter
ciliary basal body-plasma membrane docking (GO:0097711),95,18,6.20,+,2.90,1.72E-04,1.14E-02,TABI,NA,Both,Early,purity_score_500_iter
chromatin assembly or disassembly (GO:0006333),154,29,10.05,+,2.89,2.34E-06,2.53E-04,TABI,NA,Both,Early,purity_score_500_iter
DNA repair (GO:0006281),513,96,33.48,+,2.87,9.07E-18,8.50E-15,TABI,NA,Both,Early,purity_score_500_iter
regulation of cell division (GO:0051302),167,31,10.90,+,2.84,1.39E-06,1.58E-04,TABI,NA,Both,Early,purity_score_500_iter
meiosis I (GO:0007127),114,21,7.44,+,2.82,7.34E-05,5.39E-03,TABI,NA,Both,Early,purity_score_500_iter
nucleosome organization (GO:0034728),158,29,10.31,+,2.81,3.64E-06,3.72E-04,TABI,NA,Both,Early,purity_score_500_iter
protein-DNA complex subunit organization (GO:0071824),251,46,16.38,+,2.81,6.06E-09,1.10E-06,TABI,NA,Both,Early,purity_score_500_iter
anaphase-promoting complex-dependent catabolic process (GO:0031145),82,15,5.35,+,2.80,8.01E-04,4.33E-02,TABI,NA,Both,Early,purity_score_500_iter
regulation of DNA replication (GO:0006275),110,20,7.18,+,2.79,1.26E-04,8.69E-03,TABI,NA,Both,Early,purity_score_500_iter
negative regulation of cell cycle G1/S phase transition (GO:1902807),110,20,7.18,+,2.79,1.26E-04,8.66E-03,TABI,NA,Both,Early,purity_score_500_iter
meiosis I cell cycle process (GO:0061982),116,21,7.57,+,2.77,9.12E-05,6.48E-03,TABI,NA,Both,Early,purity_score_500_iter
positive regulation of mitotic cell cycle phase transition (GO:1901992),83,15,5.42,+,2.77,8.94E-04,4.65E-02,TABI,NA,Both,Early,purity_score_500_iter
microtubule cytoskeleton organization (GO:0000226),478,86,31.20,+,2.76,3.87E-15,1.99E-12,TABI,NA,Both,Early,purity_score_500_iter
negative regulation of mitotic cell cycle (GO:0045930),313,56,20.43,+,2.74,3.63E-10,8.50E-08,TABI,NA,Both,Early,purity_score_500_iter
cell cycle (GO:0007049),1331,238,86.88,+,2.74,5.98E-41,9.53E-37,TABI,NA,Both,Early,purity_score_500_iter
negative regulation of cell cycle process (GO:0010948),326,58,21.28,+,2.73,1.99E-10,5.38E-08,TABI,NA,Both,Early,purity_score_500_iter
regulation of G2/M transition of mitotic cell cycle (GO:0010389),197,35,12.86,+,2.72,1.12E-06,1.30E-04,TABI,NA,Both,Early,purity_score_500_iter
DNA duplex unwinding (GO:0032508),107,19,6.98,+,2.72,2.40E-04,1.54E-02,TABI,NA,Both,Early,purity_score_500_iter
negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),107,19,6.98,+,2.72,2.40E-04,1.54E-02,TABI,NA,Both,Early,purity_score_500_iter
regulation of microtubule-based process (GO:0032886),232,41,15.14,+,2.71,1.24E-07,1.69E-05,TABI,NA,Both,Early,purity_score_500_iter
regulation of mitotic cell cycle phase transition (GO:1901990),420,74,27.41,+,2.70,8.16E-13,3.33E-10,TABI,NA,Both,Early,purity_score_500_iter
signal transduction by p53 class mediator (GO:0072331),120,21,7.83,+,2.68,1.39E-04,9.36E-03,TABI,NA,Both,Early,purity_score_500_iter
regulation of cell cycle G2/M phase transition (GO:1902749),214,37,13.97,+,2.65,7.54E-07,8.97E-05,TABI,NA,Both,Early,purity_score_500_iter
regulation of microtubule cytoskeleton organization (GO:0070507),197,34,12.86,+,2.64,2.27E-06,2.50E-04,TABI,NA,Both,Early,purity_score_500_iter
regulation of DNA repair (GO:0006282),129,22,8.42,+,2.61,2.04E-04,1.34E-02,TABI,NA,Both,Early,purity_score_500_iter
positive regulation of cell cycle process (GO:0090068),294,50,19.19,+,2.61,1.88E-08,3.12E-06,TABI,NA,Both,Early,purity_score_500_iter
regulation of cell cycle phase transition (GO:1901987),456,76,29.76,+,2.55,5.45E-12,1.81E-09,TABI,NA,Both,Early,purity_score_500_iter
positive regulation of mitotic cell cycle (GO:0045931),158,26,10.31,+,2.52,6.75E-05,4.98E-03,TABI,NA,Both,Early,purity_score_500_iter
DNA metabolic process (GO:0006259),749,123,48.89,+,2.52,2.15E-18,2.44E-15,TABI,NA,Both,Early,purity_score_500_iter
cellular response to DNA damage stimulus (GO:0006974),781,125,50.98,+,2.45,9.32E-18,8.25E-15,TABI,NA,Both,Early,purity_score_500_iter
chromosome organization (GO:0051276),1053,168,68.73,+,2.44,1.02E-23,2.71E-20,TABI,NA,Both,Early,purity_score_500_iter
regulation of G1/S transition of mitotic cell cycle (GO:2000045),157,25,10.25,+,2.44,1.38E-04,9.38E-03,TABI,NA,Both,Early,purity_score_500_iter
regulation of mitotic cell cycle (GO:0007346),686,107,44.78,+,2.39,1.04E-14,5.16E-12,TABI,NA,Both,Early,purity_score_500_iter
positive regulation of DNA metabolic process (GO:0051054),199,31,12.99,+,2.39,3.82E-05,2.98E-03,TABI,NA,Both,Early,purity_score_500_iter
positive regulation of cell cycle (GO:0045787),391,60,25.52,+,2.35,1.40E-08,2.39E-06,TABI,NA,Both,Early,purity_score_500_iter
regulation of cell cycle process (GO:0010564),763,116,49.80,+,2.33,3.78E-15,2.00E-12,TABI,NA,Both,Early,purity_score_500_iter
regulation of chromosome organization (GO:0033044),371,56,24.22,+,2.31,6.83E-08,1.03E-05,TABI,NA,Both,Early,purity_score_500_iter
microtubule-based process (GO:0007017),667,100,43.54,+,2.30,6.19E-13,2.59E-10,TABI,NA,Both,Early,purity_score_500_iter
regulation of cell cycle G1/S phase transition (GO:1902806),176,26,11.49,+,2.26,3.14E-04,1.95E-02,TABI,NA,Both,Early,purity_score_500_iter
negative regulation of organelle organization (GO:0010639),395,56,25.78,+,2.17,4.62E-07,5.58E-05,TABI,NA,Both,Early,purity_score_500_iter
negative regulation of cell cycle (GO:0045786),575,80,37.53,+,2.13,3.83E-09,7.01E-07,TABI,NA,Both,Early,purity_score_500_iter
regulation of DNA metabolic process (GO:0051052),360,50,23.50,+,2.13,3.36E-06,3.46E-04,TABI,NA,Both,Early,purity_score_500_iter
regulation of response to DNA damage stimulus (GO:2001020),225,31,14.69,+,2.11,3.11E-04,1.95E-02,TABI,NA,Both,Early,purity_score_500_iter
regulation of cell cycle (GO:0051726),1243,171,81.13,+,2.11,3.67E-18,3.66E-15,TABI,NA,Both,Early,purity_score_500_iter
establishment of organelle localization (GO:0051656),373,49,24.35,+,2.01,1.99E-05,1.67E-03,TABI,NA,Both,Early,purity_score_500_iter
organelle localization (GO:0051640),588,76,38.38,+,1.98,1.55E-07,2.06E-05,TABI,NA,Both,Early,purity_score_500_iter
establishment of localization in cell (GO:0051649),399,50,26.04,+,1.92,5.65E-05,4.29E-03,TABI,NA,Both,Early,purity_score_500_iter
synapse organization (GO:0050808),285,35,18.60,+,1.88,8.87E-04,4.63E-02,TABI,NA,Both,Early,purity_score_500_iter
chromatin organization (GO:0006325),694,83,45.30,+,1.83,8.47E-07,1.00E-04,TABI,NA,Both,Early,purity_score_500_iter
cilium assembly (GO:0060271),338,40,22.06,+,1.81,7.25E-04,3.97E-02,TABI,NA,Both,Early,purity_score_500_iter
regulation of organelle organization (GO:0033043),1328,157,86.68,+,1.81,1.13E-11,3.59E-09,TABI,NA,Both,Early,purity_score_500_iter
covalent chromatin modification (GO:0016569),369,43,24.09,+,1.79,8.03E-04,4.32E-02,TABI,NA,Both,Early,purity_score_500_iter
regulation of cytoskeleton organization (GO:0051493),560,65,36.55,+,1.78,2.93E-05,2.34E-03,TABI,NA,Both,Early,purity_score_500_iter
organelle assembly (GO:0070925),723,83,47.19,+,1.76,3.04E-06,3.16E-04,TABI,NA,Both,Early,purity_score_500_iter
plasma membrane bounded cell projection assembly (GO:0120031),430,48,28.07,+,1.71,7.03E-04,3.89E-02,TABI,NA,Both,Early,purity_score_500_iter
positive regulation of transferase activity (GO:0051347),691,77,45.10,+,1.71,2.19E-05,1.78E-03,TABI,NA,Both,Early,purity_score_500_iter
cytoskeleton organization (GO:0007010),1106,122,72.19,+,1.69,1.13E-07,1.56E-05,TABI,NA,Both,Early,purity_score_500_iter
cellular response to stress (GO:0033554),1751,187,114.29,+,1.64,2.36E-10,5.95E-08,TABI,NA,Both,Early,purity_score_500_iter
positive regulation of organelle organization (GO:0010638),637,68,41.58,+,1.64,2.20E-04,1.43E-02,TABI,NA,Both,Early,purity_score_500_iter
regulation of transferase activity (GO:0051338),1017,107,66.38,+,1.61,5.17E-06,5.09E-04,TABI,NA,Both,Early,purity_score_500_iter
negative regulation of cellular component organization (GO:0051129),723,76,47.19,+,1.61,1.57E-04,1.05E-02,TABI,NA,Both,Early,purity_score_500_iter
organelle organization (GO:0006996),3428,359,223.75,+,1.60,4.67E-19,6.19E-16,TABI,NA,Both,Early,purity_score_500_iter
positive regulation of kinase activity (GO:0033674),614,64,40.08,+,1.60,5.95E-04,3.35E-02,TABI,NA,Both,Early,purity_score_500_iter
regulation of protein kinase activity (GO:0045859),795,82,51.89,+,1.58,1.31E-04,8.88E-03,TABI,NA,Both,Early,purity_score_500_iter
reproductive process (GO:0022414),1433,145,93.54,+,1.55,6.51E-07,7.80E-05,TABI,NA,Both,Early,purity_score_500_iter
reproduction (GO:0000003),1436,145,93.73,+,1.55,8.58E-07,1.01E-04,TABI,NA,Both,Early,purity_score_500_iter
regulation of kinase activity (GO:0043549),903,90,58.94,+,1.53,1.85E-04,1.22E-02,TABI,NA,Both,Early,purity_score_500_iter
cellular protein-containing complex assembly (GO:0034622),794,79,51.83,+,1.52,5.18E-04,2.96E-02,TABI,NA,Both,Early,purity_score_500_iter
sexual reproduction (GO:0019953),831,81,54.24,+,1.49,8.74E-04,4.59E-02,TABI,NA,Both,Early,purity_score_500_iter
positive regulation of cellular component organization (GO:0051130),1244,121,81.20,+,1.49,3.37E-05,2.65E-03,TABI,NA,Both,Early,purity_score_500_iter
regulation of cellular component organization (GO:0051128),2529,244,165.07,+,1.48,2.67E-09,5.12E-07,TABI,NA,Both,Early,purity_score_500_iter
protein phosphorylation (GO:0006468),965,93,62.99,+,1.48,4.73E-04,2.74E-02,TABI,NA,Both,Early,purity_score_500_iter
cellular component assembly (GO:0022607),2424,225,158.22,+,1.42,2.07E-07,2.68E-05,TABI,NA,Both,Early,purity_score_500_iter
cellular component organization (GO:0016043),5620,520,366.83,+,1.42,3.09E-18,3.28E-15,TABI,NA,Both,Early,purity_score_500_iter
positive regulation of protein modification process (GO:0031401),1241,114,81.00,+,1.41,5.43E-04,3.08E-02,TABI,NA,Both,Early,purity_score_500_iter
regulation of protein modification process (GO:0031399),1873,171,122.26,+,1.40,2.41E-05,1.95E-03,TABI,NA,Both,Early,purity_score_500_iter
negative regulation of nucleobase-containing compound metabolic process (GO:0045934),1484,135,96.86,+,1.39,2.42E-04,1.54E-02,TABI,NA,Both,Early,purity_score_500_iter
cellular component organization or biogenesis (GO:0071840),5810,525,379.23,+,1.38,1.64E-16,1.05E-13,TABI,NA,Both,Early,purity_score_500_iter
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),1423,128,92.88,+,1.38,5.26E-04,2.99E-02,TABI,NA,Both,Early,purity_score_500_iter
regulation of catalytic activity (GO:0050790),2376,213,155.09,+,1.37,5.47E-06,5.25E-04,TABI,NA,Both,Early,purity_score_500_iter
nucleic acid metabolic process (GO:0090304),2292,204,149.60,+,1.36,1.35E-05,1.18E-03,TABI,NA,Both,Early,purity_score_500_iter
protein-containing complex assembly (GO:0065003),1406,125,91.77,+,1.36,9.01E-04,4.67E-02,TABI,NA,Both,Early,purity_score_500_iter
negative regulation of cellular metabolic process (GO:0031324),2603,231,169.90,+,1.36,3.77E-06,3.82E-04,TABI,NA,Both,Early,purity_score_500_iter
regulation of protein phosphorylation (GO:0001932),1454,129,94.91,+,1.36,8.83E-04,4.63E-02,TABI,NA,Both,Early,purity_score_500_iter
positive regulation of catalytic activity (GO:0043085),1466,130,95.69,+,1.36,7.66E-04,4.15E-02,TABI,NA,Both,Early,purity_score_500_iter
negative regulation of macromolecule biosynthetic process (GO:0010558),1506,133,98.30,+,1.35,7.38E-04,4.01E-02,TABI,NA,Both,Early,purity_score_500_iter
regulation of cellular protein metabolic process (GO:0032268),2661,235,173.69,+,1.35,3.83E-06,3.87E-04,TABI,NA,Both,Early,purity_score_500_iter
regulation of phosphate metabolic process (GO:0019220),1818,160,118.67,+,1.35,2.26E-04,1.46E-02,TABI,NA,Both,Early,purity_score_500_iter
regulation of phosphorus metabolic process (GO:0051174),1819,160,118.73,+,1.35,2.70E-04,1.71E-02,TABI,NA,Both,Early,purity_score_500_iter
negative regulation of nitrogen compound metabolic process (GO:0051172),2403,211,156.85,+,1.35,2.02E-05,1.68E-03,TABI,NA,Both,Early,purity_score_500_iter
negative regulation of cellular process (GO:0048523),4795,421,312.98,+,1.35,8.70E-11,2.52E-08,TABI,NA,Both,Early,purity_score_500_iter
cellular component biogenesis (GO:0044085),2653,231,173.17,+,1.33,1.20E-05,1.06E-03,TABI,NA,Both,Early,purity_score_500_iter
regulation of protein metabolic process (GO:0051246),2832,246,184.85,+,1.33,6.74E-06,6.17E-04,TABI,NA,Both,Early,purity_score_500_iter
intracellular signal transduction (GO:0035556),1698,147,110.83,+,1.33,9.60E-04,4.97E-02,TABI,NA,Both,Early,purity_score_500_iter
regulation of nucleobase-containing compound metabolic process (GO:0019219),4062,351,265.14,+,1.32,4.21E-08,6.64E-06,TABI,NA,Both,Early,purity_score_500_iter
negative regulation of macromolecule metabolic process (GO:0010605),2698,233,176.11,+,1.32,1.99E-05,1.66E-03,TABI,NA,Both,Early,purity_score_500_iter
regulation of molecular function (GO:0065009),3053,262,199.28,+,1.31,7.36E-06,6.66E-04,TABI,NA,Both,Early,purity_score_500_iter
negative regulation of biological process (GO:0048519),5377,461,350.97,+,1.31,1.51E-10,4.23E-08,TABI,NA,Both,Early,purity_score_500_iter
negative regulation of metabolic process (GO:0009892),2959,253,193.14,+,1.31,1.42E-05,1.22E-03,TABI,NA,Both,Early,purity_score_500_iter
regulation of nitrogen compound metabolic process (GO:0051171),5870,501,383.15,+,1.31,2.13E-11,6.28E-09,TABI,NA,Both,Early,purity_score_500_iter
regulation of primary metabolic process (GO:0080090),6055,515,395.23,+,1.30,1.68E-11,5.04E-09,TABI,NA,Both,Early,purity_score_500_iter
regulation of cellular metabolic process (GO:0031323),6263,530,408.80,+,1.30,1.39E-11,4.34E-09,TABI,NA,Both,Early,purity_score_500_iter
nucleobase-containing compound metabolic process (GO:0006139),2805,237,183.09,+,1.29,6.50E-05,4.81E-03,TABI,NA,Both,Early,purity_score_500_iter
nervous system development (GO:0007399),2373,200,154.89,+,1.29,3.31E-04,2.04E-02,TABI,NA,Both,Early,purity_score_500_iter
cellular localization (GO:0051641),2411,203,157.37,+,1.29,3.08E-04,1.93E-02,TABI,NA,Both,Early,purity_score_500_iter
response to stress (GO:0006950),3612,303,235.76,+,1.29,7.21E-06,6.57E-04,TABI,NA,Both,Early,purity_score_500_iter
cellular macromolecule metabolic process (GO:0044260),5073,425,331.13,+,1.28,2.34E-08,3.84E-06,TABI,NA,Both,Early,purity_score_500_iter
regulation of macromolecule metabolic process (GO:0060255),6183,517,403.58,+,1.28,2.08E-10,5.35E-08,TABI,NA,Both,Early,purity_score_500_iter
cellular response to organic substance (GO:0071310),2400,200,156.65,+,1.28,5.77E-04,3.26E-02,TABI,NA,Both,Early,purity_score_500_iter
regulation of RNA metabolic process (GO:0051252),3808,317,248.56,+,1.28,6.69E-06,6.16E-04,TABI,NA,Both,Early,purity_score_500_iter
positive regulation of macromolecule metabolic process (GO:0010604),3394,282,221.54,+,1.27,3.36E-05,2.66E-03,TABI,NA,Both,Early,purity_score_500_iter
regulation of cellular macromolecule biosynthetic process (GO:2000112),3931,326,256.59,+,1.27,6.20E-06,5.84E-04,TABI,NA,Both,Early,purity_score_500_iter
positive regulation of metabolic process (GO:0009893),3691,306,240.92,+,1.27,1.43E-05,1.23E-03,TABI,NA,Both,Early,purity_score_500_iter
regulation of localization (GO:0032879),2808,232,183.29,+,1.27,2.87E-04,1.81E-02,TABI,NA,Both,Early,purity_score_500_iter
positive regulation of cellular metabolic process (GO:0031325),3383,279,220.82,+,1.26,6.28E-05,4.74E-03,TABI,NA,Both,Early,purity_score_500_iter
regulation of nucleic acid-templated transcription (GO:1903506),3544,291,231.33,+,1.26,5.35E-05,4.10E-03,TABI,NA,Both,Early,purity_score_500_iter
positive regulation of nitrogen compound metabolic process (GO:0051173),3219,264,210.11,+,1.26,1.60E-04,1.06E-02,TABI,NA,Both,Early,purity_score_500_iter
regulation of RNA biosynthetic process (GO:2001141),3549,291,231.65,+,1.26,6.30E-05,4.73E-03,TABI,NA,Both,Early,purity_score_500_iter
regulation of metabolic process (GO:0019222),6733,552,439.48,+,1.26,6.34E-10,1.42E-07,TABI,NA,Both,Early,purity_score_500_iter
"regulation of transcription, DNA-templated (GO:0006355)",3478,285,227.02,+,1.26,7.56E-05,5.50E-03,TABI,NA,Both,Early,purity_score_500_iter
heterocycle metabolic process (GO:0046483),2983,244,194.71,+,1.25,3.47E-04,2.13E-02,TABI,NA,Both,Early,purity_score_500_iter
regulation of macromolecule biosynthetic process (GO:0010556),4068,332,265.53,+,1.25,1.82E-05,1.53E-03,TABI,NA,Both,Early,purity_score_500_iter
cellular aromatic compound metabolic process (GO:0006725),3029,246,197.71,+,1.24,5.08E-04,2.93E-02,TABI,NA,Both,Early,purity_score_500_iter
regulation of cellular biosynthetic process (GO:0031326),4212,341,274.93,+,1.24,2.69E-05,2.16E-03,TABI,NA,Both,Early,purity_score_500_iter
regulation of biosynthetic process (GO:0009889),4291,346,280.08,+,1.24,3.05E-05,2.43E-03,TABI,NA,Both,Early,purity_score_500_iter
positive regulation of cellular process (GO:0048522),5516,442,360.04,+,1.23,1.81E-06,2.02E-04,TABI,NA,Both,Early,purity_score_500_iter
multicellular organism development (GO:0007275),5064,402,330.54,+,1.22,2.04E-05,1.68E-03,TABI,NA,Both,Early,purity_score_500_iter
cellular nitrogen compound metabolic process (GO:0034641),3449,273,225.13,+,1.21,9.72E-04,4.98E-02,TABI,NA,Both,Early,purity_score_500_iter
macromolecule metabolic process (GO:0043170),6181,489,403.45,+,1.21,1.38E-06,1.59E-04,TABI,NA,Both,Early,purity_score_500_iter
positive regulation of biological process (GO:0048518),6252,492,408.08,+,1.21,2.35E-06,2.53E-04,TABI,NA,Both,Early,purity_score_500_iter
regulation of cellular process (GO:0050794),11071,867,722.63,+,1.20,1.95E-14,9.16E-12,TABI,NA,Both,Early,purity_score_500_iter
regulation of gene expression (GO:0010468),4483,351,292.62,+,1.20,2.82E-04,1.78E-02,TABI,NA,Both,Early,purity_score_500_iter
anatomical structure development (GO:0048856),5451,426,355.80,+,1.20,4.21E-05,3.26E-03,TABI,NA,Both,Early,purity_score_500_iter
developmental process (GO:0032502),5901,457,385.17,+,1.19,3.81E-05,2.99E-03,TABI,NA,Both,Early,purity_score_500_iter
cellular response to stimulus (GO:0051716),6782,525,442.68,+,1.19,5.87E-06,5.57E-04,TABI,NA,Both,Early,purity_score_500_iter
localization (GO:0051179),5768,442,376.49,+,1.17,1.60E-04,1.06E-02,TABI,NA,Both,Early,purity_score_500_iter
regulation of biological process (GO:0050789),11770,899,768.26,+,1.17,2.61E-12,9.45E-10,TABI,NA,Both,Early,purity_score_500_iter
nitrogen compound metabolic process (GO:0006807),7000,529,456.91,+,1.16,7.42E-05,5.43E-03,TABI,NA,Both,Early,purity_score_500_iter
biological regulation (GO:0065007),12470,938,813.95,+,1.15,1.62E-11,4.96E-09,TABI,NA,Both,Early,purity_score_500_iter
primary metabolic process (GO:0044238),7465,550,487.26,+,1.13,6.52E-04,3.65E-02,TABI,NA,Both,Early,purity_score_500_iter
cellular process (GO:0009987),14616,1044,954.03,+,1.09,1.48E-07,1.99E-05,TABI,NA,Both,Early,purity_score_500_iter
biological_process (GO:0008150),17780,1241,1160.55,+,1.07,2.47E-10,6.15E-08,TABI,NA,Both,Early,purity_score_500_iter
system process (GO:0003008),1979,81,129.17,-,.63,5.41E-06,5.22E-04,TABI,NA,Both,Early,purity_score_500_iter
G protein-coupled receptor signaling pathway (GO:0007186),1320,53,86.16,-,.62,1.54E-04,1.03E-02,TABI,NA,Both,Early,purity_score_500_iter
Unclassified (UNCLASSIFIED),3071,120,200.45,-,.60,2.47E-10,6.05E-08,TABI,NA,Both,Early,purity_score_500_iter
nervous system process (GO:0050877),1398,52,91.25,-,.57,1.19E-05,1.05E-03,TABI,NA,Both,Early,purity_score_500_iter
sensory perception (GO:0007600),977,30,63.77,-,.47,4.24E-06,4.22E-04,TABI,NA,Both,Early,purity_score_500_iter
detection of stimulus (GO:0051606),698,21,45.56,-,.46,9.67E-05,6.85E-03,TABI,NA,Both,Early,purity_score_500_iter
muscle contraction (GO:0006936),247,4,16.12,-,.25,8.23E-04,4.36E-02,TABI,NA,Both,Early,purity_score_500_iter
detection of stimulus involved in sensory perception (GO:0050906),549,7,35.83,-,.20,1.57E-08,2.67E-06,TABI,NA,Both,Early,purity_score_500_iter
detection of chemical stimulus (GO:0009593),525,5,34.27,-,.15,2.01E-09,4.00E-07,TABI,NA,Both,Early,purity_score_500_iter
sensory perception of chemical stimulus (GO:0007606),541,5,35.31,-,.14,6.60E-10,1.46E-07,TABI,NA,Both,Early,purity_score_500_iter
detection of chemical stimulus involved in sensory perception (GO:0050907),488,4,31.85,-,.13,2.82E-09,5.35E-07,TABI,NA,Both,Early,purity_score_500_iter
sensory perception of smell (GO:0007608),468,3,30.55,-,.10,1.16E-09,2.43E-07,TABI,NA,Both,Early,purity_score_500_iter
detection of chemical stimulus involved in sensory perception of smell (GO:0050911),439,2,28.65,-,.07,5.73E-10,1.30E-07,TABI,NA,Both,Early,purity_score_500_iter
protection from natural killer cell mediated cytotoxicity (GO:0042270),5,3,.07,+,43.44,1.33E-04,3.79E-02,TABI,NA,Decrease,Early,purity_score_500_iter
"phagocytosis, recognition (GO:0006910)",106,13,1.46,+,8.88,9.16E-09,2.08E-05,TABI,NA,Decrease,Early,purity_score_500_iter
"phagocytosis, engulfment (GO:0006911)",129,14,1.78,+,7.86,1.02E-08,1.81E-05,TABI,NA,Decrease,Early,purity_score_500_iter
B cell receptor signaling pathway (GO:0050853),128,13,1.77,+,7.35,7.10E-08,7.07E-05,TABI,NA,Decrease,Early,purity_score_500_iter
plasma membrane invagination (GO:0099024),138,14,1.91,+,7.34,2.24E-08,2.75E-05,TABI,NA,Decrease,Early,purity_score_500_iter
membrane invagination (GO:0010324),145,14,2.00,+,6.99,3.98E-08,4.23E-05,TABI,NA,Decrease,Early,purity_score_500_iter
"complement activation, classical pathway (GO:0006958)",161,15,2.22,+,6.75,2.01E-08,2.67E-05,TABI,NA,Decrease,Early,purity_score_500_iter
complement activation (GO:0006956),176,16,2.43,+,6.58,9.30E-09,1.85E-05,TABI,NA,Decrease,Early,purity_score_500_iter
humoral immune response mediated by circulating immunoglobulin (GO:0002455),167,15,2.31,+,6.50,3.16E-08,3.59E-05,TABI,NA,Decrease,Early,purity_score_500_iter
granulocyte migration (GO:0097530),92,8,1.27,+,6.30,6.78E-05,2.08E-02,TABI,NA,Decrease,Early,purity_score_500_iter
immunoglobulin mediated immune response (GO:0016064),205,17,2.83,+,6.00,1.14E-08,1.81E-05,TABI,NA,Decrease,Early,purity_score_500_iter
positive regulation of B cell activation (GO:0050871),169,14,2.33,+,6.00,2.30E-07,1.53E-04,TABI,NA,Decrease,Early,purity_score_500_iter
B cell mediated immunity (GO:0019724),208,17,2.87,+,5.92,1.39E-08,2.01E-05,TABI,NA,Decrease,Early,purity_score_500_iter
lymphocyte mediated immunity (GO:0002449),263,20,3.63,+,5.51,2.27E-09,1.21E-05,TABI,NA,Decrease,Early,purity_score_500_iter
myeloid leukocyte migration (GO:0097529),121,9,1.67,+,5.39,7.46E-05,2.24E-02,TABI,NA,Decrease,Early,purity_score_500_iter
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),270,20,3.73,+,5.36,3.46E-09,1.10E-05,TABI,NA,Decrease,Early,purity_score_500_iter
regulation of B cell activation (GO:0050864),213,15,2.94,+,5.10,5.99E-07,3.29E-04,TABI,NA,Decrease,Early,purity_score_500_iter
defense response to bacterium (GO:0042742),336,22,4.64,+,4.74,4.74E-09,1.26E-05,TABI,NA,Decrease,Early,purity_score_500_iter
production of molecular mediator of immune response (GO:0002440),179,11,2.47,+,4.45,6.25E-05,1.99E-02,TABI,NA,Decrease,Early,purity_score_500_iter
cell recognition (GO:0008037),232,14,3.20,+,4.37,7.71E-06,2.92E-03,TABI,NA,Decrease,Early,purity_score_500_iter
phagocytosis (GO:0006909),325,19,4.49,+,4.23,2.89E-07,1.77E-04,TABI,NA,Decrease,Early,purity_score_500_iter
humoral immune response (GO:0006959),372,21,5.14,+,4.09,1.18E-07,1.10E-04,TABI,NA,Decrease,Early,purity_score_500_iter
cell chemotaxis (GO:0060326),203,11,2.80,+,3.92,1.80E-04,4.93E-02,TABI,NA,Decrease,Early,purity_score_500_iter
positive regulation of lymphocyte activation (GO:0051251),367,19,5.07,+,3.75,1.63E-06,7.43E-04,TABI,NA,Decrease,Early,purity_score_500_iter
antigen receptor-mediated signaling pathway (GO:0050851),296,15,4.09,+,3.67,2.61E-05,9.05E-03,TABI,NA,Decrease,Early,purity_score_500_iter
leukocyte mediated immunity (GO:0002443),760,38,10.50,+,3.62,1.95E-11,3.11E-07,TABI,NA,Decrease,Early,purity_score_500_iter
positive regulation of leukocyte activation (GO:0002696),409,20,5.65,+,3.54,1.99E-06,8.35E-04,TABI,NA,Decrease,Early,purity_score_500_iter
protein homooligomerization (GO:0051260),274,13,3.78,+,3.44,1.68E-04,4.70E-02,TABI,NA,Decrease,Early,purity_score_500_iter
positive regulation of cell activation (GO:0050867),423,20,5.84,+,3.42,3.24E-06,1.32E-03,TABI,NA,Decrease,Early,purity_score_500_iter
adaptive immune response (GO:0002250),613,27,8.47,+,3.19,2.27E-07,1.64E-04,TABI,NA,Decrease,Early,purity_score_500_iter
regulation of lymphocyte activation (GO:0051249),523,23,7.22,+,3.18,1.90E-06,8.41E-04,TABI,NA,Decrease,Early,purity_score_500_iter
immune response-activating signal transduction (GO:0002757),549,24,7.58,+,3.16,1.25E-06,5.84E-04,TABI,NA,Decrease,Early,purity_score_500_iter
activation of immune response (GO:0002253),619,27,8.55,+,3.16,2.73E-07,1.74E-04,TABI,NA,Decrease,Early,purity_score_500_iter
regulation of cell activation (GO:0050865),646,28,8.92,+,3.14,1.83E-07,1.54E-04,TABI,NA,Decrease,Early,purity_score_500_iter
regulation of leukocyte activation (GO:0002694),606,26,8.37,+,3.11,6.19E-07,3.29E-04,TABI,NA,Decrease,Early,purity_score_500_iter
immune response-activating cell surface receptor signaling pathway (GO:0002429),448,19,6.19,+,3.07,2.45E-05,8.69E-03,TABI,NA,Decrease,Early,purity_score_500_iter
immune response-regulating signaling pathway (GO:0002764),586,24,8.09,+,2.97,3.67E-06,1.46E-03,TABI,NA,Decrease,Early,purity_score_500_iter
immune response-regulating cell surface receptor signaling pathway (GO:0002768),483,19,6.67,+,2.85,6.49E-05,2.03E-02,TABI,NA,Decrease,Early,purity_score_500_iter
positive regulation of immune response (GO:0050778),847,33,11.70,+,2.82,1.51E-07,1.34E-04,TABI,NA,Decrease,Early,purity_score_500_iter
immune effector process (GO:0002252),1080,42,14.92,+,2.82,2.63E-09,1.05E-05,TABI,NA,Decrease,Early,purity_score_500_iter
endocytosis (GO:0006897),547,21,7.56,+,2.78,3.76E-05,1.28E-02,TABI,NA,Decrease,Early,purity_score_500_iter
innate immune response (GO:0045087),774,29,10.69,+,2.71,1.91E-06,8.24E-04,TABI,NA,Decrease,Early,purity_score_500_iter
cytokine-mediated signaling pathway (GO:0019221),694,26,9.59,+,2.71,6.69E-06,2.60E-03,TABI,NA,Decrease,Early,purity_score_500_iter
response to bacterium (GO:0009617),704,26,9.72,+,2.67,8.53E-06,3.16E-03,TABI,NA,Decrease,Early,purity_score_500_iter
defense response to other organism (GO:0098542),962,35,13.29,+,2.63,2.98E-07,1.76E-04,TABI,NA,Decrease,Early,purity_score_500_iter
import into cell (GO:0098657),668,23,9.23,+,2.49,8.05E-05,2.37E-02,TABI,NA,Decrease,Early,purity_score_500_iter
regulation of immune response (GO:0050776),1144,38,15.80,+,2.40,8.47E-07,4.21E-04,TABI,NA,Decrease,Early,purity_score_500_iter
positive regulation of immune system process (GO:0002684),1160,38,16.02,+,2.37,1.14E-06,5.50E-04,TABI,NA,Decrease,Early,purity_score_500_iter
immune response (GO:0006955),1869,61,25.82,+,2.36,3.71E-10,2.96E-06,TABI,NA,Decrease,Early,purity_score_500_iter
defense response (GO:0006952),1352,44,18.67,+,2.36,2.19E-07,1.74E-04,TABI,NA,Decrease,Early,purity_score_500_iter
regulation of defense response (GO:0031347),769,25,10.62,+,2.35,1.10E-04,3.19E-02,TABI,NA,Decrease,Early,purity_score_500_iter
response to biotic stimulus (GO:0009607),1356,44,18.73,+,2.35,2.29E-07,1.59E-04,TABI,NA,Decrease,Early,purity_score_500_iter
response to external biotic stimulus (GO:0043207),1332,43,18.40,+,2.34,3.60E-07,2.05E-04,TABI,NA,Decrease,Early,purity_score_500_iter
response to other organism (GO:0051707),1330,42,18.37,+,2.29,7.83E-07,4.02E-04,TABI,NA,Decrease,Early,purity_score_500_iter
regulation of immune system process (GO:0002682),1681,46,23.22,+,1.98,1.08E-05,3.89E-03,TABI,NA,Decrease,Early,purity_score_500_iter
immune system process (GO:0002376),2807,72,38.77,+,1.86,2.19E-07,1.66E-04,TABI,NA,Decrease,Early,purity_score_500_iter
response to external stimulus (GO:0009605),2449,58,33.83,+,1.71,4.65E-05,1.51E-02,TABI,NA,Decrease,Early,purity_score_500_iter
multi-organism process (GO:0051704),2842,65,39.25,+,1.66,4.42E-05,1.47E-02,TABI,NA,Decrease,Early,purity_score_500_iter
nuclear cell cycle DNA replication initiation (GO:1902315),4,4,.21,+,19.41,3.42E-04,1.50E-02,TABI,NA,Increase,Early,purity_score_500_iter
cell cycle DNA replication initiation (GO:1902292),4,4,.21,+,19.41,3.42E-04,1.50E-02,TABI,NA,Increase,Early,purity_score_500_iter
leading strand elongation (GO:0006272),4,4,.21,+,19.41,3.42E-04,1.49E-02,TABI,NA,Increase,Early,purity_score_500_iter
mitotic DNA replication initiation (GO:1902975),4,4,.21,+,19.41,3.42E-04,1.49E-02,TABI,NA,Increase,Early,purity_score_500_iter
mitotic DNA replication (GO:1902969),11,8,.57,+,14.12,1.51E-06,1.24E-04,TABI,NA,Increase,Early,purity_score_500_iter
pre-replicative complex assembly involved in cell cycle DNA replication (GO:1902299),7,5,.36,+,13.87,1.66E-04,8.10E-03,TABI,NA,Increase,Early,purity_score_500_iter
pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),7,5,.36,+,13.87,1.66E-04,8.08E-03,TABI,NA,Increase,Early,purity_score_500_iter
pre-replicative complex assembly (GO:0036388),7,5,.36,+,13.87,1.66E-04,8.05E-03,TABI,NA,Increase,Early,purity_score_500_iter
maintenance of DNA methylation (GO:0010216),6,4,.31,+,12.94,9.48E-04,3.78E-02,TABI,NA,Increase,Early,purity_score_500_iter
DNA strand elongation involved in DNA replication (GO:0006271),18,12,.93,+,12.94,6.84E-09,9.01E-07,TABI,NA,Increase,Early,purity_score_500_iter
spindle assembly involved in meiosis (GO:0090306),6,4,.31,+,12.94,9.48E-04,3.77E-02,TABI,NA,Increase,Early,purity_score_500_iter
double-strand break repair via break-induced replication (GO:0000727),11,7,.57,+,12.35,1.31E-05,8.53E-04,TABI,NA,Increase,Early,purity_score_500_iter
mitotic spindle elongation (GO:0000022),8,5,.41,+,12.13,2.59E-04,1.18E-02,TABI,NA,Increase,Early,purity_score_500_iter
protein localization to kinetochore (GO:0034501),13,8,.67,+,11.95,3.71E-06,2.78E-04,TABI,NA,Increase,Early,purity_score_500_iter
prophase (GO:0051324),15,9,.77,+,11.65,1.05E-06,8.93E-05,TABI,NA,Increase,Early,purity_score_500_iter
mitotic prophase (GO:0000088),15,9,.77,+,11.65,1.05E-06,8.88E-05,TABI,NA,Increase,Early,purity_score_500_iter
DNA strand elongation (GO:0022616),23,13,1.18,+,10.97,7.02E-09,9.16E-07,TABI,NA,Increase,Early,purity_score_500_iter
spindle elongation (GO:0051231),9,5,.46,+,10.79,3.86E-04,1.67E-02,TABI,NA,Increase,Early,purity_score_500_iter
"protein localization to chromosome, centromeric region (GO:0071459)",17,9,.88,+,10.28,2.30E-06,1.79E-04,TABI,NA,Increase,Early,purity_score_500_iter
mitotic spindle assembly checkpoint (GO:0007094),25,13,1.29,+,10.10,1.50E-08,1.85E-06,TABI,NA,Increase,Early,purity_score_500_iter
mitotic spindle checkpoint (GO:0071174),25,13,1.29,+,10.10,1.50E-08,1.84E-06,TABI,NA,Increase,Early,purity_score_500_iter
spindle assembly checkpoint (GO:0071173),25,13,1.29,+,10.10,1.50E-08,1.82E-06,TABI,NA,Increase,Early,purity_score_500_iter
spindle checkpoint (GO:0031577),25,13,1.29,+,10.10,1.50E-08,1.81E-06,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of mitotic metaphase/anaphase transition (GO:0045841),27,14,1.39,+,10.07,4.29E-09,6.05E-07,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100),28,14,1.44,+,9.71,6.14E-09,8.29E-07,TABI,NA,Increase,Early,purity_score_500_iter
positive regulation of ubiquitin protein ligase activity (GO:1904668),12,6,.62,+,9.71,1.52E-04,7.52E-03,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of mitotic sister chromatid separation (GO:2000816),30,15,1.55,+,9.71,1.76E-09,2.67E-07,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of chromosome separation (GO:1905819),31,15,1.60,+,9.39,2.49E-09,3.64E-07,TABI,NA,Increase,Early,purity_score_500_iter
regulation of attachment of spindle microtubules to kinetochore (GO:0051988),13,6,.67,+,8.96,2.13E-04,1.01E-02,TABI,NA,Increase,Early,purity_score_500_iter
meiotic spindle organization (GO:0000212),13,6,.67,+,8.96,2.13E-04,1.01E-02,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of sister chromatid segregation (GO:0033046),35,16,1.80,+,8.88,1.40E-09,2.16E-07,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of mitotic sister chromatid segregation (GO:0033048),33,15,1.70,+,8.82,4.86E-09,6.67E-07,TABI,NA,Increase,Early,purity_score_500_iter
DNA replication initiation (GO:0006270),33,15,1.70,+,8.82,4.86E-09,6.61E-07,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of chromosome segregation (GO:0051985),36,16,1.85,+,8.63,1.93E-09,2.87E-07,TABI,NA,Increase,Early,purity_score_500_iter
kinetochore organization (GO:0051383),18,8,.93,+,8.63,2.29E-05,1.42E-03,TABI,NA,Increase,Early,purity_score_500_iter
nuclear DNA replication (GO:0033260),43,18,2.21,+,8.13,4.06E-10,6.74E-08,TABI,NA,Increase,Early,purity_score_500_iter
mitotic chromosome condensation (GO:0007076),17,7,.88,+,7.99,1.10E-04,5.77E-03,TABI,NA,Increase,Early,purity_score_500_iter
DNA replication checkpoint (GO:0000076),17,7,.88,+,7.99,1.10E-04,5.75E-03,TABI,NA,Increase,Early,purity_score_500_iter
cell cycle DNA replication (GO:0044786),44,18,2.27,+,7.94,5.47E-10,8.89E-08,TABI,NA,Increase,Early,purity_score_500_iter
centromere complex assembly (GO:0034508),37,15,1.91,+,7.87,1.65E-08,1.97E-06,TABI,NA,Increase,Early,purity_score_500_iter
CENP-A containing nucleosome assembly (GO:0034080),30,12,1.55,+,7.77,5.07E-07,4.54E-05,TABI,NA,Increase,Early,purity_score_500_iter
CENP-A containing chromatin organization (GO:0061641),30,12,1.55,+,7.77,5.07E-07,4.51E-05,TABI,NA,Increase,Early,purity_score_500_iter
chromatin remodeling at centromere (GO:0031055),33,13,1.70,+,7.65,1.96E-07,1.90E-05,TABI,NA,Increase,Early,purity_score_500_iter
regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),28,11,1.44,+,7.63,1.75E-06,1.39E-04,TABI,NA,Increase,Early,purity_score_500_iter
mitotic spindle organization (GO:0007052),77,30,3.97,+,7.56,2.86E-15,1.04E-12,TABI,NA,Increase,Early,purity_score_500_iter
regulation of mitotic sister chromatid separation (GO:0010965),63,24,3.25,+,7.40,2.52E-12,5.90E-10,TABI,NA,Increase,Early,purity_score_500_iter
attachment of spindle microtubules to kinetochore (GO:0008608),21,8,1.08,+,7.40,5.52E-05,3.02E-03,TABI,NA,Increase,Early,purity_score_500_iter
regulation of mitotic metaphase/anaphase transition (GO:0030071),58,22,2.99,+,7.36,2.20E-11,4.17E-09,TABI,NA,Increase,Early,purity_score_500_iter
mitotic spindle assembly (GO:0090307),37,14,1.91,+,7.35,9.94E-08,1.01E-05,TABI,NA,Increase,Early,purity_score_500_iter
mitotic sister chromatid segregation (GO:0000070),106,40,5.46,+,7.33,1.67E-19,9.53E-17,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of mitotic nuclear division (GO:0045839),43,16,2.21,+,7.22,1.47E-08,1.84E-06,TABI,NA,Increase,Early,purity_score_500_iter
regulation of chromosome separation (GO:1905818),68,25,3.50,+,7.14,1.67E-12,4.03E-10,TABI,NA,Increase,Early,purity_score_500_iter
regulation of metaphase/anaphase transition of cell cycle (GO:1902099),60,22,3.09,+,7.12,3.75E-11,7.04E-09,TABI,NA,Increase,Early,purity_score_500_iter
regulation of nuclease activity (GO:0032069),22,8,1.13,+,7.06,7.20E-05,3.90E-03,TABI,NA,Increase,Early,purity_score_500_iter
DNA replication-independent nucleosome assembly (GO:0006336),39,14,2.01,+,6.97,1.69E-07,1.66E-05,TABI,NA,Increase,Early,purity_score_500_iter
microtubule depolymerization (GO:0007019),17,6,.88,+,6.85,6.70E-04,2.77E-02,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of cell division (GO:0051782),17,6,.88,+,6.85,6.70E-04,2.77E-02,TABI,NA,Increase,Early,purity_score_500_iter
sister chromatid segregation (GO:0000819),139,49,7.16,+,6.84,1.50E-22,1.49E-19,TABI,NA,Increase,Early,purity_score_500_iter
DNA replication-independent nucleosome organization (GO:0034724),40,14,2.06,+,6.80,2.17E-07,2.10E-05,TABI,NA,Increase,Early,purity_score_500_iter
"nucleotide-excision repair, DNA gap filling (GO:0006297)",23,8,1.18,+,6.75,9.29E-05,4.92E-03,TABI,NA,Increase,Early,purity_score_500_iter
microtubule cytoskeleton organization involved in mitosis (GO:1902850),108,37,5.56,+,6.65,5.03E-17,2.11E-14,TABI,NA,Increase,Early,purity_score_500_iter
regulation of mitotic sister chromatid segregation (GO:0033047),74,25,3.81,+,6.56,7.62E-12,1.56E-09,TABI,NA,Increase,Early,purity_score_500_iter
mitotic nuclear division (GO:0140014),143,48,7.37,+,6.52,2.21E-21,1.95E-18,TABI,NA,Increase,Early,purity_score_500_iter
regulation of chromosome segregation (GO:0051983),108,36,5.56,+,6.47,2.71E-16,1.08E-13,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of nuclear division (GO:0051784),52,17,2.68,+,6.35,2.54E-08,2.86E-06,TABI,NA,Increase,Early,purity_score_500_iter
regulation of sister chromatid segregation (GO:0033045),86,28,4.43,+,6.32,8.91E-13,2.18E-10,TABI,NA,Increase,Early,purity_score_500_iter
telomere maintenance via semi-conservative replication (GO:0032201),25,8,1.29,+,6.21,1.50E-04,7.44E-03,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of DNA-dependent DNA replication (GO:2000104),19,6,.98,+,6.13,1.08E-03,4.24E-02,TABI,NA,Increase,Early,purity_score_500_iter
positive regulation of chromosome segregation (GO:0051984),33,10,1.70,+,5.88,3.33E-05,1.98E-03,TABI,NA,Increase,Early,purity_score_500_iter
centrosome duplication (GO:0051298),30,9,1.55,+,5.82,8.79E-05,4.73E-03,TABI,NA,Increase,Early,purity_score_500_iter
histone phosphorylation (GO:0016572),30,9,1.55,+,5.82,8.79E-05,4.72E-03,TABI,NA,Increase,Early,purity_score_500_iter
mitotic metaphase plate congression (GO:0007080),44,13,2.27,+,5.74,2.85E-06,2.17E-04,TABI,NA,Increase,Early,purity_score_500_iter
regulation of ubiquitin protein ligase activity (GO:1904666),24,7,1.24,+,5.66,6.20E-04,2.59E-02,TABI,NA,Increase,Early,purity_score_500_iter
centrosome cycle (GO:0007098),83,24,4.28,+,5.61,2.88E-10,4.88E-08,TABI,NA,Increase,Early,purity_score_500_iter
sister chromatid cohesion (GO:0007062),49,14,2.52,+,5.55,1.66E-06,1.34E-04,TABI,NA,Increase,Early,purity_score_500_iter
regulation of DNA-dependent DNA replication (GO:0090329),49,14,2.52,+,5.55,1.66E-06,1.33E-04,TABI,NA,Increase,Early,purity_score_500_iter
DNA-dependent DNA replication (GO:0006261),120,34,6.18,+,5.50,9.46E-14,2.90E-11,TABI,NA,Increase,Early,purity_score_500_iter
spindle organization (GO:0007051),142,40,7.31,+,5.47,7.32E-16,2.84E-13,TABI,NA,Increase,Early,purity_score_500_iter
nuclear chromosome segregation (GO:0098813),217,61,11.18,+,5.46,1.79E-23,2.38E-20,TABI,NA,Increase,Early,purity_score_500_iter
mitotic prometaphase (GO:0000236),170,47,8.76,+,5.37,3.93E-18,1.96E-15,TABI,NA,Increase,Early,purity_score_500_iter
mitotic cytokinesis (GO:0000281),70,19,3.61,+,5.27,4.79E-08,5.05E-06,TABI,NA,Increase,Early,purity_score_500_iter
histone exchange (GO:0043486),48,13,2.47,+,5.26,6.37E-06,4.36E-04,TABI,NA,Increase,Early,purity_score_500_iter
M phase (GO:0000279),170,46,8.76,+,5.25,1.81E-17,8.46E-15,TABI,NA,Increase,Early,purity_score_500_iter
mitotic M phase (GO:0000087),170,46,8.76,+,5.25,1.81E-17,8.22E-15,TABI,NA,Increase,Early,purity_score_500_iter
chromosome segregation (GO:0007059),275,74,14.16,+,5.22,3.01E-27,5.99E-24,TABI,NA,Increase,Early,purity_score_500_iter
microtubule organizing center organization (GO:0031023),93,25,4.79,+,5.22,4.48E-10,7.35E-08,TABI,NA,Increase,Early,purity_score_500_iter
metaphase plate congression (GO:0051310),53,14,2.73,+,5.13,3.62E-06,2.72E-04,TABI,NA,Increase,Early,purity_score_500_iter
mitotic cell cycle checkpoint (GO:0007093),160,42,8.24,+,5.10,1.12E-15,4.16E-13,TABI,NA,Increase,Early,purity_score_500_iter
nuclear division (GO:0000280),284,74,14.63,+,5.06,1.63E-26,2.60E-23,TABI,NA,Increase,Early,purity_score_500_iter
female meiotic nuclear division (GO:0007143),31,8,1.60,+,5.01,5.12E-04,2.17E-02,TABI,NA,Increase,Early,purity_score_500_iter
chromosome condensation (GO:0030261),43,11,2.21,+,4.97,5.09E-05,2.83E-03,TABI,NA,Increase,Early,purity_score_500_iter
cell cycle checkpoint (GO:0000075),201,51,10.35,+,4.93,3.20E-18,1.65E-15,TABI,NA,Increase,Early,purity_score_500_iter
cell cycle G1/S phase transition (GO:0044843),124,31,6.39,+,4.85,1.80E-11,3.50E-09,TABI,NA,Increase,Early,purity_score_500_iter
DNA replication (GO:0006260),208,52,10.71,+,4.85,2.56E-18,1.36E-15,TABI,NA,Increase,Early,purity_score_500_iter
regulation of cytokinesis (GO:0032465),88,22,4.53,+,4.85,1.52E-08,1.82E-06,TABI,NA,Increase,Early,purity_score_500_iter
establishment of mitotic spindle localization (GO:0040001),36,9,1.85,+,4.85,2.82E-04,1.26E-02,TABI,NA,Increase,Early,purity_score_500_iter
establishment of chromosome localization (GO:0051303),72,18,3.71,+,4.85,3.05E-07,2.88E-05,TABI,NA,Increase,Early,purity_score_500_iter
protein localization to chromosome (GO:0034502),64,16,3.30,+,4.85,1.38E-06,1.14E-04,TABI,NA,Increase,Early,purity_score_500_iter
organelle fission (GO:0048285),313,78,16.12,+,4.84,7.90E-27,1.40E-23,TABI,NA,Increase,Early,purity_score_500_iter
chromosome localization (GO:0050000),73,18,3.76,+,4.79,3.63E-07,3.36E-05,TABI,NA,Increase,Early,purity_score_500_iter
G1/S transition of mitotic cell cycle (GO:0000082),122,30,6.28,+,4.77,5.39E-11,9.75E-09,TABI,NA,Increase,Early,purity_score_500_iter
anaphase (GO:0051322),156,38,8.04,+,4.73,1.90E-13,5.41E-11,TABI,NA,Increase,Early,purity_score_500_iter
mitotic anaphase (GO:0000090),156,38,8.04,+,4.73,1.90E-13,5.32E-11,TABI,NA,Increase,Early,purity_score_500_iter
DNA packaging (GO:0006323),177,42,9.12,+,4.61,2.19E-14,7.14E-12,TABI,NA,Increase,Early,purity_score_500_iter
mitotic cell cycle process (GO:1903047),614,145,31.63,+,4.58,2.99E-47,1.19E-43,TABI,NA,Increase,Early,purity_score_500_iter
somatic diversification of immune receptors via germline recombination within a single locus (GO:0002562),34,8,1.75,+,4.57,8.62E-04,3.48E-02,TABI,NA,Increase,Early,purity_score_500_iter
postreplication repair (GO:0006301),51,12,2.63,+,4.57,4.73E-05,2.66E-03,TABI,NA,Increase,Early,purity_score_500_iter
somatic cell DNA recombination (GO:0016444),34,8,1.75,+,4.57,8.62E-04,3.48E-02,TABI,NA,Increase,Early,purity_score_500_iter
microtubule polymerization or depolymerization (GO:0031109),51,12,2.63,+,4.57,4.73E-05,2.65E-03,TABI,NA,Increase,Early,purity_score_500_iter
cytoskeleton-dependent cytokinesis (GO:0061640),98,23,5.05,+,4.56,1.98E-08,2.32E-06,TABI,NA,Increase,Early,purity_score_500_iter
biological phase (GO:0044848),269,63,13.86,+,4.55,1.10E-20,7.65E-18,TABI,NA,Increase,Early,purity_score_500_iter
mitotic cell cycle phase (GO:0098763),269,63,13.86,+,4.55,1.10E-20,7.33E-18,TABI,NA,Increase,Early,purity_score_500_iter
cell cycle phase (GO:0022403),269,63,13.86,+,4.55,1.10E-20,7.04E-18,TABI,NA,Increase,Early,purity_score_500_iter
meiotic chromosome segregation (GO:0045132),90,21,4.64,+,4.53,8.83E-08,9.01E-06,TABI,NA,Increase,Early,purity_score_500_iter
DNA integrity checkpoint (GO:0031570),150,35,7.73,+,4.53,4.86E-12,1.06E-09,TABI,NA,Increase,Early,purity_score_500_iter
mitotic cell cycle phase transition (GO:0044772),280,65,14.42,+,4.51,3.95E-21,3.15E-18,TABI,NA,Increase,Early,purity_score_500_iter
positive regulation of cytokinesis (GO:0032467),39,9,2.01,+,4.48,4.68E-04,2.00E-02,TABI,NA,Increase,Early,purity_score_500_iter
meiotic nuclear division (GO:0140013),156,36,8.04,+,4.48,3.18E-12,7.13E-10,TABI,NA,Increase,Early,purity_score_500_iter
cell cycle phase transition (GO:0044770),288,66,14.83,+,4.45,3.52E-21,2.95E-18,TABI,NA,Increase,Early,purity_score_500_iter
somatic diversification of immunoglobulins (GO:0016445),35,8,1.80,+,4.44,1.01E-03,4.02E-02,TABI,NA,Increase,Early,purity_score_500_iter
regulation of mitotic nuclear division (GO:0007088),171,39,8.81,+,4.43,5.45E-13,1.40E-10,TABI,NA,Increase,Early,purity_score_500_iter
nucleosome assembly (GO:0006334),115,26,5.92,+,4.39,4.68E-09,6.54E-07,TABI,NA,Increase,Early,purity_score_500_iter
mitotic cell cycle (GO:0000278),696,157,35.85,+,4.38,4.75E-49,3.78E-45,TABI,NA,Increase,Early,purity_score_500_iter
G2/M transition of mitotic cell cycle (GO:0000086),139,31,7.16,+,4.33,2.11E-10,3.65E-08,TABI,NA,Increase,Early,purity_score_500_iter
mitotic DNA integrity checkpoint (GO:0044774),108,24,5.56,+,4.31,2.42E-08,2.75E-06,TABI,NA,Increase,Early,purity_score_500_iter
cytokinetic process (GO:0032506),36,8,1.85,+,4.31,1.19E-03,4.56E-02,TABI,NA,Increase,Early,purity_score_500_iter
positive regulation of cyclin-dependent protein kinase activity (GO:1904031),36,8,1.85,+,4.31,1.19E-03,4.54E-02,TABI,NA,Increase,Early,purity_score_500_iter
signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431),59,13,3.04,+,4.28,4.17E-05,2.41E-03,TABI,NA,Increase,Early,purity_score_500_iter
signal transduction involved in mitotic cell cycle checkpoint (GO:0072413),59,13,3.04,+,4.28,4.17E-05,2.40E-03,TABI,NA,Increase,Early,purity_score_500_iter
signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403),59,13,3.04,+,4.28,4.17E-05,2.39E-03,TABI,NA,Increase,Early,purity_score_500_iter
signal transduction involved in mitotic DNA damage checkpoint (GO:1902402),59,13,3.04,+,4.28,4.17E-05,2.38E-03,TABI,NA,Increase,Early,purity_score_500_iter
intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400),59,13,3.04,+,4.28,4.17E-05,2.37E-03,TABI,NA,Increase,Early,purity_score_500_iter
double-strand break repair via nonhomologous end joining (GO:0006303),59,13,3.04,+,4.28,4.17E-05,2.37E-03,TABI,NA,Increase,Early,purity_score_500_iter
base-excision repair (GO:0006284),50,11,2.58,+,4.27,1.63E-04,7.97E-03,TABI,NA,Increase,Early,purity_score_500_iter
cell cycle G2/M phase transition (GO:0044839),141,31,7.26,+,4.27,2.86E-10,4.90E-08,TABI,NA,Increase,Early,purity_score_500_iter
signal transduction involved in DNA damage checkpoint (GO:0072422),73,16,3.76,+,4.26,5.95E-06,4.10E-04,TABI,NA,Increase,Early,purity_score_500_iter
signal transduction involved in DNA integrity checkpoint (GO:0072401),73,16,3.76,+,4.26,5.95E-06,4.09E-04,TABI,NA,Increase,Early,purity_score_500_iter
meiotic cell cycle process (GO:1903046),169,37,8.70,+,4.25,6.09E-12,1.28E-09,TABI,NA,Increase,Early,purity_score_500_iter
cytokinesis (GO:0000910),110,24,5.67,+,4.24,3.27E-08,3.57E-06,TABI,NA,Increase,Early,purity_score_500_iter
chromatin assembly (GO:0031497),133,29,6.85,+,4.23,1.26E-09,1.97E-07,TABI,NA,Increase,Early,purity_score_500_iter
somatic diversification of immune receptors (GO:0002200),46,10,2.37,+,4.22,3.48E-04,1.51E-02,TABI,NA,Increase,Early,purity_score_500_iter
spindle assembly (GO:0051225),83,18,4.28,+,4.21,1.81E-06,1.43E-04,TABI,NA,Increase,Early,purity_score_500_iter
signal transduction involved in cell cycle checkpoint (GO:0072395),74,16,3.81,+,4.20,6.91E-06,4.69E-04,TABI,NA,Increase,Early,purity_score_500_iter
cell division (GO:0051301),495,107,25.50,+,4.20,6.23E-32,1.65E-28,TABI,NA,Increase,Early,purity_score_500_iter
establishment of spindle localization (GO:0051293),47,10,2.42,+,4.13,4.03E-04,1.74E-02,TABI,NA,Increase,Early,purity_score_500_iter
double-strand break repair via homologous recombination (GO:0000724),99,21,5.10,+,4.12,3.50E-07,3.28E-05,TABI,NA,Increase,Early,purity_score_500_iter
reciprocal meiotic recombination (GO:0007131),52,11,2.68,+,4.11,2.19E-04,1.03E-02,TABI,NA,Increase,Early,purity_score_500_iter
spindle localization (GO:0051653),52,11,2.68,+,4.11,2.19E-04,1.03E-02,TABI,NA,Increase,Early,purity_score_500_iter
interstrand cross-link repair (GO:0036297),52,11,2.68,+,4.11,2.19E-04,1.03E-02,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of chromosome organization (GO:2001251),138,29,7.11,+,4.08,2.62E-09,3.79E-07,TABI,NA,Increase,Early,purity_score_500_iter
mitotic DNA damage checkpoint (GO:0044773),100,21,5.15,+,4.08,4.05E-07,3.73E-05,TABI,NA,Increase,Early,purity_score_500_iter
recombinational repair (GO:0000725),100,21,5.15,+,4.08,4.05E-07,3.71E-05,TABI,NA,Increase,Early,purity_score_500_iter
DNA damage checkpoint (GO:0000077),139,29,7.16,+,4.05,3.02E-09,4.29E-07,TABI,NA,Increase,Early,purity_score_500_iter
homologous recombination (GO:0035825),53,11,2.73,+,4.03,2.53E-04,1.16E-02,TABI,NA,Increase,Early,purity_score_500_iter
"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",58,12,2.99,+,4.02,1.38E-04,6.93E-03,TABI,NA,Increase,Early,purity_score_500_iter
regulation of centrosome cycle (GO:0046605),58,12,2.99,+,4.02,1.38E-04,6.91E-03,TABI,NA,Increase,Early,purity_score_500_iter
positive regulation of mitotic nuclear division (GO:0045840),58,12,2.99,+,4.02,1.38E-04,6.89E-03,TABI,NA,Increase,Early,purity_score_500_iter
meiotic cell cycle (GO:0051321),223,46,11.49,+,4.00,1.06E-13,3.17E-11,TABI,NA,Increase,Early,purity_score_500_iter
DNA conformation change (GO:0071103),291,60,14.99,+,4.00,1.80E-17,8.70E-15,TABI,NA,Increase,Early,purity_score_500_iter
regulation of nuclear division (GO:0051783),195,40,10.04,+,3.98,5.00E-12,1.08E-09,TABI,NA,Increase,Early,purity_score_500_iter
non-recombinational repair (GO:0000726),65,13,3.35,+,3.88,9.89E-05,5.22E-03,TABI,NA,Increase,Early,purity_score_500_iter
"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",80,16,4.12,+,3.88,1.62E-05,1.04E-03,TABI,NA,Increase,Early,purity_score_500_iter
double-strand break repair (GO:0006302),186,37,9.58,+,3.86,6.77E-11,1.21E-08,TABI,NA,Increase,Early,purity_score_500_iter
protein-DNA complex assembly (GO:0065004),207,41,10.66,+,3.85,7.14E-12,1.48E-09,TABI,NA,Increase,Early,purity_score_500_iter
mitotic G1/S transition checkpoint (GO:0044819),66,13,3.40,+,3.82,1.13E-04,5.85E-03,TABI,NA,Increase,Early,purity_score_500_iter
mitotic G1 DNA damage checkpoint (GO:0031571),66,13,3.40,+,3.82,1.13E-04,5.83E-03,TABI,NA,Increase,Early,purity_score_500_iter
DNA synthesis involved in DNA repair (GO:0000731),51,10,2.63,+,3.81,7.05E-04,2.90E-02,TABI,NA,Increase,Early,purity_score_500_iter
G1 DNA damage checkpoint (GO:0044783),67,13,3.45,+,3.77,1.29E-04,6.55E-03,TABI,NA,Increase,Early,purity_score_500_iter
DNA recombination (GO:0006310),222,43,11.43,+,3.76,4.17E-12,9.23E-10,TABI,NA,Increase,Early,purity_score_500_iter
positive regulation of cell cycle arrest (GO:0071158),83,16,4.28,+,3.74,2.41E-05,1.49E-03,TABI,NA,Increase,Early,purity_score_500_iter
signal transduction in response to DNA damage (GO:0042770),104,20,5.36,+,3.73,2.50E-06,1.93E-04,TABI,NA,Increase,Early,purity_score_500_iter
regulation of cyclin-dependent protein kinase activity (GO:1904029),104,20,5.36,+,3.73,2.50E-06,1.92E-04,TABI,NA,Increase,Early,purity_score_500_iter
DNA geometric change (GO:0032392),115,22,5.92,+,3.71,8.61E-07,7.41E-05,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of mitotic cell cycle phase transition (GO:1901991),220,42,11.33,+,3.71,1.11E-11,2.19E-09,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of cell cycle phase transition (GO:1901988),236,45,12.16,+,3.70,2.11E-12,5.03E-10,TABI,NA,Increase,Early,purity_score_500_iter
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),100,19,5.15,+,3.69,5.16E-06,3.72E-04,TABI,NA,Increase,Early,purity_score_500_iter
chromatin assembly or disassembly (GO:0006333),154,29,7.93,+,3.66,2.22E-08,2.57E-06,TABI,NA,Increase,Early,purity_score_500_iter
cell cycle process (GO:0022402),995,186,51.25,+,3.63,6.69E-48,3.55E-44,TABI,NA,Increase,Early,purity_score_500_iter
telomere maintenance (GO:0000723),97,18,5.00,+,3.60,1.20E-05,7.89E-04,TABI,NA,Increase,Early,purity_score_500_iter
positive regulation of nuclear division (GO:0051785),71,13,3.66,+,3.55,2.14E-04,1.01E-02,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of cell cycle G1/S phase transition (GO:1902807),110,20,5.67,+,3.53,5.26E-06,3.72E-04,TABI,NA,Increase,Early,purity_score_500_iter
positive regulation of mitotic cell cycle phase transition (GO:1901992),83,15,4.28,+,3.51,8.18E-05,4.42E-03,TABI,NA,Increase,Early,purity_score_500_iter
telomere organization (GO:0032200),100,18,5.15,+,3.49,1.73E-05,1.10E-03,TABI,NA,Increase,Early,purity_score_500_iter
regulation of cell division (GO:0051302),167,30,8.60,+,3.49,3.24E-08,3.56E-06,TABI,NA,Increase,Early,purity_score_500_iter
ATP-dependent chromatin remodeling (GO:0043044),78,14,4.02,+,3.48,1.49E-04,7.42E-03,TABI,NA,Increase,Early,purity_score_500_iter
"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",84,15,4.33,+,3.47,9.21E-05,4.89E-03,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),107,19,5.51,+,3.45,1.21E-05,7.88E-04,TABI,NA,Increase,Early,purity_score_500_iter
DNA repair (GO:0006281),513,91,26.42,+,3.44,5.75E-22,5.39E-19,TABI,NA,Increase,Early,purity_score_500_iter
nucleosome organization (GO:0034728),158,28,8.14,+,3.44,1.19E-07,1.20E-05,TABI,NA,Increase,Early,purity_score_500_iter
chromosome organization involved in meiotic cell cycle (GO:0070192),68,12,3.50,+,3.43,4.97E-04,2.11E-02,TABI,NA,Increase,Early,purity_score_500_iter
microtubule cytoskeleton organization (GO:0000226),478,84,24.62,+,3.41,4.03E-20,2.47E-17,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of mitotic cell cycle (GO:0045930),313,55,16.12,+,3.41,1.41E-13,4.17E-11,TABI,NA,Increase,Early,purity_score_500_iter
meiosis I (GO:0007127),114,20,5.87,+,3.41,8.41E-06,5.68E-04,TABI,NA,Increase,Early,purity_score_500_iter
signal transduction by p53 class mediator (GO:0072331),120,21,6.18,+,3.40,5.22E-06,3.71E-04,TABI,NA,Increase,Early,purity_score_500_iter
vascular endothelial growth factor receptor signaling pathway (GO:0048010),69,12,3.55,+,3.38,5.58E-04,2.35E-02,TABI,NA,Increase,Early,purity_score_500_iter
regulation of mitotic cell cycle phase transition (GO:1901990),420,73,21.63,+,3.37,2.15E-17,9.49E-15,TABI,NA,Increase,Early,purity_score_500_iter
regulation of DNA replication (GO:0006275),110,19,5.67,+,3.35,1.70E-05,1.09E-03,TABI,NA,Increase,Early,purity_score_500_iter
regulation of G2/M transition of mitotic cell cycle (GO:0010389),197,34,10.15,+,3.35,9.68E-09,1.24E-06,TABI,NA,Increase,Early,purity_score_500_iter
meiosis I cell cycle process (GO:0061982),116,20,5.97,+,3.35,1.05E-05,7.00E-04,TABI,NA,Increase,Early,purity_score_500_iter
cell cycle (GO:0007049),1331,229,68.56,+,3.34,4.03E-54,6.42E-50,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of cell cycle process (GO:0010948),326,56,16.79,+,3.33,1.93E-13,5.29E-11,TABI,NA,Increase,Early,purity_score_500_iter
protein-DNA complex subunit organization (GO:0071824),251,43,12.93,+,3.33,1.34E-10,2.37E-08,TABI,NA,Increase,Early,purity_score_500_iter
anaphase-promoting complex-dependent catabolic process (GO:0031145),82,14,4.22,+,3.31,2.36E-04,1.09E-02,TABI,NA,Increase,Early,purity_score_500_iter
positive regulation of cell cycle process (GO:0090068),294,50,15.14,+,3.30,5.30E-12,1.13E-09,TABI,NA,Increase,Early,purity_score_500_iter
ciliary basal body-plasma membrane docking (GO:0097711),95,16,4.89,+,3.27,1.00E-04,5.27E-03,TABI,NA,Increase,Early,purity_score_500_iter
regulation of cell cycle G2/M phase transition (GO:1902749),214,36,11.02,+,3.27,6.48E-09,8.60E-07,TABI,NA,Increase,Early,purity_score_500_iter
DNA duplex unwinding (GO:0032508),107,18,5.51,+,3.27,3.83E-05,2.23E-03,TABI,NA,Increase,Early,purity_score_500_iter
regulation of microtubule-based process (GO:0032886),232,39,11.95,+,3.26,1.55E-09,2.38E-07,TABI,NA,Increase,Early,purity_score_500_iter
regulation of microtubule cytoskeleton organization (GO:0070507),197,33,10.15,+,3.25,3.00E-08,3.35E-06,TABI,NA,Increase,Early,purity_score_500_iter
regulation of double-strand break repair (GO:2000779),84,14,4.33,+,3.24,2.94E-04,1.30E-02,TABI,NA,Increase,Early,purity_score_500_iter
peptidyl-threonine phosphorylation (GO:0018107),72,12,3.71,+,3.24,7.79E-04,3.18E-02,TABI,NA,Increase,Early,purity_score_500_iter
DNA biosynthetic process (GO:0071897),109,18,5.61,+,3.21,4.75E-05,2.65E-03,TABI,NA,Increase,Early,purity_score_500_iter
regulation of cell cycle arrest (GO:0071156),109,18,5.61,+,3.21,4.75E-05,2.64E-03,TABI,NA,Increase,Early,purity_score_500_iter
regulation of cell cycle phase transition (GO:1901987),456,75,23.49,+,3.19,1.11E-16,4.54E-14,TABI,NA,Increase,Early,purity_score_500_iter
regulation of G1/S transition of mitotic cell cycle (GO:2000045),157,25,8.09,+,3.09,3.11E-06,2.35E-04,TABI,NA,Increase,Early,purity_score_500_iter
positive regulation of cell cycle phase transition (GO:1901989),101,16,5.20,+,3.08,1.88E-04,9.05E-03,TABI,NA,Increase,Early,purity_score_500_iter
chromatin silencing (GO:0006342),76,12,3.91,+,3.07,1.18E-03,4.57E-02,TABI,NA,Increase,Early,purity_score_500_iter
chromatin organization involved in negative regulation of transcription (GO:0097549),76,12,3.91,+,3.07,1.18E-03,4.56E-02,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of cell cycle G2/M phase transition (GO:1902750),103,16,5.31,+,3.02,2.29E-04,1.07E-02,TABI,NA,Increase,Early,purity_score_500_iter
chromosome organization (GO:0051276),1053,163,54.24,+,3.01,6.45E-33,2.05E-29,TABI,NA,Increase,Early,purity_score_500_iter
nucleotide-excision repair (GO:0006289),110,17,5.67,+,3.00,1.56E-04,7.71E-03,TABI,NA,Increase,Early,purity_score_500_iter
DNA metabolic process (GO:0006259),749,115,38.58,+,2.98,6.14E-23,6.99E-20,TABI,NA,Increase,Early,purity_score_500_iter
cellular response to DNA damage stimulus (GO:0006974),781,119,40.23,+,2.96,1.80E-23,2.20E-20,TABI,NA,Increase,Early,purity_score_500_iter
positive regulation of mitotic cell cycle (GO:0045931),158,24,8.14,+,2.95,9.88E-06,6.59E-04,TABI,NA,Increase,Early,purity_score_500_iter
chromatin organization involved in regulation of transcription (GO:0034401),86,13,4.43,+,2.93,1.08E-03,4.24E-02,TABI,NA,Increase,Early,purity_score_500_iter
regulation of mitotic cell cycle (GO:0007346),686,103,35.33,+,2.91,5.56E-20,3.28E-17,TABI,NA,Increase,Early,purity_score_500_iter
positive regulation of cell division (GO:0051781),87,13,4.48,+,2.90,1.18E-03,4.57E-02,TABI,NA,Increase,Early,purity_score_500_iter
regulation of cell cycle G1/S phase transition (GO:1902806),176,26,9.07,+,2.87,6.69E-06,4.55E-04,TABI,NA,Increase,Early,purity_score_500_iter
"negative regulation of gene expression, epigenetic (GO:0045814)",95,14,4.89,+,2.86,8.79E-04,3.53E-02,TABI,NA,Increase,Early,purity_score_500_iter
regulation of DNA repair (GO:0006282),129,19,6.64,+,2.86,1.16E-04,5.93E-03,TABI,NA,Increase,Early,purity_score_500_iter
microtubule-based process (GO:0007017),667,98,34.36,+,2.85,1.77E-18,9.74E-16,TABI,NA,Increase,Early,purity_score_500_iter
regulation of cell cycle process (GO:0010564),763,112,39.30,+,2.85,5.47E-21,4.15E-18,TABI,NA,Increase,Early,purity_score_500_iter
positive regulation of cell cycle (GO:0045787),391,57,20.14,+,2.83,4.17E-11,7.73E-09,TABI,NA,Increase,Early,purity_score_500_iter
regulation of chromosome organization (GO:0033044),371,54,19.11,+,2.83,1.44E-10,2.52E-08,TABI,NA,Increase,Early,purity_score_500_iter
peptidyl-serine phosphorylation (GO:0018105),174,24,8.96,+,2.68,4.05E-05,2.35E-03,TABI,NA,Increase,Early,purity_score_500_iter
regulation of signal transduction by p53 class mediator (GO:1901796),182,25,9.37,+,2.67,3.00E-05,1.79E-03,TABI,NA,Increase,Early,purity_score_500_iter
chromatin remodeling (GO:0006338),168,23,8.65,+,2.66,6.44E-05,3.50E-03,TABI,NA,Increase,Early,purity_score_500_iter
positive regulation of DNA metabolic process (GO:0051054),199,27,10.25,+,2.63,2.89E-05,1.73E-03,TABI,NA,Increase,Early,purity_score_500_iter
regulation of DNA biosynthetic process (GO:2000278),111,15,5.72,+,2.62,1.29E-03,4.91E-02,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of cell cycle (GO:0045786),575,77,29.62,+,2.60,8.46E-13,2.11E-10,TABI,NA,Increase,Early,purity_score_500_iter
establishment of cell polarity (GO:0030010),122,16,6.28,+,2.55,1.20E-03,4.59E-02,TABI,NA,Increase,Early,purity_score_500_iter
regulation of cell cycle (GO:0051726),1243,163,64.02,+,2.55,1.53E-25,2.21E-22,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of organelle organization (GO:0010639),395,51,20.35,+,2.51,2.10E-08,2.44E-06,TABI,NA,Increase,Early,purity_score_500_iter
establishment of organelle localization (GO:0051656),373,48,19.21,+,2.50,6.23E-08,6.49E-06,TABI,NA,Increase,Early,purity_score_500_iter
response to ionizing radiation (GO:0010212),144,18,7.42,+,2.43,1.29E-03,4.91E-02,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of cytoskeleton organization (GO:0051494),152,19,7.83,+,2.43,9.23E-04,3.69E-02,TABI,NA,Increase,Early,purity_score_500_iter
regulation of response to DNA damage stimulus (GO:2001020),225,28,11.59,+,2.42,5.38E-05,2.95E-03,TABI,NA,Increase,Early,purity_score_500_iter
positive regulation of chromosome organization (GO:2001252),185,23,9.53,+,2.41,2.61E-04,1.19E-02,TABI,NA,Increase,Early,purity_score_500_iter
establishment of localization in cell (GO:0051649),399,49,20.55,+,2.38,1.73E-07,1.69E-05,TABI,NA,Increase,Early,purity_score_500_iter
regulation of DNA metabolic process (GO:0051052),360,44,18.54,+,2.37,9.60E-07,8.22E-05,TABI,NA,Increase,Early,purity_score_500_iter
peptidyl-serine modification (GO:0018209),198,24,10.20,+,2.35,2.57E-04,1.17E-02,TABI,NA,Increase,Early,purity_score_500_iter
organelle localization (GO:0051640),588,71,30.29,+,2.34,5.59E-10,8.99E-08,TABI,NA,Increase,Early,purity_score_500_iter
chromatin organization (GO:0006325),694,82,35.75,+,2.29,4.86E-11,8.89E-09,TABI,NA,Increase,Early,purity_score_500_iter
organelle localization by membrane tethering (GO:0140056),170,20,8.76,+,2.28,1.15E-03,4.46E-02,TABI,NA,Increase,Early,purity_score_500_iter
covalent chromatin modification (GO:0016569),369,43,19.01,+,2.26,4.28E-06,3.16E-04,TABI,NA,Increase,Early,purity_score_500_iter
histone modification (GO:0016570),358,41,18.44,+,2.22,9.50E-06,6.36E-04,TABI,NA,Increase,Early,purity_score_500_iter
regulation of synapse structure or activity (GO:0050803),237,26,12.21,+,2.13,7.39E-04,3.04E-02,TABI,NA,Increase,Early,purity_score_500_iter
synapse organization (GO:0050808),285,31,14.68,+,2.11,3.00E-04,1.33E-02,TABI,NA,Increase,Early,purity_score_500_iter
microtubule-based movement (GO:0007018),271,29,13.96,+,2.08,5.98E-04,2.51E-02,TABI,NA,Increase,Early,purity_score_500_iter
cilium assembly (GO:0060271),338,36,17.41,+,2.07,1.37E-04,6.91E-03,TABI,NA,Increase,Early,purity_score_500_iter
regulation of organelle organization (GO:0033043),1328,141,68.40,+,2.06,8.22E-15,2.85E-12,TABI,NA,Increase,Early,purity_score_500_iter
cytoskeleton organization (GO:0007010),1106,117,56.97,+,2.05,2.62E-12,6.04E-10,TABI,NA,Increase,Early,purity_score_500_iter
positive regulation of neuron projection development (GO:0010976),294,31,15.14,+,2.05,3.94E-04,1.70E-02,TABI,NA,Increase,Early,purity_score_500_iter
cilium organization (GO:0044782),358,37,18.44,+,2.01,2.11E-04,1.01E-02,TABI,NA,Increase,Early,purity_score_500_iter
regulation of small GTPase mediated signal transduction (GO:0051056),320,33,16.48,+,2.00,4.08E-04,1.75E-02,TABI,NA,Increase,Early,purity_score_500_iter
regulation of cytoskeleton organization (GO:0051493),560,57,28.84,+,1.98,4.29E-06,3.15E-04,TABI,NA,Increase,Early,purity_score_500_iter
organelle assembly (GO:0070925),723,73,37.24,+,1.96,2.42E-07,2.32E-05,TABI,NA,Increase,Early,purity_score_500_iter
plasma membrane bounded cell projection assembly (GO:0120031),430,43,22.15,+,1.94,9.20E-05,4.90E-03,TABI,NA,Increase,Early,purity_score_500_iter
positive regulation of cell projection organization (GO:0031346),395,39,20.35,+,1.92,2.74E-04,1.23E-02,TABI,NA,Increase,Early,purity_score_500_iter
positive regulation of transferase activity (GO:0051347),691,68,35.59,+,1.91,1.87E-06,1.47E-04,TABI,NA,Increase,Early,purity_score_500_iter
cell projection assembly (GO:0030031),445,43,22.92,+,1.88,2.61E-04,1.18E-02,TABI,NA,Increase,Early,purity_score_500_iter
organelle organization (GO:0006996),3428,331,176.57,+,1.87,1.35E-29,3.07E-26,TABI,NA,Increase,Early,purity_score_500_iter
response to radiation (GO:0009314),435,42,22.41,+,1.87,2.35E-04,1.09E-02,TABI,NA,Increase,Early,purity_score_500_iter
positive regulation of organelle organization (GO:0010638),637,61,32.81,+,1.86,1.51E-05,9.78E-04,TABI,NA,Increase,Early,purity_score_500_iter
regulation of transferase activity (GO:0051338),1017,97,52.38,+,1.85,3.03E-08,3.35E-06,TABI,NA,Increase,Early,purity_score_500_iter
positive regulation of protein kinase activity (GO:0045860),537,51,27.66,+,1.84,8.91E-05,4.76E-03,TABI,NA,Increase,Early,purity_score_500_iter
cellular response to stress (GO:0033554),1751,166,90.19,+,1.84,2.21E-13,5.96E-11,TABI,NA,Increase,Early,purity_score_500_iter
regulation of protein kinase activity (GO:0045859),795,75,40.95,+,1.83,1.84E-06,1.45E-04,TABI,NA,Increase,Early,purity_score_500_iter
regulation of protein serine/threonine kinase activity (GO:0071900),514,47,26.48,+,1.78,3.28E-04,1.45E-02,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of cellular component organization (GO:0051129),723,66,37.24,+,1.77,2.27E-05,1.41E-03,TABI,NA,Increase,Early,purity_score_500_iter
positive regulation of kinase activity (GO:0033674),614,56,31.63,+,1.77,1.15E-04,5.91E-03,TABI,NA,Increase,Early,purity_score_500_iter
regulation of kinase activity (GO:0043549),903,81,46.51,+,1.74,4.81E-06,3.50E-04,TABI,NA,Increase,Early,purity_score_500_iter
regulation of neuron projection development (GO:0010975),513,46,26.42,+,1.74,6.58E-04,2.73E-02,TABI,NA,Increase,Early,purity_score_500_iter
cellular protein-containing complex assembly (GO:0034622),794,71,40.90,+,1.74,2.48E-05,1.53E-03,TABI,NA,Increase,Early,purity_score_500_iter
reproductive process (GO:0022414),1433,127,73.81,+,1.72,1.16E-08,1.48E-06,TABI,NA,Increase,Early,purity_score_500_iter
reproduction (GO:0000003),1436,127,73.97,+,1.72,1.23E-08,1.55E-06,TABI,NA,Increase,Early,purity_score_500_iter
positive regulation of cellular component organization (GO:0051130),1244,110,64.08,+,1.72,1.58E-07,1.56E-05,TABI,NA,Increase,Early,purity_score_500_iter
regulation of cellular protein localization (GO:1903827),556,49,28.64,+,1.71,5.45E-04,2.30E-02,TABI,NA,Increase,Early,purity_score_500_iter
protein phosphorylation (GO:0006468),965,85,49.71,+,1.71,4.82E-06,3.49E-04,TABI,NA,Increase,Early,purity_score_500_iter
regulation of neuron differentiation (GO:0045664),670,59,34.51,+,1.71,1.57E-04,7.73E-03,TABI,NA,Increase,Early,purity_score_500_iter
regulation of plasma membrane bounded cell projection organization (GO:0120035),686,60,35.33,+,1.70,1.83E-04,8.86E-03,TABI,NA,Increase,Early,purity_score_500_iter
regulation of cell projection organization (GO:0031344),695,60,35.80,+,1.68,2.81E-04,1.26E-02,TABI,NA,Increase,Early,purity_score_500_iter
regulation of cellular component organization (GO:0051128),2529,216,130.26,+,1.66,6.19E-13,1.56E-10,TABI,NA,Increase,Early,purity_score_500_iter
chordate embryonic development (GO:0043009),644,55,33.17,+,1.66,6.49E-04,2.70E-02,TABI,NA,Increase,Early,purity_score_500_iter
plasma membrane bounded cell projection organization (GO:0120036),1114,95,57.38,+,1.66,5.21E-06,3.74E-04,TABI,NA,Increase,Early,purity_score_500_iter
cell projection organization (GO:0030030),1159,98,59.70,+,1.64,5.62E-06,3.93E-04,TABI,NA,Increase,Early,purity_score_500_iter
embryo development ending in birth or egg hatching (GO:0009792),661,55,34.05,+,1.62,1.04E-03,4.13E-02,TABI,NA,Increase,Early,purity_score_500_iter
regulation of neurogenesis (GO:0050767),834,69,42.96,+,1.61,2.68E-04,1.21E-02,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),1423,117,73.30,+,1.60,2.10E-06,1.64E-04,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of nucleobase-containing compound metabolic process (GO:0045934),1484,122,76.44,+,1.60,1.01E-06,8.63E-05,TABI,NA,Increase,Early,purity_score_500_iter
regulation of nervous system development (GO:0051960),943,77,48.57,+,1.59,1.86E-04,9.00E-03,TABI,NA,Increase,Early,purity_score_500_iter
"negative regulation of transcription, DNA-templated (GO:0045892)",1230,100,63.36,+,1.58,1.84E-05,1.17E-03,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of RNA metabolic process (GO:0051253),1381,112,71.13,+,1.57,5.29E-06,3.73E-04,TABI,NA,Increase,Early,purity_score_500_iter
multicellular organismal reproductive process (GO:0048609),830,67,42.75,+,1.57,6.36E-04,2.65E-02,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of nucleic acid-templated transcription (GO:1903507),1284,103,66.14,+,1.56,2.06E-05,1.30E-03,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of RNA biosynthetic process (GO:1902679),1286,103,66.24,+,1.55,2.70E-05,1.65E-03,TABI,NA,Increase,Early,purity_score_500_iter
phosphorylation (GO:0016310),1300,104,66.96,+,1.55,2.25E-05,1.40E-03,TABI,NA,Increase,Early,purity_score_500_iter
positive regulation of protein modification process (GO:0031401),1241,99,63.92,+,1.55,4.68E-05,2.64E-03,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of macromolecule biosynthetic process (GO:0010558),1506,120,77.57,+,1.55,5.22E-06,3.73E-04,TABI,NA,Increase,Early,purity_score_500_iter
multicellular organism reproduction (GO:0032504),842,67,43.37,+,1.54,9.20E-04,3.69E-02,TABI,NA,Increase,Early,purity_score_500_iter
sexual reproduction (GO:0019953),831,66,42.80,+,1.54,1.13E-03,4.40E-02,TABI,NA,Increase,Early,purity_score_500_iter
generation of neurons (GO:0048699),1562,124,80.46,+,1.54,4.24E-06,3.14E-04,TABI,NA,Increase,Early,purity_score_500_iter
regulation of cellular localization (GO:0060341),820,65,42.24,+,1.54,1.08E-03,4.24E-02,TABI,NA,Increase,Early,purity_score_500_iter
regulation of protein modification process (GO:0031399),1873,148,96.48,+,1.53,5.72E-07,5.01E-05,TABI,NA,Increase,Early,purity_score_500_iter
cellular component organization (GO:0016043),5620,443,289.48,+,1.53,7.76E-23,8.24E-20,TABI,NA,Increase,Early,purity_score_500_iter
nucleic acid metabolic process (GO:0090304),2292,180,118.06,+,1.52,3.45E-08,3.74E-06,TABI,NA,Increase,Early,purity_score_500_iter
cellular component assembly (GO:0022607),2424,190,124.86,+,1.52,1.40E-08,1.75E-06,TABI,NA,Increase,Early,purity_score_500_iter
neurogenesis (GO:0022008),1664,130,85.71,+,1.52,5.87E-06,4.07E-04,TABI,NA,Increase,Early,purity_score_500_iter
positive regulation of catalytic activity (GO:0043085),1466,114,75.51,+,1.51,2.76E-05,1.67E-03,TABI,NA,Increase,Early,purity_score_500_iter
regulation of catalytic activity (GO:0050790),2376,184,122.38,+,1.50,5.68E-08,5.96E-06,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of cellular biosynthetic process (GO:0031327),1565,121,80.61,+,1.50,2.16E-05,1.36E-03,TABI,NA,Increase,Early,purity_score_500_iter
regulation of cell development (GO:0060284),960,74,49.45,+,1.50,1.11E-03,4.33E-02,TABI,NA,Increase,Early,purity_score_500_iter
cellular component organization or biogenesis (GO:0071840),5810,447,299.26,+,1.49,6.04E-21,4.37E-18,TABI,NA,Increase,Early,purity_score_500_iter
developmental process involved in reproduction (GO:0003006),964,74,49.65,+,1.49,1.15E-03,4.45E-02,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of biosynthetic process (GO:0009890),1593,122,82.05,+,1.49,2.56E-05,1.57E-03,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of cellular metabolic process (GO:0031324),2603,199,134.08,+,1.48,3.68E-08,3.96E-06,TABI,NA,Increase,Early,purity_score_500_iter
nervous system development (GO:0007399),2373,180,122.23,+,1.47,3.51E-07,3.27E-05,TABI,NA,Increase,Early,purity_score_500_iter
regulation of protein phosphorylation (GO:0001932),1454,110,74.89,+,1.47,1.21E-04,6.14E-03,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of nitrogen compound metabolic process (GO:0051172),2403,181,123.77,+,1.46,5.21E-07,4.61E-05,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of cellular process (GO:0048523),4795,361,246.98,+,1.46,1.60E-14,5.31E-12,TABI,NA,Increase,Early,purity_score_500_iter
cellular localization (GO:0051641),2411,181,124.19,+,1.46,6.94E-07,6.04E-05,TABI,NA,Increase,Early,purity_score_500_iter
regulation of phosphate metabolic process (GO:0019220),1818,136,93.64,+,1.45,2.80E-05,1.69E-03,TABI,NA,Increase,Early,purity_score_500_iter
regulation of phosphorus metabolic process (GO:0051174),1819,136,93.69,+,1.45,2.81E-05,1.69E-03,TABI,NA,Increase,Early,purity_score_500_iter
regulation of nucleobase-containing compound metabolic process (GO:0019219),4062,303,209.23,+,1.45,2.20E-11,4.22E-09,TABI,NA,Increase,Early,purity_score_500_iter
macromolecule biosynthetic process (GO:0009059),1770,132,91.17,+,1.45,3.71E-05,2.17E-03,TABI,NA,Increase,Early,purity_score_500_iter
regulation of cellular protein metabolic process (GO:0032268),2661,198,137.06,+,1.44,2.89E-07,2.74E-05,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of gene expression (GO:0010629),1766,131,90.96,+,1.44,5.78E-05,3.15E-03,TABI,NA,Increase,Early,purity_score_500_iter
nucleobase-containing compound metabolic process (GO:0006139),2805,208,144.48,+,1.44,1.56E-07,1.56E-05,TABI,NA,Increase,Early,purity_score_500_iter
regulation of molecular function (GO:0065009),3053,226,157.25,+,1.44,4.72E-08,5.01E-06,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of macromolecule metabolic process (GO:0010605),2698,199,138.97,+,1.43,4.38E-07,3.97E-05,TABI,NA,Increase,Early,purity_score_500_iter
regulation of hydrolase activity (GO:0051336),1290,95,66.45,+,1.43,8.04E-04,3.28E-02,TABI,NA,Increase,Early,purity_score_500_iter
intracellular signal transduction (GO:0035556),1698,125,87.46,+,1.43,1.11E-04,5.79E-03,TABI,NA,Increase,Early,purity_score_500_iter
cellular component biogenesis (GO:0044085),2653,195,136.65,+,1.43,7.51E-07,6.50E-05,TABI,NA,Increase,Early,purity_score_500_iter
regulation of phosphorylation (GO:0042325),1623,119,83.60,+,1.42,2.04E-04,9.77E-03,TABI,NA,Increase,Early,purity_score_500_iter
positive regulation of cellular protein metabolic process (GO:0032270),1616,118,83.24,+,1.42,2.49E-04,1.15E-02,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of metabolic process (GO:0009892),2959,216,152.41,+,1.42,2.88E-07,2.74E-05,TABI,NA,Increase,Early,purity_score_500_iter
positive regulation of molecular function (GO:0044093),1817,132,93.59,+,1.41,1.15E-04,5.91E-03,TABI,NA,Increase,Early,purity_score_500_iter
protein-containing complex assembly (GO:0065003),1406,102,72.42,+,1.41,8.24E-04,3.35E-02,TABI,NA,Increase,Early,purity_score_500_iter
negative regulation of biological process (GO:0048519),5377,390,276.96,+,1.41,1.46E-13,4.24E-11,TABI,NA,Increase,Early,purity_score_500_iter
cellular macromolecule biosynthetic process (GO:0034645),1711,124,88.13,+,1.41,2.30E-04,1.07E-02,TABI,NA,Increase,Early,purity_score_500_iter
regulation of protein metabolic process (GO:0051246),2832,205,145.87,+,1.41,1.16E-06,9.71E-05,TABI,NA,Increase,Early,purity_score_500_iter
regulation of nitrogen compound metabolic process (GO:0051171),5870,424,302.35,+,1.40,9.11E-15,3.09E-12,TABI,NA,Increase,Early,purity_score_500_iter
regulation of RNA metabolic process (GO:0051252),3808,275,196.14,+,1.40,6.40E-09,8.57E-07,TABI,NA,Increase,Early,purity_score_500_iter
cellular macromolecule metabolic process (GO:0044260),5073,366,261.30,+,1.40,2.89E-12,6.58E-10,TABI,NA,Increase,Early,purity_score_500_iter
regulation of primary metabolic process (GO:0080090),6055,436,311.88,+,1.40,4.05E-15,1.43E-12,TABI,NA,Increase,Early,purity_score_500_iter
regulation of cellular macromolecule biosynthetic process (GO:2000112),3931,283,202.48,+,1.40,4.72E-09,6.54E-07,TABI,NA,Increase,Early,purity_score_500_iter
regulation of cellular metabolic process (GO:0031323),6263,450,322.60,+,1.39,1.10E-15,4.18E-13,TABI,NA,Increase,Early,purity_score_500_iter
regulation of nucleic acid-templated transcription (GO:1903506),3544,254,182.55,+,1.39,6.94E-08,7.18E-06,TABI,NA,Increase,Early,purity_score_500_iter
regulation of RNA biosynthetic process (GO:2001141),3549,254,182.80,+,1.39,7.13E-08,7.33E-06,TABI,NA,Increase,Early,purity_score_500_iter
heterocycle metabolic process (GO:0046483),2983,213,153.65,+,1.39,1.56E-06,1.27E-04,TABI,NA,Increase,Early,purity_score_500_iter
positive regulation of protein metabolic process (GO:0051247),1724,123,88.80,+,1.39,4.61E-04,1.97E-02,TABI,NA,Increase,Early,purity_score_500_iter
"regulation of transcription, DNA-templated (GO:0006355)",3478,248,179.15,+,1.38,1.43E-07,1.43E-05,TABI,NA,Increase,Early,purity_score_500_iter
protein-containing complex subunit organization (GO:0043933),1649,117,84.94,+,1.38,8.26E-04,3.35E-02,TABI,NA,Increase,Early,purity_score_500_iter
regulation of macromolecule metabolic process (GO:0060255),6183,438,318.48,+,1.38,5.01E-14,1.60E-11,TABI,NA,Increase,Early,purity_score_500_iter
regulation of macromolecule biosynthetic process (GO:0010556),4068,288,209.54,+,1.37,1.84E-08,2.17E-06,TABI,NA,Increase,Early,purity_score_500_iter
phosphate-containing compound metabolic process (GO:0006796),2142,151,110.33,+,1.37,1.49E-04,7.43E-03,TABI,NA,Increase,Early,purity_score_500_iter
cellular aromatic compound metabolic process (GO:0006725),3029,213,156.02,+,1.37,4.30E-06,3.15E-04,TABI,NA,Increase,Early,purity_score_500_iter
regulation of cellular biosynthetic process (GO:0031326),4212,295,216.95,+,1.36,2.81E-08,3.15E-06,TABI,NA,Increase,Early,purity_score_500_iter
regulation of biosynthetic process (GO:0009889),4291,300,221.02,+,1.36,2.26E-08,2.59E-06,TABI,NA,Increase,Early,purity_score_500_iter
positive regulation of macromolecule metabolic process (GO:0010604),3394,237,174.82,+,1.36,1.52E-06,1.24E-04,TABI,NA,Increase,Early,purity_score_500_iter
phosphorus metabolic process (GO:0006793),2169,151,111.72,+,1.35,2.44E-04,1.13E-02,TABI,NA,Increase,Early,purity_score_500_iter
positive regulation of cellular metabolic process (GO:0031325),3383,234,174.25,+,1.34,4.09E-06,3.04E-04,TABI,NA,Increase,Early,purity_score_500_iter
regulation of metabolic process (GO:0019222),6733,465,346.81,+,1.34,2.37E-13,6.30E-11,TABI,NA,Increase,Early,purity_score_500_iter
positive regulation of nitrogen compound metabolic process (GO:0051173),3219,222,165.81,+,1.34,8.99E-06,6.04E-04,TABI,NA,Increase,Early,purity_score_500_iter
positive regulation of nucleobase-containing compound metabolic process (GO:0045935),1909,131,98.33,+,1.33,1.21E-03,4.61E-02,TABI,NA,Increase,Early,purity_score_500_iter
positive regulation of metabolic process (GO:0009893),3691,253,190.12,+,1.33,2.65E-06,2.03E-04,TABI,NA,Increase,Early,purity_score_500_iter
cellular protein modification process (GO:0006464),3079,209,158.59,+,1.32,5.33E-05,2.95E-03,TABI,NA,Increase,Early,purity_score_500_iter
protein modification process (GO:0036211),3079,209,158.59,+,1.32,5.33E-05,2.94E-03,TABI,NA,Increase,Early,purity_score_500_iter
cellular nitrogen compound metabolic process (GO:0034641),3449,234,177.65,+,1.32,1.56E-05,1.00E-03,TABI,NA,Increase,Early,purity_score_500_iter
macromolecule modification (GO:0043412),3299,223,169.93,+,1.31,3.44E-05,2.04E-03,TABI,NA,Increase,Early,purity_score_500_iter
regulation of gene expression (GO:0010468),4483,300,230.91,+,1.30,1.42E-06,1.17E-04,TABI,NA,Increase,Early,purity_score_500_iter
organic substance biosynthetic process (GO:1901576),2871,192,147.88,+,1.30,2.50E-04,1.15E-02,TABI,NA,Increase,Early,purity_score_500_iter
macromolecule metabolic process (GO:0043170),6181,412,318.37,+,1.29,2.66E-09,3.82E-07,TABI,NA,Increase,Early,purity_score_500_iter
organic cyclic compound metabolic process (GO:1901360),3262,217,168.02,+,1.29,1.13E-04,5.86E-03,TABI,NA,Increase,Early,purity_score_500_iter
multicellular organism development (GO:0007275),5064,336,260.84,+,1.29,4.23E-07,3.85E-05,TABI,NA,Increase,Early,purity_score_500_iter
system development (GO:0048731),4439,293,228.65,+,1.28,5.80E-06,4.03E-04,TABI,NA,Increase,Early,purity_score_500_iter
biosynthetic process (GO:0009058),2948,194,151.85,+,1.28,4.89E-04,2.08E-02,TABI,NA,Increase,Early,purity_score_500_iter
anatomical structure development (GO:0048856),5451,357,280.77,+,1.27,5.45E-07,4.79E-05,TABI,NA,Increase,Early,purity_score_500_iter
response to stress (GO:0006950),3612,235,186.05,+,1.26,2.09E-04,9.99E-03,TABI,NA,Increase,Early,purity_score_500_iter
positive regulation of cellular process (GO:0048522),5516,358,284.12,+,1.26,1.24E-06,1.03E-04,TABI,NA,Increase,Early,purity_score_500_iter
developmental process (GO:0032502),5901,382,303.95,+,1.26,4.98E-07,4.48E-05,TABI,NA,Increase,Early,purity_score_500_iter
cellular protein metabolic process (GO:0044267),3704,239,190.79,+,1.25,2.82E-04,1.26E-02,TABI,NA,Increase,Early,purity_score_500_iter
regulation of cellular process (GO:0050794),11071,711,570.25,+,1.25,2.23E-17,9.60E-15,TABI,NA,Increase,Early,purity_score_500_iter
nitrogen compound metabolic process (GO:0006807),7000,436,360.56,+,1.21,3.06E-06,2.32E-04,TABI,NA,Increase,Early,purity_score_500_iter
positive regulation of biological process (GO:0048518),6252,389,322.03,+,1.21,2.03E-05,1.28E-03,TABI,NA,Increase,Early,purity_score_500_iter
regulation of biological process (GO:0050789),11770,729,606.25,+,1.20,8.96E-14,2.80E-11,TABI,NA,Increase,Early,purity_score_500_iter
cellular response to stimulus (GO:0051716),6782,415,349.33,+,1.19,4.08E-05,2.37E-03,TABI,NA,Increase,Early,purity_score_500_iter
cellular metabolic process (GO:0044237),7652,466,394.14,+,1.18,1.19E-05,7.84E-04,TABI,NA,Increase,Early,purity_score_500_iter
biological regulation (GO:0065007),12470,759,642.31,+,1.18,5.22E-13,1.36E-10,TABI,NA,Increase,Early,purity_score_500_iter
primary metabolic process (GO:0044238),7465,452,384.51,+,1.18,3.47E-05,2.05E-03,TABI,NA,Increase,Early,purity_score_500_iter
organic substance metabolic process (GO:0071704),7840,472,403.83,+,1.17,3.59E-05,2.11E-03,TABI,NA,Increase,Early,purity_score_500_iter
metabolic process (GO:0008152),8403,490,432.82,+,1.13,5.75E-04,2.42E-02,TABI,NA,Increase,Early,purity_score_500_iter
cellular process (GO:0009987),14616,839,752.85,+,1.11,9.27E-09,1.20E-06,TABI,NA,Increase,Early,purity_score_500_iter
biological_process (GO:0008150),17780,991,915.82,+,1.08,9.26E-12,1.87E-09,TABI,NA,Increase,Early,purity_score_500_iter
immune response (GO:0006955),1869,63,96.27,-,.65,3.21E-04,1.42E-02,TABI,NA,Increase,Early,purity_score_500_iter
system process (GO:0003008),1979,61,101.93,-,.60,1.19E-05,7.84E-04,TABI,NA,Increase,Early,purity_score_500_iter
nervous system process (GO:0050877),1398,39,72.01,-,.54,2.75E-05,1.67E-03,TABI,NA,Increase,Early,purity_score_500_iter
Unclassified (UNCLASSIFIED),3071,83,158.18,-,.52,9.26E-12,1.84E-09,TABI,NA,Increase,Early,purity_score_500_iter
detection of stimulus (GO:0051606),698,17,35.95,-,.47,7.59E-04,3.11E-02,TABI,NA,Increase,Early,purity_score_500_iter
G protein-coupled receptor signaling pathway (GO:0007186),1320,32,67.99,-,.47,1.74E-06,1.40E-04,TABI,NA,Increase,Early,purity_score_500_iter
adaptive immune response (GO:0002250),613,14,31.57,-,.44,9.29E-04,3.71E-02,TABI,NA,Increase,Early,purity_score_500_iter
sensory perception (GO:0007600),977,21,50.32,-,.42,5.58E-06,3.92E-04,TABI,NA,Increase,Early,purity_score_500_iter
drug metabolic process (GO:0017144),493,10,25.39,-,.39,1.08E-03,4.24E-02,TABI,NA,Increase,Early,purity_score_500_iter
humoral immune response (GO:0006959),372,5,19.16,-,.26,2.71E-04,1.22E-02,TABI,NA,Increase,Early,purity_score_500_iter
detection of stimulus involved in sensory perception (GO:0050906),549,4,28.28,-,.14,3.81E-08,4.07E-06,TABI,NA,Increase,Early,purity_score_500_iter
detection of chemical stimulus (GO:0009593),525,2,27.04,-,.07,2.07E-09,3.06E-07,TABI,NA,Increase,Early,purity_score_500_iter
sensory perception of chemical stimulus (GO:0007606),541,2,27.87,-,.07,9.68E-10,1.53E-07,TABI,NA,Increase,Early,purity_score_500_iter
sensory perception of smell (GO:0007608),468,1,24.11,-,.04,1.87E-09,2.81E-07,TABI,NA,Increase,Early,purity_score_500_iter
detection of chemical stimulus involved in sensory perception (GO:0050907),488,1,25.14,-,.04,8.84E-10,1.41E-07,TABI,NA,Increase,Early,purity_score_500_iter
detection of chemical stimulus involved in sensory perception of smell (GO:0050911),439,0,22.61,-, < 0.01,3.77E-10,6.32E-08,TABI,NA,Increase,Early,purity_score_500_iter
skeletal muscle thin filament assembly (GO:0030240),9,5,.23,+,21.65,1.60E-05,8.77E-03,TABI,NA,Both,Late,purity_score_500_iter
skeletal myofibril assembly (GO:0014866),11,5,.28,+,17.72,3.34E-05,1.77E-02,TABI,NA,Both,Late,purity_score_500_iter
actin-myosin filament sliding (GO:0033275),38,15,.98,+,15.38,2.02E-12,3.21E-08,TABI,NA,Both,Late,purity_score_500_iter
muscle filament sliding (GO:0030049),38,15,.98,+,15.38,2.02E-12,1.61E-08,TABI,NA,Both,Late,purity_score_500_iter
skeletal muscle contraction (GO:0003009),32,9,.82,+,10.96,6.16E-07,7.01E-04,TABI,NA,Both,Late,purity_score_500_iter
sarcomere organization (GO:0045214),40,10,1.03,+,9.74,3.69E-07,4.90E-04,TABI,NA,Both,Late,purity_score_500_iter
myofibril assembly (GO:0030239),61,14,1.57,+,8.94,4.39E-09,1.17E-05,TABI,NA,Both,Late,purity_score_500_iter
muscle fiber development (GO:0048747),56,11,1.44,+,7.66,7.85E-07,7.81E-04,TABI,NA,Both,Late,purity_score_500_iter
musculoskeletal movement (GO:0050881),46,9,1.18,+,7.63,8.19E-06,5.67E-03,TABI,NA,Both,Late,purity_score_500_iter
multicellular organismal movement (GO:0050879),46,9,1.18,+,7.63,8.19E-06,5.44E-03,TABI,NA,Both,Late,purity_score_500_iter
actin-mediated cell contraction (GO:0070252),90,15,2.31,+,6.50,5.44E-08,8.66E-05,TABI,NA,Both,Late,purity_score_500_iter
cardiac muscle tissue morphogenesis (GO:0055008),64,10,1.64,+,6.09,1.51E-05,8.58E-03,TABI,NA,Both,Late,purity_score_500_iter
striated muscle contraction (GO:0006941),113,17,2.90,+,5.86,2.74E-08,5.46E-05,TABI,NA,Both,Late,purity_score_500_iter
cilium movement (GO:0003341),63,9,1.62,+,5.57,7.53E-05,3.53E-02,TABI,NA,Both,Late,purity_score_500_iter
cellular component assembly involved in morphogenesis (GO:0010927),101,14,2.59,+,5.40,1.12E-06,9.88E-04,TABI,NA,Both,Late,purity_score_500_iter
actomyosin structure organization (GO:0031032),110,15,2.82,+,5.31,5.60E-07,6.86E-04,TABI,NA,Both,Late,purity_score_500_iter
actin filament-based movement (GO:0030048),112,15,2.87,+,5.22,6.88E-07,7.31E-04,TABI,NA,Both,Late,purity_score_500_iter
muscle tissue morphogenesis (GO:0060415),75,10,1.92,+,5.20,5.14E-05,2.56E-02,TABI,NA,Both,Late,purity_score_500_iter
muscle cell development (GO:0055001),146,19,3.75,+,5.07,3.46E-08,6.13E-05,TABI,NA,Both,Late,purity_score_500_iter
striated muscle cell development (GO:0055002),133,17,3.41,+,4.98,2.29E-07,3.32E-04,TABI,NA,Both,Late,purity_score_500_iter
muscle organ morphogenesis (GO:0048644),82,10,2.10,+,4.75,1.01E-04,4.61E-02,TABI,NA,Both,Late,purity_score_500_iter
muscle contraction (GO:0006936),247,30,6.34,+,4.73,1.78E-11,9.45E-08,TABI,NA,Both,Late,purity_score_500_iter
muscle system process (GO:0003012),295,32,7.57,+,4.23,5.46E-11,2.18E-07,TABI,NA,Both,Late,purity_score_500_iter
muscle organ development (GO:0007517),294,29,7.54,+,3.84,3.27E-09,1.04E-05,TABI,NA,Both,Late,purity_score_500_iter
striated muscle cell differentiation (GO:0051146),204,20,5.23,+,3.82,9.95E-07,9.32E-04,TABI,NA,Both,Late,purity_score_500_iter
muscle cell differentiation (GO:0042692),247,22,6.34,+,3.47,1.28E-06,1.07E-03,TABI,NA,Both,Late,purity_score_500_iter
striated muscle tissue development (GO:0014706),285,23,7.31,+,3.15,3.47E-06,2.76E-03,TABI,NA,Both,Late,purity_score_500_iter
muscle structure development (GO:0061061),481,37,12.34,+,3.00,1.22E-08,2.77E-05,TABI,NA,Both,Late,purity_score_500_iter
muscle tissue development (GO:0060537),299,23,7.67,+,3.00,7.24E-06,5.24E-03,TABI,NA,Both,Late,purity_score_500_iter
adaptive immune response (GO:0002250),613,36,15.73,+,2.29,8.95E-06,5.71E-03,TABI,NA,Both,Late,purity_score_500_iter
nitrogen compound transport (GO:0071705),1859,23,47.70,-,.48,7.27E-05,3.51E-02,TABI,NA,Both,Late,purity_score_500_iter
establishment of protein localization (GO:0045184),1617,18,41.49,-,.43,4.72E-05,2.43E-02,TABI,NA,Both,Late,purity_score_500_iter
amide transport (GO:0042886),1589,16,40.77,-,.39,1.28E-05,7.85E-03,TABI,NA,Both,Late,purity_score_500_iter
protein transport (GO:0015031),1525,15,39.13,-,.38,1.30E-05,7.67E-03,TABI,NA,Both,Late,purity_score_500_iter
peptide transport (GO:0015833),1555,15,39.90,-,.38,7.17E-06,5.44E-03,TABI,NA,Both,Late,purity_score_500_iter
detoxification of copper ion (GO:0010273),16,7,1.03,+,6.77,3.10E-04,2.56E-02,TABI,NA,Decrease,Late,purity_score_500_iter
stress response to copper ion (GO:1990169),16,7,1.03,+,6.77,3.10E-04,2.55E-02,TABI,NA,Decrease,Late,purity_score_500_iter
glutathione derivative biosynthetic process (GO:1901687),22,9,1.42,+,6.33,6.51E-05,8.86E-03,TABI,NA,Decrease,Late,purity_score_500_iter
glutathione derivative metabolic process (GO:1901685),22,9,1.42,+,6.33,6.51E-05,8.79E-03,TABI,NA,Decrease,Late,purity_score_500_iter
detoxification of inorganic compound (GO:0061687),18,7,1.16,+,6.02,5.47E-04,3.75E-02,TABI,NA,Decrease,Late,purity_score_500_iter
stress response to metal ion (GO:0097501),18,7,1.16,+,6.02,5.47E-04,3.74E-02,TABI,NA,Decrease,Late,purity_score_500_iter
smooth muscle contraction (GO:0006939),52,18,3.36,+,5.35,1.27E-07,5.95E-05,TABI,NA,Decrease,Late,purity_score_500_iter
protein localization to cell surface (GO:0034394),26,9,1.68,+,5.35,1.83E-04,1.81E-02,TABI,NA,Decrease,Late,purity_score_500_iter
cellular response to zinc ion (GO:0071294),24,8,1.55,+,5.16,5.13E-04,3.62E-02,TABI,NA,Decrease,Late,purity_score_500_iter
long-term synaptic potentiation (GO:0060291),48,15,3.10,+,4.83,4.01E-06,1.08E-03,TABI,NA,Decrease,Late,purity_score_500_iter
"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",26,8,1.68,+,4.76,7.95E-04,4.81E-02,TABI,NA,Decrease,Late,purity_score_500_iter
cellular response to copper ion (GO:0071280),30,9,1.94,+,4.64,4.41E-04,3.27E-02,TABI,NA,Decrease,Late,purity_score_500_iter
negative regulation of reactive oxygen species biosynthetic process (GO:1903427),30,9,1.94,+,4.64,4.41E-04,3.25E-02,TABI,NA,Decrease,Late,purity_score_500_iter
vasoconstriction (GO:0042310),32,9,2.07,+,4.35,6.53E-04,4.23E-02,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of cardiac conduction (GO:1903779),68,18,4.40,+,4.09,3.30E-06,1.01E-03,TABI,NA,Decrease,Late,purity_score_500_iter
cell-substrate junction assembly (GO:0007044),42,11,2.72,+,4.05,2.85E-04,2.42E-02,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044),47,12,3.04,+,3.95,1.87E-04,1.83E-02,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of vasoconstriction (GO:0019229),59,15,3.81,+,3.93,3.19E-05,5.18E-03,TABI,NA,Decrease,Late,purity_score_500_iter
antibacterial humoral response (GO:0019731),45,11,2.91,+,3.78,4.71E-04,3.41E-02,TABI,NA,Decrease,Late,purity_score_500_iter
negative regulation of smooth muscle cell proliferation (GO:0048662),46,11,2.97,+,3.70,5.52E-04,3.73E-02,TABI,NA,Decrease,Late,purity_score_500_iter
intermediate filament cytoskeleton organization (GO:0045104),51,12,3.30,+,3.64,3.56E-04,2.84E-02,TABI,NA,Decrease,Late,purity_score_500_iter
intermediate filament-based process (GO:0045103),52,12,3.36,+,3.57,4.14E-04,3.14E-02,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of cardiac muscle contraction (GO:0055117),79,18,5.11,+,3.52,1.93E-05,3.53E-03,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of systemic arterial blood pressure (GO:0003073),100,22,6.46,+,3.40,3.91E-06,1.07E-03,TABI,NA,Decrease,Late,purity_score_500_iter
positive regulation of synapse assembly (GO:0051965),66,14,4.27,+,3.28,3.00E-04,2.49E-02,TABI,NA,Decrease,Late,purity_score_500_iter
glutathione metabolic process (GO:0006749),57,12,3.69,+,3.26,8.41E-04,5.00E-02,TABI,NA,Decrease,Late,purity_score_500_iter
tissue migration (GO:0090130),95,20,6.14,+,3.26,1.85E-05,3.47E-03,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of smooth muscle contraction (GO:0006940),62,13,4.01,+,3.24,5.36E-04,3.71E-02,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of muscle contraction (GO:0006937),163,34,10.54,+,3.23,3.15E-08,2.18E-05,TABI,NA,Decrease,Late,purity_score_500_iter
muscle contraction (GO:0006936),247,51,15.97,+,3.19,1.67E-11,6.66E-08,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of sprouting angiogenesis (GO:1903670),68,14,4.40,+,3.18,3.90E-04,3.06E-02,TABI,NA,Decrease,Late,purity_score_500_iter
positive regulation of blood circulation (GO:1903524),74,15,4.78,+,3.14,2.84E-04,2.42E-02,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of striated muscle contraction (GO:0006942),94,19,6.08,+,3.13,4.81E-05,7.09E-03,TABI,NA,Decrease,Late,purity_score_500_iter
epithelial cell migration (GO:0010631),85,17,5.50,+,3.09,1.32E-04,1.41E-02,TABI,NA,Decrease,Late,purity_score_500_iter
plasma membrane organization (GO:0007009),92,18,5.95,+,3.03,1.08E-04,1.26E-02,TABI,NA,Decrease,Late,purity_score_500_iter
vascular process in circulatory system (GO:0003018),169,33,10.93,+,3.02,1.91E-07,8.46E-05,TABI,NA,Decrease,Late,purity_score_500_iter
epithelium migration (GO:0090132),88,17,5.69,+,2.99,1.90E-04,1.83E-02,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of blood vessel diameter (GO:0097746),137,26,8.86,+,2.94,5.77E-06,1.46E-03,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of tube diameter (GO:0035296),137,26,8.86,+,2.94,5.77E-06,1.44E-03,TABI,NA,Decrease,Late,purity_score_500_iter
actin-mediated cell contraction (GO:0070252),90,17,5.82,+,2.92,2.40E-04,2.14E-02,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of reactive oxygen species biosynthetic process (GO:1903426),90,17,5.82,+,2.92,2.40E-04,2.12E-02,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of tube size (GO:0035150),138,26,8.92,+,2.91,6.47E-06,1.56E-03,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of heart rate (GO:0002027),96,18,6.21,+,2.90,1.73E-04,1.74E-02,TABI,NA,Decrease,Late,purity_score_500_iter
muscle system process (GO:0003012),295,55,19.07,+,2.88,8.19E-11,1.31E-07,TABI,NA,Decrease,Late,purity_score_500_iter
detoxification (GO:0098754),133,24,8.60,+,2.79,2.69E-05,4.55E-03,TABI,NA,Decrease,Late,purity_score_500_iter
myelination (GO:0042552),111,20,7.18,+,2.79,1.24E-04,1.37E-02,TABI,NA,Decrease,Late,purity_score_500_iter
ensheathment of neurons (GO:0007272),113,20,7.31,+,2.74,1.54E-04,1.59E-02,TABI,NA,Decrease,Late,purity_score_500_iter
axon ensheathment (GO:0008366),113,20,7.31,+,2.74,1.54E-04,1.58E-02,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of blood circulation (GO:1903522),290,51,18.75,+,2.72,2.75E-09,2.44E-06,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of calcium ion transport into cytosol (GO:0010522),103,18,6.66,+,2.70,3.68E-04,2.91E-02,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of blood pressure (GO:0008217),184,32,11.90,+,2.69,3.89E-06,1.09E-03,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of heart contraction (GO:0008016),243,42,15.71,+,2.67,1.06E-07,5.10E-05,TABI,NA,Decrease,Late,purity_score_500_iter
glial cell development (GO:0021782),110,19,7.11,+,2.67,2.92E-04,2.44E-02,TABI,NA,Decrease,Late,purity_score_500_iter
positive regulation of synaptic transmission (GO:0050806),146,25,9.44,+,2.65,6.11E-05,8.61E-03,TABI,NA,Decrease,Late,purity_score_500_iter
actin filament-based movement (GO:0030048),112,19,7.24,+,2.62,3.57E-04,2.83E-02,TABI,NA,Decrease,Late,purity_score_500_iter
extracellular matrix organization (GO:0030198),342,58,22.11,+,2.62,9.06E-10,1.03E-06,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of muscle system process (GO:0090257),236,40,15.26,+,2.62,3.12E-07,1.27E-04,TABI,NA,Decrease,Late,purity_score_500_iter
extracellular structure organization (GO:0043062),343,58,22.17,+,2.62,9.52E-10,1.01E-06,TABI,NA,Decrease,Late,purity_score_500_iter
blood circulation (GO:0008015),392,65,25.34,+,2.56,1.40E-10,2.03E-07,TABI,NA,Decrease,Late,purity_score_500_iter
positive regulation of cell-substrate adhesion (GO:0010811),123,20,7.95,+,2.52,5.36E-04,3.73E-02,TABI,NA,Decrease,Late,purity_score_500_iter
circulatory system process (GO:0003013),401,65,25.92,+,2.51,3.79E-10,4.65E-07,TABI,NA,Decrease,Late,purity_score_500_iter
cell-substrate adhesion (GO:0031589),181,29,11.70,+,2.48,3.16E-05,5.19E-03,TABI,NA,Decrease,Late,purity_score_500_iter
positive regulation of calcium ion transport (GO:0051928),127,20,8.21,+,2.44,6.87E-04,4.40E-02,TABI,NA,Decrease,Late,purity_score_500_iter
multicellular organismal signaling (GO:0035637),136,21,8.79,+,2.39,6.00E-04,3.93E-02,TABI,NA,Decrease,Late,purity_score_500_iter
learning (GO:0007612),150,23,9.70,+,2.37,3.54E-04,2.83E-02,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of cell-substrate adhesion (GO:0010810),212,32,13.71,+,2.33,3.73E-05,5.83E-03,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of angiogenesis (GO:0045765),297,44,19.20,+,2.29,2.88E-06,9.00E-04,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of system process (GO:0044057),594,88,38.40,+,2.29,1.73E-11,5.51E-08,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of synaptic plasticity (GO:0048167),190,28,12.28,+,2.28,1.63E-04,1.66E-02,TABI,NA,Decrease,Late,purity_score_500_iter
ameboidal-type cell migration (GO:0001667),170,25,10.99,+,2.27,3.97E-04,3.08E-02,TABI,NA,Decrease,Late,purity_score_500_iter
cell junction assembly (GO:0034329),170,25,10.99,+,2.27,3.97E-04,3.07E-02,TABI,NA,Decrease,Late,purity_score_500_iter
aminoglycan metabolic process (GO:0006022),165,24,10.67,+,2.25,5.90E-04,3.93E-02,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of metal ion transport (GO:0010959),400,57,25.86,+,2.20,2.63E-07,1.13E-04,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of vasculature development (GO:1901342),329,46,21.27,+,2.16,5.48E-06,1.43E-03,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of cation channel activity (GO:2001257),187,26,12.09,+,2.15,7.16E-04,4.47E-02,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of cation transmembrane transport (GO:1904062),347,48,22.43,+,2.14,5.39E-06,1.43E-03,TABI,NA,Decrease,Late,purity_score_500_iter
gliogenesis (GO:0042063),225,31,14.55,+,2.13,2.88E-04,2.43E-02,TABI,NA,Decrease,Late,purity_score_500_iter
angiogenesis (GO:0001525),320,44,20.69,+,2.13,1.23E-05,2.47E-03,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of calcium ion transport (GO:0051924),264,36,17.07,+,2.11,1.21E-04,1.34E-02,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of ion transmembrane transporter activity (GO:0032412),269,36,17.39,+,2.07,1.42E-04,1.48E-02,TABI,NA,Decrease,Late,purity_score_500_iter
muscle cell differentiation (GO:0042692),247,33,15.97,+,2.07,3.32E-04,2.67E-02,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of transmembrane transporter activity (GO:0022898),278,37,17.97,+,2.06,1.16E-04,1.31E-02,TABI,NA,Decrease,Late,purity_score_500_iter
negative regulation of cellular component movement (GO:0051271),314,41,20.30,+,2.02,7.28E-05,9.51E-03,TABI,NA,Decrease,Late,purity_score_500_iter
positive regulation of ion transport (GO:0043270),284,37,18.36,+,2.02,2.09E-04,1.92E-02,TABI,NA,Decrease,Late,purity_score_500_iter
calcium ion transport (GO:0006816),258,33,16.68,+,1.98,7.08E-04,4.46E-02,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of transporter activity (GO:0032409),290,37,18.75,+,1.97,2.55E-04,2.23E-02,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of neurotransmitter levels (GO:0001505),356,45,23.02,+,1.96,7.58E-05,9.82E-03,TABI,NA,Decrease,Late,purity_score_500_iter
blood vessel morphogenesis (GO:0048514),412,52,26.64,+,1.95,1.94E-05,3.51E-03,TABI,NA,Decrease,Late,purity_score_500_iter
muscle structure development (GO:0061061),481,60,31.10,+,1.93,6.30E-06,1.54E-03,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of actin filament-based process (GO:0032970),402,50,25.99,+,1.92,3.84E-05,5.78E-03,TABI,NA,Decrease,Late,purity_score_500_iter
cellular divalent inorganic cation homeostasis (GO:0072503),478,59,30.90,+,1.91,9.48E-06,2.13E-03,TABI,NA,Decrease,Late,purity_score_500_iter
positive regulation of cytosolic calcium ion concentration (GO:0007204),296,36,19.14,+,1.88,7.05E-04,4.47E-02,TABI,NA,Decrease,Late,purity_score_500_iter
response to acid chemical (GO:0001101),354,43,22.89,+,1.88,2.62E-04,2.27E-02,TABI,NA,Decrease,Late,purity_score_500_iter
cognition (GO:0050890),306,37,19.78,+,1.87,8.19E-04,4.91E-02,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of cytosolic calcium ion concentration (GO:0051480),340,41,21.98,+,1.87,4.57E-04,3.34E-02,TABI,NA,Decrease,Late,purity_score_500_iter
response to toxic substance (GO:0009636),523,63,33.81,+,1.86,9.83E-06,2.14E-03,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of membrane potential (GO:0042391),435,52,28.12,+,1.85,7.27E-05,9.57E-03,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of ion transport (GO:0043269),703,84,45.45,+,1.85,4.20E-07,1.63E-04,TABI,NA,Decrease,Late,purity_score_500_iter
negative regulation of locomotion (GO:0040013),328,39,21.20,+,1.84,8.22E-04,4.91E-02,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of epithelial cell proliferation (GO:0050678),338,40,21.85,+,1.83,6.64E-04,4.29E-02,TABI,NA,Decrease,Late,purity_score_500_iter
second-messenger-mediated signaling (GO:0019932),338,40,21.85,+,1.83,6.64E-04,4.27E-02,TABI,NA,Decrease,Late,purity_score_500_iter
divalent inorganic cation homeostasis (GO:0072507),499,59,32.26,+,1.83,3.14E-05,5.22E-03,TABI,NA,Decrease,Late,purity_score_500_iter
response to hypoxia (GO:0001666),343,40,22.17,+,1.80,7.62E-04,4.65E-02,TABI,NA,Decrease,Late,purity_score_500_iter
cellular calcium ion homeostasis (GO:0006874),446,52,28.83,+,1.80,1.31E-04,1.41E-02,TABI,NA,Decrease,Late,purity_score_500_iter
cellular metal ion homeostasis (GO:0006875),568,66,36.72,+,1.80,2.05E-05,3.62E-03,TABI,NA,Decrease,Late,purity_score_500_iter
cell adhesion (GO:0007155),921,107,59.54,+,1.80,4.53E-08,2.78E-05,TABI,NA,Decrease,Late,purity_score_500_iter
biological adhesion (GO:0022610),927,107,59.93,+,1.79,5.16E-08,2.84E-05,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of anatomical structure size (GO:0090066),520,60,33.62,+,1.78,6.25E-05,8.73E-03,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of ion transmembrane transport (GO:0034765),487,56,31.48,+,1.78,1.15E-04,1.31E-02,TABI,NA,Decrease,Late,purity_score_500_iter
actin filament-based process (GO:0030029),575,66,37.17,+,1.78,3.32E-05,5.34E-03,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of cellular component movement (GO:0051270),1022,116,66.07,+,1.76,3.29E-08,2.18E-05,TABI,NA,Decrease,Late,purity_score_500_iter
calcium ion homeostasis (GO:0055074),459,52,29.67,+,1.75,3.26E-04,2.63E-02,TABI,NA,Decrease,Late,purity_score_500_iter
negative regulation of cell population proliferation (GO:0008285),690,78,44.61,+,1.75,9.82E-06,2.17E-03,TABI,NA,Decrease,Late,purity_score_500_iter
cardiovascular system development (GO:0072358),531,60,34.33,+,1.75,1.06E-04,1.25E-02,TABI,NA,Decrease,Late,purity_score_500_iter
modulation of chemical synaptic transmission (GO:0050804),453,51,29.29,+,1.74,4.28E-04,3.20E-02,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of trans-synaptic signaling (GO:0099177),454,51,29.35,+,1.74,4.33E-04,3.22E-02,TABI,NA,Decrease,Late,purity_score_500_iter
positive regulation of cellular component movement (GO:0051272),561,63,36.27,+,1.74,8.00E-05,1.03E-02,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of transmembrane transport (GO:0034762),570,64,36.85,+,1.74,6.47E-05,8.89E-03,TABI,NA,Decrease,Late,purity_score_500_iter
metal ion homeostasis (GO:0055065),633,71,40.92,+,1.73,2.65E-05,4.53E-03,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of cell motility (GO:2000145),938,105,60.64,+,1.73,2.67E-07,1.12E-04,TABI,NA,Decrease,Late,purity_score_500_iter
positive regulation of cell motility (GO:2000147),545,61,35.23,+,1.73,1.30E-04,1.40E-02,TABI,NA,Decrease,Late,purity_score_500_iter
tube morphogenesis (GO:0035239),662,74,42.80,+,1.73,1.96E-05,3.50E-03,TABI,NA,Decrease,Late,purity_score_500_iter
positive regulation of cell migration (GO:0030335),519,58,33.55,+,1.73,1.83E-04,1.82E-02,TABI,NA,Decrease,Late,purity_score_500_iter
vasculature development (GO:0001944),521,58,33.68,+,1.72,1.89E-04,1.84E-02,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of cell migration (GO:0030334),873,97,56.44,+,1.72,1.23E-06,4.27E-04,TABI,NA,Decrease,Late,purity_score_500_iter
blood vessel development (GO:0001568),499,55,32.26,+,1.70,3.96E-04,3.09E-02,TABI,NA,Decrease,Late,purity_score_500_iter
response to wounding (GO:0009611),578,63,37.37,+,1.69,1.98E-04,1.86E-02,TABI,NA,Decrease,Late,purity_score_500_iter
circulatory system development (GO:0072359),874,95,56.50,+,1.68,3.53E-06,1.04E-03,TABI,NA,Decrease,Late,purity_score_500_iter
cellular chemical homeostasis (GO:0055082),759,82,49.07,+,1.67,2.38E-05,4.12E-03,TABI,NA,Decrease,Late,purity_score_500_iter
behavior (GO:0007610),594,64,38.40,+,1.67,1.81E-04,1.81E-02,TABI,NA,Decrease,Late,purity_score_500_iter
cellular ion homeostasis (GO:0006873),659,71,42.60,+,1.67,1.00E-04,1.19E-02,TABI,NA,Decrease,Late,purity_score_500_iter
positive regulation of locomotion (GO:0040017),576,62,37.24,+,1.66,2.70E-04,2.31E-02,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of locomotion (GO:0040012),1010,108,65.30,+,1.65,1.69E-06,5.59E-04,TABI,NA,Decrease,Late,purity_score_500_iter
positive regulation of nervous system development (GO:0051962),554,59,35.82,+,1.65,5.50E-04,3.75E-02,TABI,NA,Decrease,Late,purity_score_500_iter
response to lipid (GO:0033993),866,92,55.99,+,1.64,1.18E-05,2.54E-03,TABI,NA,Decrease,Late,purity_score_500_iter
tube development (GO:0035295),861,91,55.66,+,1.63,1.55E-05,2.97E-03,TABI,NA,Decrease,Late,purity_score_500_iter
cellular cation homeostasis (GO:0030003),645,68,41.70,+,1.63,2.26E-04,2.03E-02,TABI,NA,Decrease,Late,purity_score_500_iter
cation homeostasis (GO:0055080),714,75,46.16,+,1.62,1.33E-04,1.42E-02,TABI,NA,Decrease,Late,purity_score_500_iter
inorganic ion homeostasis (GO:0098771),726,76,46.94,+,1.62,1.13E-04,1.30E-02,TABI,NA,Decrease,Late,purity_score_500_iter
negative regulation of developmental process (GO:0051093),959,100,62.00,+,1.61,1.20E-05,2.54E-03,TABI,NA,Decrease,Late,purity_score_500_iter
ion homeostasis (GO:0050801),798,83,51.59,+,1.61,6.85E-05,9.17E-03,TABI,NA,Decrease,Late,purity_score_500_iter
cellular homeostasis (GO:0019725),895,93,57.86,+,1.61,2.89E-05,4.84E-03,TABI,NA,Decrease,Late,purity_score_500_iter
cell-cell signaling (GO:0007267),1122,116,72.54,+,1.60,2.85E-06,9.09E-04,TABI,NA,Decrease,Late,purity_score_500_iter
cell development (GO:0048468),1623,167,104.93,+,1.59,1.54E-08,1.17E-05,TABI,NA,Decrease,Late,purity_score_500_iter
anatomical structure formation involved in morphogenesis (GO:0048646),900,92,58.18,+,1.58,5.44E-05,7.95E-03,TABI,NA,Decrease,Late,purity_score_500_iter
cell migration (GO:0016477),950,97,61.42,+,1.58,3.58E-05,5.70E-03,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of anatomical structure morphogenesis (GO:0022603),1098,112,70.98,+,1.58,7.45E-06,1.77E-03,TABI,NA,Decrease,Late,purity_score_500_iter
metal ion transport (GO:0030001),639,65,41.31,+,1.57,7.23E-04,4.50E-02,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of cell adhesion (GO:0030155),701,71,45.32,+,1.57,5.19E-04,3.64E-02,TABI,NA,Decrease,Late,purity_score_500_iter
cation transport (GO:0006812),842,85,54.43,+,1.56,1.39E-04,1.47E-02,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of cell population proliferation (GO:0042127),1645,166,106.35,+,1.56,6.02E-08,3.20E-05,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of MAPK cascade (GO:0043408),729,73,47.13,+,1.55,5.11E-04,3.62E-02,TABI,NA,Decrease,Late,purity_score_500_iter
negative regulation of multicellular organismal process (GO:0051241),1210,121,78.23,+,1.55,8.12E-06,1.90E-03,TABI,NA,Decrease,Late,purity_score_500_iter
chemical homeostasis (GO:0048878),1128,112,72.92,+,1.54,2.22E-05,3.89E-03,TABI,NA,Decrease,Late,purity_score_500_iter
response to hormone (GO:0009725),918,91,59.35,+,1.53,1.48E-04,1.54E-02,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of cellular localization (GO:0060341),820,81,53.01,+,1.53,4.54E-04,3.33E-02,TABI,NA,Decrease,Late,purity_score_500_iter
positive regulation of developmental process (GO:0051094),1390,137,89.86,+,1.52,3.65E-06,1.06E-03,TABI,NA,Decrease,Late,purity_score_500_iter
neuron development (GO:0048666),824,81,53.27,+,1.52,4.69E-04,3.41E-02,TABI,NA,Decrease,Late,purity_score_500_iter
positive regulation of cell population proliferation (GO:0008284),926,91,59.87,+,1.52,2.05E-04,1.90E-02,TABI,NA,Decrease,Late,purity_score_500_iter
positive regulation of multicellular organismal process (GO:0051240),1771,174,114.49,+,1.52,1.58E-07,7.18E-05,TABI,NA,Decrease,Late,purity_score_500_iter
neuron differentiation (GO:0030182),1018,100,65.81,+,1.52,1.07E-04,1.26E-02,TABI,NA,Decrease,Late,purity_score_500_iter
neurogenesis (GO:0022008),1664,163,107.58,+,1.52,4.82E-07,1.78E-04,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of nervous system development (GO:0051960),943,92,60.96,+,1.51,2.33E-04,2.08E-02,TABI,NA,Decrease,Late,purity_score_500_iter
ion transport (GO:0006811),1335,130,86.31,+,1.51,1.20E-05,2.51E-03,TABI,NA,Decrease,Late,purity_score_500_iter
nervous system development (GO:0007399),2373,231,153.41,+,1.51,1.44E-09,1.43E-06,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of multicellular organismal process (GO:0051239),3183,308,205.78,+,1.50,1.67E-12,2.66E-08,TABI,NA,Decrease,Late,purity_score_500_iter
export from cell (GO:0140352),1042,100,67.36,+,1.48,2.13E-04,1.95E-02,TABI,NA,Decrease,Late,purity_score_500_iter
ion transmembrane transport (GO:0034220),919,88,59.41,+,1.48,5.50E-04,3.73E-02,TABI,NA,Decrease,Late,purity_score_500_iter
anatomical structure morphogenesis (GO:0009653),2177,208,140.74,+,1.48,4.65E-08,2.74E-05,TABI,NA,Decrease,Late,purity_score_500_iter
locomotion (GO:0040011),1305,124,84.37,+,1.47,5.72E-05,8.21E-03,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of cell development (GO:0060284),960,91,62.06,+,1.47,7.04E-04,4.49E-02,TABI,NA,Decrease,Late,purity_score_500_iter
secretion by cell (GO:0032940),998,94,64.52,+,1.46,5.60E-04,3.77E-02,TABI,NA,Decrease,Late,purity_score_500_iter
generation of neurons (GO:0048699),1562,147,100.98,+,1.46,1.44E-05,2.83E-03,TABI,NA,Decrease,Late,purity_score_500_iter
localization of cell (GO:0051674),1066,100,68.92,+,1.45,5.06E-04,3.61E-02,TABI,NA,Decrease,Late,purity_score_500_iter
cell motility (GO:0048870),1066,100,68.92,+,1.45,5.06E-04,3.60E-02,TABI,NA,Decrease,Late,purity_score_500_iter
secretion (GO:0046903),1114,104,72.02,+,1.44,4.17E-04,3.15E-02,TABI,NA,Decrease,Late,purity_score_500_iter
response to drug (GO:0042493),1018,95,65.81,+,1.44,7.79E-04,4.74E-02,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of developmental process (GO:0050793),2624,243,169.64,+,1.43,3.61E-08,2.30E-05,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of localization (GO:0032879),2808,258,181.53,+,1.42,2.16E-08,1.56E-05,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of multicellular organismal development (GO:2000026),2065,189,133.50,+,1.42,3.82E-06,1.09E-03,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of transport (GO:0051049),1887,172,121.99,+,1.41,1.25E-05,2.48E-03,TABI,NA,Decrease,Late,purity_score_500_iter
response to oxygen-containing compound (GO:1901700),1599,145,103.37,+,1.40,8.67E-05,1.07E-02,TABI,NA,Decrease,Late,purity_score_500_iter
negative regulation of response to stimulus (GO:0048585),1648,149,106.54,+,1.40,8.61E-05,1.07E-02,TABI,NA,Decrease,Late,purity_score_500_iter
response to endogenous stimulus (GO:0009719),1507,136,97.43,+,1.40,2.04E-04,1.90E-02,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of cell differentiation (GO:0045595),1841,166,119.02,+,1.39,3.65E-05,5.76E-03,TABI,NA,Decrease,Late,purity_score_500_iter
system process (GO:0003008),1979,178,127.94,+,1.39,1.86E-05,3.45E-03,TABI,NA,Decrease,Late,purity_score_500_iter
negative regulation of cell communication (GO:0010648),1371,123,88.63,+,1.39,4.93E-04,3.54E-02,TABI,NA,Decrease,Late,purity_score_500_iter
negative regulation of signaling (GO:0023057),1375,123,88.89,+,1.38,6.11E-04,3.99E-02,TABI,NA,Decrease,Late,purity_score_500_iter
movement of cell or subcellular component (GO:0006928),1544,138,99.82,+,1.38,2.42E-04,2.13E-02,TABI,NA,Decrease,Late,purity_score_500_iter
homeostatic process (GO:0042592),1661,148,107.38,+,1.38,1.71E-04,1.73E-02,TABI,NA,Decrease,Late,purity_score_500_iter
positive regulation of cell communication (GO:0010647),1853,165,119.79,+,1.38,7.18E-05,9.53E-03,TABI,NA,Decrease,Late,purity_score_500_iter
system development (GO:0048731),4439,395,286.98,+,1.38,2.69E-11,7.15E-08,TABI,NA,Decrease,Late,purity_score_500_iter
tissue development (GO:0009888),1777,158,114.88,+,1.38,9.94E-05,1.19E-02,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of biological quality (GO:0065008),4106,365,265.45,+,1.38,2.50E-10,3.32E-07,TABI,NA,Decrease,Late,purity_score_500_iter
positive regulation of signaling (GO:0023056),1862,165,120.38,+,1.37,9.11E-05,1.12E-02,TABI,NA,Decrease,Late,purity_score_500_iter
small molecule metabolic process (GO:0044281),1713,150,110.74,+,1.35,3.12E-04,2.55E-02,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of signaling (GO:0023051),3570,312,230.80,+,1.35,4.99E-08,2.84E-05,TABI,NA,Decrease,Late,purity_score_500_iter
multicellular organism development (GO:0007275),5064,442,327.38,+,1.35,1.12E-11,5.95E-08,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of cell communication (GO:0010646),3529,307,228.15,+,1.35,9.98E-08,4.97E-05,TABI,NA,Decrease,Late,purity_score_500_iter
anatomical structure development (GO:0048856),5451,474,352.40,+,1.35,1.86E-12,1.48E-08,TABI,NA,Decrease,Late,purity_score_500_iter
positive regulation of signal transduction (GO:0009967),1702,147,110.03,+,1.34,6.42E-04,4.18E-02,TABI,NA,Decrease,Late,purity_score_500_iter
animal organ development (GO:0048513),3212,276,207.65,+,1.33,1.60E-06,5.44E-04,TABI,NA,Decrease,Late,purity_score_500_iter
cell differentiation (GO:0030154),3729,318,241.08,+,1.32,3.31E-07,1.32E-04,TABI,NA,Decrease,Late,purity_score_500_iter
cellular developmental process (GO:0048869),3822,323,247.09,+,1.31,6.14E-07,2.17E-04,TABI,NA,Decrease,Late,purity_score_500_iter
developmental process (GO:0032502),5901,498,381.49,+,1.31,3.43E-11,7.82E-08,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of signal transduction (GO:0009966),3142,264,203.13,+,1.30,1.46E-05,2.84E-03,TABI,NA,Decrease,Late,purity_score_500_iter
cellular response to chemical stimulus (GO:0070887),2937,243,189.87,+,1.28,9.79E-05,1.18E-02,TABI,NA,Decrease,Late,purity_score_500_iter
response to organic substance (GO:0010033),3026,244,195.63,+,1.25,4.76E-04,3.43E-02,TABI,NA,Decrease,Late,purity_score_500_iter
multicellular organismal process (GO:0032501),7014,563,453.45,+,1.24,1.99E-09,1.86E-06,TABI,NA,Decrease,Late,purity_score_500_iter
negative regulation of cellular process (GO:0048523),4795,383,309.99,+,1.24,8.26E-06,1.91E-03,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of response to stimulus (GO:0048583),4334,342,280.19,+,1.22,9.66E-05,1.18E-02,TABI,NA,Decrease,Late,purity_score_500_iter
negative regulation of biological process (GO:0048519),5377,423,347.62,+,1.22,8.56E-06,1.95E-03,TABI,NA,Decrease,Late,purity_score_500_iter
localization (GO:0051179),5768,437,372.90,+,1.17,1.93E-04,1.84E-02,TABI,NA,Decrease,Late,purity_score_500_iter
response to stimulus (GO:0050896),8534,629,551.72,+,1.14,3.90E-05,5.81E-03,TABI,NA,Decrease,Late,purity_score_500_iter
biological regulation (GO:0065007),12470,869,806.18,+,1.08,7.05E-04,4.46E-02,TABI,NA,Decrease,Late,purity_score_500_iter
cellular process (GO:0009987),14616,1009,944.91,+,1.07,1.94E-04,1.84E-02,TABI,NA,Decrease,Late,purity_score_500_iter
biological_process (GO:0008150),17780,1203,1149.46,+,1.05,3.80E-05,5.83E-03,TABI,NA,Decrease,Late,purity_score_500_iter
macromolecule metabolic process (GO:0043170),6181,331,399.60,-,.83,5.93E-05,8.43E-03,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of macromolecule biosynthetic process (GO:0010556),4068,212,262.99,-,.81,5.44E-04,3.75E-02,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of cellular macromolecule biosynthetic process (GO:2000112),3931,204,254.14,-,.80,5.98E-04,3.94E-02,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of RNA biosynthetic process (GO:2001141),3549,182,229.44,-,.79,7.10E-04,4.45E-02,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of nucleic acid-templated transcription (GO:1903506),3544,180,229.12,-,.79,4.04E-04,3.09E-02,TABI,NA,Decrease,Late,purity_score_500_iter
"regulation of transcription, DNA-templated (GO:0006355)",3478,176,224.85,-,.78,4.18E-04,3.14E-02,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of nucleobase-containing compound metabolic process (GO:0019219),4062,205,262.60,-,.78,8.59E-05,1.08E-02,TABI,NA,Decrease,Late,purity_score_500_iter
cellular protein modification process (GO:0006464),3079,155,199.05,-,.78,8.10E-04,4.89E-02,TABI,NA,Decrease,Late,purity_score_500_iter
protein modification process (GO:0036211),3079,155,199.05,-,.78,8.10E-04,4.87E-02,TABI,NA,Decrease,Late,purity_score_500_iter
regulation of RNA metabolic process (GO:0051252),3808,191,246.18,-,.78,1.21E-04,1.35E-02,TABI,NA,Decrease,Late,purity_score_500_iter
macromolecule modification (GO:0043412),3299,164,213.28,-,.77,2.67E-04,2.30E-02,TABI,NA,Decrease,Late,purity_score_500_iter
cellular macromolecule metabolic process (GO:0044260),5073,252,327.97,-,.77,1.76E-06,5.72E-04,TABI,NA,Decrease,Late,purity_score_500_iter
cellular protein metabolic process (GO:0044267),3704,183,239.46,-,.76,6.37E-05,8.82E-03,TABI,NA,Decrease,Late,purity_score_500_iter
cellular aromatic compound metabolic process (GO:0006725),3029,146,195.82,-,.75,1.15E-04,1.31E-02,TABI,NA,Decrease,Late,purity_score_500_iter
Unclassified (UNCLASSIFIED),3071,145,198.54,-,.73,3.80E-05,5.77E-03,TABI,NA,Decrease,Late,purity_score_500_iter
heterocycle metabolic process (GO:0046483),2983,137,192.85,-,.71,1.22E-05,2.49E-03,TABI,NA,Decrease,Late,purity_score_500_iter
gene expression (GO:0010467),2026,92,130.98,-,.70,3.25E-04,2.64E-02,TABI,NA,Decrease,Late,purity_score_500_iter
nucleobase-containing compound metabolic process (GO:0006139),2805,125,181.34,-,.69,5.74E-06,1.47E-03,TABI,NA,Decrease,Late,purity_score_500_iter
RNA metabolic process (GO:0016070),1690,74,109.26,-,.68,3.98E-04,3.06E-02,TABI,NA,Decrease,Late,purity_score_500_iter
cell cycle (GO:0007049),1331,56,86.05,-,.65,7.33E-04,4.51E-02,TABI,NA,Decrease,Late,purity_score_500_iter
nucleic acid metabolic process (GO:0090304),2292,92,148.18,-,.62,5.45E-07,1.97E-04,TABI,NA,Decrease,Late,purity_score_500_iter
protein modification by small protein conjugation or removal (GO:0070647),989,36,63.94,-,.56,2.18E-04,1.98E-02,TABI,NA,Decrease,Late,purity_score_500_iter
sensory perception (GO:0007600),977,35,63.16,-,.55,1.97E-04,1.85E-02,TABI,NA,Decrease,Late,purity_score_500_iter
cellular macromolecule catabolic process (GO:0044265),912,31,58.96,-,.53,1.17E-04,1.31E-02,TABI,NA,Decrease,Late,purity_score_500_iter
cellular response to DNA damage stimulus (GO:0006974),781,26,50.49,-,.51,2.89E-04,2.43E-02,TABI,NA,Decrease,Late,purity_score_500_iter
chromosome organization (GO:0051276),1053,35,68.08,-,.51,1.58E-05,3.00E-03,TABI,NA,Decrease,Late,purity_score_500_iter
chromatin organization (GO:0006325),694,23,44.87,-,.51,5.90E-04,3.92E-02,TABI,NA,Decrease,Late,purity_score_500_iter
mRNA metabolic process (GO:0016071),696,23,45.00,-,.51,5.96E-04,3.94E-02,TABI,NA,Decrease,Late,purity_score_500_iter
DNA metabolic process (GO:0006259),749,24,48.42,-,.50,2.14E-04,1.94E-02,TABI,NA,Decrease,Late,purity_score_500_iter
RNA processing (GO:0006396),874,26,56.50,-,.46,1.20E-05,2.49E-03,TABI,NA,Decrease,Late,purity_score_500_iter
ncRNA metabolic process (GO:0034660),476,13,30.77,-,.42,7.25E-04,4.50E-02,TABI,NA,Decrease,Late,purity_score_500_iter
DNA repair (GO:0006281),513,14,33.17,-,.42,4.05E-04,3.08E-02,TABI,NA,Decrease,Late,purity_score_500_iter
immune response-activating cell surface receptor signaling pathway (GO:0002429),448,12,28.96,-,.41,7.35E-04,4.51E-02,TABI,NA,Decrease,Late,purity_score_500_iter
immune response-regulating cell surface receptor signaling pathway (GO:0002768),483,12,31.23,-,.38,1.84E-04,1.81E-02,TABI,NA,Decrease,Late,purity_score_500_iter
detection of stimulus (GO:0051606),698,17,45.13,-,.38,3.33E-06,1.00E-03,TABI,NA,Decrease,Late,purity_score_500_iter
ncRNA processing (GO:0034470),384,9,24.83,-,.36,5.86E-04,3.93E-02,TABI,NA,Decrease,Late,purity_score_500_iter
peptidyl-lysine modification (GO:0018205),306,6,19.78,-,.30,7.28E-04,4.49E-02,TABI,NA,Decrease,Late,purity_score_500_iter
ribonucleoprotein complex biogenesis (GO:0022613),423,8,27.35,-,.29,3.75E-05,5.79E-03,TABI,NA,Decrease,Late,purity_score_500_iter
sensory perception of chemical stimulus (GO:0007606),541,9,34.98,-,.26,4.74E-07,1.80E-04,TABI,NA,Decrease,Late,purity_score_500_iter
detection of stimulus involved in sensory perception (GO:0050906),549,8,35.49,-,.23,7.65E-08,3.93E-05,TABI,NA,Decrease,Late,purity_score_500_iter
"mRNA splicing, via spliceosome (GO:0000398)",299,4,19.33,-,.21,8.09E-05,1.03E-02,TABI,NA,Decrease,Late,purity_score_500_iter
"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",299,4,19.33,-,.21,8.09E-05,1.02E-02,TABI,NA,Decrease,Late,purity_score_500_iter
"RNA splicing, via transesterification reactions (GO:0000375)",302,4,19.52,-,.20,5.64E-05,8.17E-03,TABI,NA,Decrease,Late,purity_score_500_iter
"regulation of gene expression, epigenetic (GO:0040029)",249,3,16.10,-,.19,2.61E-04,2.27E-02,TABI,NA,Decrease,Late,purity_score_500_iter
detection of chemical stimulus (GO:0009593),525,6,33.94,-,.18,1.17E-08,9.34E-06,TABI,NA,Decrease,Late,purity_score_500_iter
meiotic cell cycle (GO:0051321),223,2,14.42,-,.14,1.92E-04,1.84E-02,TABI,NA,Decrease,Late,purity_score_500_iter
sensory perception of smell (GO:0007608),468,4,30.26,-,.13,7.95E-09,6.67E-06,TABI,NA,Decrease,Late,purity_score_500_iter
gene silencing (GO:0016458),168,1,10.86,-,.09,5.28E-04,3.69E-02,TABI,NA,Decrease,Late,purity_score_500_iter
detection of chemical stimulus involved in sensory perception (GO:0050907),488,2,31.55,-,.06,3.90E-11,7.77E-08,TABI,NA,Decrease,Late,purity_score_500_iter
detection of chemical stimulus involved in sensory perception of smell (GO:0050911),439,1,28.38,-,.04,4.94E-11,8.75E-08,TABI,NA,Decrease,Late,purity_score_500_iter
meiotic nuclear division (GO:0140013),156,0,10.09,-, < 0.01,1.25E-04,1.36E-02,TABI,NA,Decrease,Late,purity_score_500_iter
skeletal muscle thin filament assembly (GO:0030240),9,5,.23,+,21.65,1.60E-05,8.77E-03,TABI,NA,Increase,Late,purity_score_500_iter
skeletal myofibril assembly (GO:0014866),11,5,.28,+,17.72,3.34E-05,1.77E-02,TABI,NA,Increase,Late,purity_score_500_iter
actin-myosin filament sliding (GO:0033275),38,15,.98,+,15.38,2.02E-12,3.21E-08,TABI,NA,Increase,Late,purity_score_500_iter
muscle filament sliding (GO:0030049),38,15,.98,+,15.38,2.02E-12,1.61E-08,TABI,NA,Increase,Late,purity_score_500_iter
skeletal muscle contraction (GO:0003009),32,9,.82,+,10.96,6.16E-07,7.01E-04,TABI,NA,Increase,Late,purity_score_500_iter
sarcomere organization (GO:0045214),40,10,1.03,+,9.74,3.69E-07,4.90E-04,TABI,NA,Increase,Late,purity_score_500_iter
myofibril assembly (GO:0030239),61,14,1.57,+,8.94,4.39E-09,1.17E-05,TABI,NA,Increase,Late,purity_score_500_iter
muscle fiber development (GO:0048747),56,11,1.44,+,7.66,7.85E-07,7.81E-04,TABI,NA,Increase,Late,purity_score_500_iter
musculoskeletal movement (GO:0050881),46,9,1.18,+,7.63,8.19E-06,5.67E-03,TABI,NA,Increase,Late,purity_score_500_iter
multicellular organismal movement (GO:0050879),46,9,1.18,+,7.63,8.19E-06,5.44E-03,TABI,NA,Increase,Late,purity_score_500_iter
actin-mediated cell contraction (GO:0070252),90,15,2.31,+,6.50,5.44E-08,8.66E-05,TABI,NA,Increase,Late,purity_score_500_iter
cardiac muscle tissue morphogenesis (GO:0055008),64,10,1.64,+,6.09,1.51E-05,8.58E-03,TABI,NA,Increase,Late,purity_score_500_iter
striated muscle contraction (GO:0006941),113,17,2.90,+,5.86,2.74E-08,5.46E-05,TABI,NA,Increase,Late,purity_score_500_iter
cilium movement (GO:0003341),63,9,1.62,+,5.57,7.53E-05,3.53E-02,TABI,NA,Increase,Late,purity_score_500_iter
cellular component assembly involved in morphogenesis (GO:0010927),101,14,2.59,+,5.40,1.12E-06,9.88E-04,TABI,NA,Increase,Late,purity_score_500_iter
actomyosin structure organization (GO:0031032),110,15,2.82,+,5.31,5.60E-07,6.86E-04,TABI,NA,Increase,Late,purity_score_500_iter
actin filament-based movement (GO:0030048),112,15,2.87,+,5.22,6.88E-07,7.31E-04,TABI,NA,Increase,Late,purity_score_500_iter
muscle tissue morphogenesis (GO:0060415),75,10,1.92,+,5.20,5.14E-05,2.56E-02,TABI,NA,Increase,Late,purity_score_500_iter
muscle cell development (GO:0055001),146,19,3.75,+,5.07,3.46E-08,6.13E-05,TABI,NA,Increase,Late,purity_score_500_iter
striated muscle cell development (GO:0055002),133,17,3.41,+,4.98,2.29E-07,3.32E-04,TABI,NA,Increase,Late,purity_score_500_iter
muscle organ morphogenesis (GO:0048644),82,10,2.10,+,4.75,1.01E-04,4.61E-02,TABI,NA,Increase,Late,purity_score_500_iter
muscle contraction (GO:0006936),247,30,6.34,+,4.73,1.78E-11,9.45E-08,TABI,NA,Increase,Late,purity_score_500_iter
muscle system process (GO:0003012),295,32,7.57,+,4.23,5.46E-11,2.18E-07,TABI,NA,Increase,Late,purity_score_500_iter
muscle organ development (GO:0007517),294,29,7.54,+,3.84,3.27E-09,1.04E-05,TABI,NA,Increase,Late,purity_score_500_iter
striated muscle cell differentiation (GO:0051146),204,20,5.23,+,3.82,9.95E-07,9.32E-04,TABI,NA,Increase,Late,purity_score_500_iter
muscle cell differentiation (GO:0042692),247,22,6.34,+,3.47,1.28E-06,1.07E-03,TABI,NA,Increase,Late,purity_score_500_iter
striated muscle tissue development (GO:0014706),285,23,7.31,+,3.15,3.47E-06,2.76E-03,TABI,NA,Increase,Late,purity_score_500_iter
muscle structure development (GO:0061061),481,37,12.34,+,3.00,1.22E-08,2.77E-05,TABI,NA,Increase,Late,purity_score_500_iter
muscle tissue development (GO:0060537),299,23,7.67,+,3.00,7.24E-06,5.24E-03,TABI,NA,Increase,Late,purity_score_500_iter
adaptive immune response (GO:0002250),613,36,15.73,+,2.29,8.95E-06,5.71E-03,TABI,NA,Increase,Late,purity_score_500_iter
nitrogen compound transport (GO:0071705),1859,23,47.70,-,.48,7.27E-05,3.51E-02,TABI,NA,Increase,Late,purity_score_500_iter
establishment of protein localization (GO:0045184),1617,18,41.49,-,.43,4.72E-05,2.43E-02,TABI,NA,Increase,Late,purity_score_500_iter
amide transport (GO:0042886),1589,16,40.77,-,.39,1.28E-05,7.85E-03,TABI,NA,Increase,Late,purity_score_500_iter
protein transport (GO:0015031),1525,15,39.13,-,.38,1.30E-05,7.67E-03,TABI,NA,Increase,Late,purity_score_500_iter
peptide transport (GO:0015833),1555,15,39.90,-,.38,7.17E-06,5.44E-03,TABI,NA,Increase,Late,purity_score_500_iter
